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ABSTRACT 
Dementia is a neurocognitive disorder that negatively affects independence and 
significantly contributes to the global mortality rate. Alzheimer’s disease is the most 
pervasive type of dementia and is the sixth leading overall cause of mortality in the United 
States. Although the exact etiologies of Alzheimer’s disease and related dementias (ADRD) 
are not fully understood, research suggests that it may stem from genetic and environmental 
factors. There is currently is no cure for ADRD, thus, it would behoove the public health 
field to identify factors associated with brain health and cognitive performance so that 
individuals could modify their lifestyles across their life spans in an effort to strengthen 
cognitive reserves. As such, the current study focused on identifying life span 
biopsychosocial factors protective against cognitive decline and dementia. Specifically, this 
study used longitudinal data from the Kuakini Honolulu-Asia Aging Study (HAAS) to test 
three research aims. The HAAS provides biological and psychosocial data on 8,006 men of 
Japanese descent across 12 exams spanning from Exam 1 (1965-1968; Mage = 54.40, Rangeage 
= 45-68) to Exam 12 (2011-2012; Mage =  93.50, Rangeage =  91-106). Aim 1 employed 
growth curve models to examine biopsychosocial associates of cognitive performance over 
time [level and slope (changes across Exams 4-6)]. Results suggest that education was 
consistently and positively associated with baseline cognition as well the slope. There were 
several cognitive risk factors, indicating that older participants, those who had an APOE-ԑ4 
allele, men with greater levels of inflammatory associates (e.g., uric acid, glucose), and those 
who reported more depressive symptoms at baseline tended to have poorer cognitive 
performance at baseline along with steeper declines in cognition over time. Aim 2 examined 
how patterns of cognitive performance were associated with age at ADRD diagnosis through 
xv 
survival analyses. Findings indicated that men who had the greatest declines in cognition 
tended to be at greater risk for ADRD at a younger age than those with less severe cognitive 
declines. Aim 3 employed bootstrapping methods to determine if level and change in 
cognitive abilities mediated the relationship between biopsychosocial factors and ADRD. 
Results demonstrated that education was positively associated with cognition, whereas age, 
associates of inflammation, presence of an APOE-ԑ4 allele, and depressive symptoms were 
negatively related with cognition, both baseline performance and slope. There was no support 
for mediation by cognition nor were there significant direct relationships between 
biopsychosocial factors and ADRD. Discussion focuses on practical implications of findings, 
including noting methods individuals could engage in to strengthen reserves in an effort to 
maximize cognitive health in later life, as well as offering future directions for research. 
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CHAPTER 1.    INTRODUCTION 
Dementia is a neurocognitive disorder that negatively impacts independence and 
significantly contributes to the global mortality rate. Alzheimer’s disease, the most pervasive 
type of dementia, is ranked as the sixth leading overall cause of mortality in the U.S. after 
“heart disease, cancer, unintentional injuries, chronic lower respiratory disease, and stroke” 
(Xu et al., 2018, p. 1). Prevalence of Alzheimer’s disease and related dementias (ADRD) 
increases over the life span; for instance, 3% of Americans between 65-74 years of age have 
ADRD whereas 17% of individuals 75-84 years old have ADRD (Alzheimer’s Association, 
2017).  
Behavioral cues linked to the cognitive changes associated with ADRD emerge 
decades prior to formal diagnosis (Weintraub, Wicklund, & Salmon, 2012). For example, 
individuals can experience difficulties or changes with their memory, judgment, and 
reasoning, which may be precursors for behavioral problems in completing everyday 
activities (e.g., managing finances, making purchases and meals; Alzheimer’s Association, 
2016). Changes in cognition across the life span are linked to neurodegeneration and are 
antecedents for ADRD (Ferreira et al., 2017). As such, it may be helpful to assess trajectories 
of cognitive functioning in an effort to identify anomalies in performance. For example, 
within person (i.e., intra-individual) changes in cognition vary across the life span and by 
cognitive dimension such that crystallized abilities (culture and semantic-based abilities; e.g., 
language abilities, long-term memory) tend to be maintained in later life whereas fluid 
abilities (basic processing; e.g., short-term memory, attention) peak earlier in life, and 
decline in older adulthood (Baltes, 1987; Salthouse, 2004; Staudinger, Cornelius, & Baltes, 
1989).  
2 
In an effort to protect against cognitive decline, it may be helpful to identify 
biopsychosocial factors (e.g., diet, social support, physical activity) individuals could build 
and strengthen across their lives that may be advantageous to later life cognitive health (e.g., 
de Frias & Dixon, 2013; Giles, D’Anci, & Kanarek, 2015; Stern, 2012). For example, diets 
including a greater consumption of saturated fats and refined sugars are linked to numerous 
health ailments and poorer cognition, whereas diets with a higher intake of plant-based foods, 
moderate levels of seafood, and lower consumption of saturated fats and dairy products are 
associated with better cognition and slowing cognitive decline (e.g., Martinez-Lapiscina et 
al., 2013; Spencer, Korosi, Layé, Shukitt-Hale, & Barrientos, 2017). Additionally, aspects of 
social support may be protective against cognitive decline. For instance, individuals who 
reported higher levels of social support tended to demonstrate better cognitive performance 
over time (Seeman, Lusignolo, Albert, & Berkman, 2001) and self-reported health (White, 
Philogene, Fine, & Sinha, 2009). Furthermore, higher levels of physical activity are 
associated with greater cognitive health and may buffer against ADRD (Kramer & Erickson, 
2007). Thus, engaging in diverse biopsychosocial activities advantageous to cognitive health 
across the life span can help to build reserves that may be protective against cognitive decline 
and ADRD in later life.  
As such, the current study investigated the relationship between biopsychosocial 
factors and ADRD through the role of cognitive abilities in a longitudinal manner. A 
conceptual model is illustrated in Figure 1 and depicts how patterns of change in cognitive 
factors (e.g., crystallized and fluid abilities) are believed to mediate the relationship between 
biopsychosocial variables and ADRD. The current study utilized data from the Honolulu-
Asia Aging Study to test the following research aims: (1) determine the relationship between 
3 
biopsychosocial factors and changes in cognitive abilities; (2) investigate the association of 
patterns of change in cognitive abilities and ADRD; and (3) establish the overall relationship 
between biopsychosocial factors and ADRD via testing for mediation by cognitive abilities. 
Each of the research aims were evaluated through quantitative methods. 
 
Figure 1. Conceptual model. ADRD=Alzheimer’s disease and related dementias. 
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CHAPTER 2.    BACKGROUND AND SIGNIFICANCE 
ADRD is a grand challenge that greatly contributes to national medical costs and 
global mortality rate. By 2025, Medicare expenses for Alzheimer’s disease alone will reach 
$300 billion in the U.S. (Steinerman & Lipton, 2012). Although there are variations in the 
exact classification of types and symptoms of dementia [e.g., Diagnostic and Statistical 
Manual (DSM); International Statistical Classification of Diseases and Related Health 
Problems], it is characterized by cognitive decline severe enough to interfere with daily life 
(American Psychiatric Association, 2013; Ballard & Bannister, 2010; World Health 
Organization, 1992). Each dementia typology (e.g., Alzheimer’s disease, mixed dementia, 
and dementia with Lewy bodies) can vary in etiology and disease progression (Alzheimer’s 
Association, 2007). Alzheimer’s disease development, for example, is thought to have four 
progressive stages: (1) no cognitive impairment, (2) no cognitive impairment with biological 
evidence of Alzheimer’s disease, (3) mild cognitive impairment, and (4) Alzheimer’s disease 
dementia (Steinerman & Lipton, 2012). This progression encompasses behavioral (functional 
abilities) and neurological (biochemical biomarkers, structural changes in brain) components 
(Steinerman & Lipton).  
The national prevalence of ADRD is greatest among individuals above 60 years of 
age (Alzheimer’s Association, 2007, 2016). While the exact etiology of ADRD is not fully 
understood, research suggests that it may stem from genetic and environmental factors 
(Ballesteros, Kraft, Santana, & Tziraki, 2015; Cassarino & Setti, 2015; Tucker-Drob, Briley, 
& Harden, 2014). For instance, the likelihood of Alzheimer’s disease increases with the 
presence of the Apolipoprotein E (APOE) ԑ-4 allele (e.g., Corder et al., 1993; Kim, Basak, & 
Holtzman, 2009; Loy, Schofield, Turner, & Kwok, 2014) and TREM2 (Jonsson et al., 2013; 
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Lill et al., 2015) genes, whereas risk for frontotemporal dementia increases with the presence 
of the MAPT (Gerrish et al., 2012; Sassi et al., 2014) and GRN (Rademakers et al., 2008; 
Sassi et al., 2014) genes. 
As such, dementia is not a part of normal cognitive aging (Alzheimer’s Association, 
2007). In the following sections of this chapter, I describe cognitive aging literature with an 
emphasis on two classes of cognitive abilities, provide the theoretical framework of the 
current study, describe extant literature on biopsychosocial factors and cognition, and 
conclude with the research aims of the study.   
Cognitive Aging: An Emphasis on Crystallized and Fluid Abilities 
Research on age-associated changes in cognition indicate that cognitive performance 
varies by cognitive dimension or ability (Anstey & Christensen, 2000; Christensen, 2001). 
These abilities are often categorized into crystallized pragmatics or dimensions and fluid 
mechanics or dimensions (Baltes, 1987; Staudinger, Cornelius, & Baltes, 1989). Crystallized 
pragmatics reflect culture-based dimensions of intelligence (e.g., language, professional, and 
life skills) whereas fluid mechanics include basic processing of sensory information and 
visual memory (Baltes, 1993).  
Cross-sectional research reveals that older adults perform well on crystallized 
dimensions of cognition (e.g., language abilities, long-term memory) whereas younger adults 
tend to exhibit better performance in fluid abilities (e.g., short-term memory, attention; 
Hartshorne & Germine, 2015; Salthouse, 2004). For instance, cross-sectional studies 
demonstrate that aging affects fluid dimensions of short-term memory (storing mental 
information for a brief period, such as remembering phone numbers) and working memory 
(processing or manipulating information, such as mental math; Verhaeghen & Cerella, 2008). 
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There are steeper age-related declines in working memory compared to short-term memory 
among older adults, which indicates that tasks requiring the processing of information are 
susceptible to age-related effects more than tasks that simply require the storage of 
information (Park et al., 2002). These declines in performance translate to slower response 
times for older adults (Cahana-Amitay et al., 2016). 
Longitudinal studies demonstrate that crystallized dimensions, which are experience 
and culture-based, are often built across life and maintained in older adulthood whereas fluid 
dimensions tend to peak early in life and decline in late life (Schaie, 1994). These age-related 
declines are due to several factors, including decreased processing speed (Salthouse, 2004) 
and limited cognitive resources (Craik & Byrd, 1982; Park & Festini, 2017). Findings hold 
true for centenarians across cultures. For instance, Hagberg, Alfredson, Poon, and Homma 
(2001) assessed the cognitive performance of centenarians from Sweden, Japan, and the U.S. 
and demonstrated that centenarians had better performance on crystallized intelligence tasks 
compared to fluid intelligence tasks. The researchers also noted that the centenarians had 
poorer overall cognitive performance and greater intra-individual fluctuations in performance 
than octogenarians in their study.  
Cognitive aging and developmental researchers use the term variability to describe 
intra-individual changes that reflect fluctuations and stability in performance over time 
(Hultsch & MacDonald, 2004; Nesselroade, 1991). Extant research demonstrates that greater 
levels of intra-individual cognitive variability (i.e., within person fluctuations in performance 
over time) may be a precursor for ADRD (Bielak, Hultsch, Strauss, MacDonald, & Hunter, 
2010; Christensen, 2001; Gorus, Raedt, Lambert, Lemper, & Mets, 2008; Hultsch, 
MacDonald, Hunter, Levy-Bencheton, & Strauss, 2000). For example, levels of intra-
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individual cognitive task variability measuring fluid performance (e.g., reaction time and 
episodic memory) were greater for a group of adults with mild dementia compared to a group 
of healthy adults and a group of adults with arthritis (Hultsch, MacDonald, Hunter, Levy-
Bencheton, & Strauss, 2000). As such, researchers including Hultsch et al. suggested that 
intra-individual cognitive performance variability could be used as an indicator of non-
normative cognitive aging. 
Although there is evidence for distinct cognitive abilities, as well as how these 
abilities tend to change over time (e.g., fluid abilities peak in early life whereas crystallized 
abilities are built across the life and tend to be maintained in later life), there is also support 
for the dedifferentiation hypothesis of cognitive aging. This framework posits that cognitive 
abilities coalesce in late life such that there are increases in the age-related associations of 
cognitive abilities in older adulthood (Baltes, Cornelius, Spiro, Nesselroade, & Willis, 1980; 
de Frias, Lovden, Lindenberger, & Nilsson, 2007; Hülür, Ram, Willis, Schaie, & Gerstof, 
2015; Tucker-Drob, 2009; Wilson, Segawa, Hizel, & Bennett, 2012). For example, Hülür et 
al., used data from the Seattle Longitudinal Study to test the dedifferentiation hypothesis 
using three cognitive abilities (e.g., fluid, crystallized, and visualization). Data came from 
419 deceased adults who had at least four time points of data for each cognitive ability. The 
average participant age at Time 1 was 48.50 years and the average age at death was 84.52 
years. Hülür et al. used an intra-individual change approach, worked backwards from time of 
death, and found support for the dedifferentiation hypothesis of cognitive aging. Specifically, 
as participants got older and closer to death, there was coupling between fluid and 
crystallized abilities as well as among visualization abilities with both fluid and crystallized 
abilities.  
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However, literature is equivocal and some findings do not support the 
dedifferentiation hypothesis (e.g., Anstey, Hofer, & Luszcz, 2003; Batterham, Christensen, & 
Mackinnon, 2011; Finkel, Reynolds, McArdle, & Pedersen, 2007; Zelinski & Lewis, 2003). 
La Fleur, Meyer, and Dodson (2018) were interested in exploring inconsistences in extant 
literature and tested this hypothesis using data from 11 cognitive batteries that assessed 
domains representative of crystallized (e.g., general knowledge) and fluid abilities (e.g., 
mental transformation, processing speed). Findings from La Fleur et al. supported the 
dedifferentiation hypothesis of cognitive aging of these abilities.  
Theoretical Framework  
In this subsection, I describe the biopsychosocial and life span theoretical frameworks 
used in the current study.  
Researchers using the biopsychosocial framework posit that it is vital to integrate 
biological (e.g., genetic, biochemical), psychological (e.g., cognitive, perceptual, emotional, 
personality), and sociocultural (e.g., familial, societal, cultural, socioeconomic) forces when 
examining aspects of health (Engel, 1980; Kail & Cavanaugh, 2010). This approach was 
developed in response to the biomedical model, which “assumes disease to be fully 
accounted for by deviations from the norm or measurable biological (somatic) variables. The 
biomedical model leaves no room within its framework for the social, psychological, and 
behavioral dimensions of illness” (Engel, 1980, p.130). As such, researchers using the 
biopsychosocial perspective note that it is important to incorporate aspects beyond the 
biomedical model when assessing determinants of health and well-being. For example, 
Vance, Wadley, Ball, Roenker, and Rizzo (2005) used structural equation modeling 
techniques to examine the relationship between biopsychosocial factors (e.g., physical 
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activity, social network, depressive symptoms) and cognition among older adults and found 
support for direct and indirect relationships (i.e., mediation) among variables in the model. 
More specifically, Vance et al. demonstrated that physical activity, sedentary behaviors, and 
depressive symptoms were directly related to cognition whereas factors such as social 
networks were indirectly related to cognition.    
Life span scholars place great emphasis on assessing intra-individual changes over 
time and exploring inter-individual commonalities and differences in development (Baltes, 
1987; Baltes, Staudinger, & Lindenberger, 1999). This approach also posits that capacity is 
not entirely fixed, such that skills may be learned, refined, and improved over time and that 
there are both gains and losses (e.g., growth and decline) across the life span; gains tend to 
occur in early life and losses are common in later life (Baltes, 1987; Baltes et al., 1999). 
Researchers have employed this paradigm to assess life span changes in cognition (Craik & 
Bialystok, 2006; Li & Baltes, 2006; Schaie, 1994). Schaie (1994; Schaie & Willis, 2010), for 
instance, used this approach to collect and examine three decades worth of intra-individual 
changes and inter-individual differences in cognition in the Seattle Longitudinal Study. They 
demonstrated how longitudinal performance in domains reflective of crystallized abilities 
(e.g., verbal and reasoning) do not decline as quickly as domains reflecting fluid abilities 
(e.g., word fluency).   
Biopsychosocial Factors and Cognition 
Below I highlight research examining the relationship between cognition and 
biopsychosocial variables used in the current study. This section is organized by 
sociodemographic variables, biological factors, and psychosocial factors.  
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Sociodemographic factors  
Sociodemographic factors such as age (Salthouse, 1994), marital status (Bourassa, 
Memel, Woolverton, & Sbarra, 2015), and education (Stern, 2012) are used in the current 
study and are associated with cognition.  
Age.  Research demonstrates that older adults tend to have poorer performance on 
cognitive tasks reflective of fluid abilities that assess basic processing and speed (e.g., 
memory and attention; Murman, 2015). On the other hand, older adults tend to perform better 
on measures of crystallized abilities, which are culture and semantic-based (e.g., language, 
tests of knowledge; Glisky, 2007; Murman, 2015). For example, Verhaeghen and Salthouse 
(1997) performed a meta-analysis to assess the relationship between age and cognition. The 
researchers were particularly interested in fluid ability processes and focused on studies 
pertaining to processing speed, memory, and reasoning. Verhaeghen and Salthouse included 
91 studies in their analysis and found that older age was associated with poorer fluid 
cognition. Verhaeghen and Salthouse compared age groups, finding that the most 
pronounced declines in processing speed and reasoning occurred for individuals over 50 
years old. Possible explanations for the negative relationship between age and cognition may 
be due to reductions in attentional resources that become more pronounced as individuals get 
older (Glisky, 2007).  
Although there are normative age-related changes in cognition, it is important to note 
that there are inter-individual differences in performance; as such, it is possible for 
individuals to maintain and improve their cognition, as well as experience declines in 
cognition (Glisky, 2007).  
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Marital status. Research indicates that being married is associated with 
psychological and physical well-being (Bourassa, Memel, Woolverton, & Sbarra, 2015). 
Having a spouse is associated with greater levels of cognition (Elovainio et al., 2017; 
Fincham, 1994; Mousavi-Nasab, Kormi-Nouri, Sundström, & Nilsson, 2012) and is 
considered protective against dementia (Fan et al., 2015) for a variety of reasons, including 
facilitation of communication, engagement, and cognitive-stimulation (Mousavi-Nasab et 
al.).  
Elovainio et al. (2017) explored the relationship between social relations, including 
marital status, and cognitive performance trajectories spanning more than 20 years using data 
from the Whitehall II study, which is a longitudinal study in London. Participants included 
6,072 older adults who were 35 to 55 years old (Mage= 61.40) at the baseline examination, 
which occurred between 1985 to 1988. Social aspects and marital status were assessed in 
1985 and 1989. Cognition was measured at five time points (1991, 1997, 2003, 2007, and 
2012). Through growth curve and latent class analyses, Elovainio et al. identified three 
groups of low, intermediate, and high cognitive performance. They then assessed how social 
aspects and marital status were associated with these cognitive performance groups and 
demonstrated that married individuals had a greater likelihood of being in the high cognitive 
performance trajectory group than the other groups.  
Others, including Mousavi‐Nasab et al. (2012) examined how marital status was 
associated with specific cognitive domains. Participants included 1,882 Swedish adults from 
the Betula study (a longitudinal study spanning more than two decades focused on cognitive 
aging). Episodic memory (recall tasks, i.e., fluid abilities) and semantic memory (tasks 
assessing knowledge, i.e., crystallized abilities) were measured at two time points, with a 
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five-year span between the assessments. Mousavi‐Nasab et al. found that married participants 
demonstrated greater performance in both episodic and semantic memory than those who 
were single. They indicated that the episodic memory declines over time were significantly 
greater for participants who were single or widowed compared to persons who were married.  
Education. Education is associated with cognitive performance and is considered one 
of the greatest buffers against dementia (Davey et al., 2010; Schmand, Smit, Geerlings, & 
Lindeboom, 1997; Stern, 2012; Tucker & Stern, 2011; Vallesi, 2016). A systematic review 
spanning 25 years of literature on the association between education and dementia noted that 
lower levels of education were associated with greater likelihood of dementia (Sharp & Gatz, 
2011). 
The beneficial effect of education on cognitive health may be explained by the 
cognitive reserve hypothesis. The cognitive reserve hypothesis posits that individuals with 
higher levels of education who live engaged lifestyles tend to have greater levels of cognition 
and may be able to tolerate dementia pathology better than those who do not; thus, they tend 
to have a reduced risk for dementia and less severe declines in cognition (Scarmeas & Stern, 
2004).  
This hypothesis was supported by a meta-analysis investigating the relationship 
between education and dementia using 133 articles assessing dementia prevalence and 
incidence spanning from 1980 to 2011 (Meng & D’Arcy, 2012). Meng and D’Arcy found 
that those who had lower levels of education consistently had a greater likelihood of 
dementia. Specifically, the pooled odds ratio (OR) was 2.61 for studies that examined 
dementia prevalence and the OR was 1.88 for studies investigating dementia incidence. 
There was further support for the cognitive reserve hypothesis as Meng and D’Arcy 
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elucidated that although participants with higher levels of education tended to have more 
structural brain damage, this pathology was not associated with poorer levels of cognition.  
Biological factors 
Biological factors employed in the current study, including APOE (Loy et al., 2014), 
inflammation (Suzuki et al., 2016), diet (Loef & Walach, 2013), body mass index (García-
Ptacek, Faxén-Irving, Čermáková, Eriksdotter, & Religa, 2014), hypertension (Aronow, 
2017), physical activity (Muiños and Ballesteros, 2018), and daytime sleepiness (Waller et 
al., 2016) are associated with cognition and ADRD.  
APOE. APOE is a protein involved with the transport and metabolism of lipoproteins 
(Loy et al., 2014). APOE is a primary genetic factor known to affect ADRD and it has three 
allelic forms, including ԑ2, ԑ3, and ԑ4; humans have one pair of APOE, which is a 
combination of two alleles (e.g., ԑ2/ԑ2, ԑ2/ԑ3, ԑ2/ԑ4, ԑ3/ԑ3, ԑ3/ԑ4, and ԑ4/ԑ4; Loy et al.).  
The ԑ2 allele is a protective factor that may buffer against cognitive impairment (e.g., 
Qiu, Kivipelto, Auero-Torres, Winbald, & Fratiglioni, 2004; Small, Basun, & Bäckman, 
1998). The ԑ4 allele is a risk factor for ADRD; the presence of one ԑ4 allele (i.e., 
heterozygous presence of ԑ4) is associated with a doubled likelihood of ADRD development 
whereas the presence of two ԑ4 alleles (i.e., homozygous presence of ԑ4) is associated with a 
five times greater likelihood of developing ADRD (e.g., Craft et al., 1998; Deary et al., 2002; 
Feskens et al., 1994; Haan, Shemanski, Jagust, Manolio, & Kuller, 1999; Hofer et al., 2002; 
Hyman et al., 1996; Jonker, Schmand, Lindeboom, Havekes, & Launer, 1998; Smith, 2000; 
Yaffe, Cauley, Sands, & Browner, 1997).  
Rawle et al. (2018) examined the association between presence of APOE-ԑ4 and 
changes in cognition using 2,365 participants from the National Survey of Health and 
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Development, which is a longitudinal study consisting of participants from England, 
Scotland, and Wales. Memory and processing speed (i.e., fluid abilities) were assessed at 
four time points across mid- and late-life (when participants were 43, 53, 60-64, and 69 years 
old). APOE was categorized as no APOE-ԑ4 allele, heterozygous presence of ԑ4, and 
homozygous presence of ԑ4; those with the APOE ԑ2/ԑ4 combination were excluded from 
analyses since each allele has an opposite effect on dementia risk. Using cross-sectional 
analyses, Rawle et al. found that participants who were 69 years old and had homozygous ԑ4 
alleles had the poorest memory performance. Longitudinally, they found that participants 
who had homozygous ԑ4 allele had the steepest declines in memory. There was no support 
for the association between APOE and processing speed.   
Associates of inflammation. Inflammation is an underlying cause of cognitive 
dysfunction (Sanada et al., 2018; Simen, Bordner, Martin, Moy, & Barry, 2011; Trollor et al., 
2012). Multiple factors contribute to inflammation including poor diet (Phinney, 2005), lack 
of exercise (Booth, Roberts, & Laye, 2012), metabolic conditions such as diabetes (Wellen & 
Hotamisligil, 2005), as well as stress (Liu, Wang, & Jiang, 2017). There are a variety of 
biological factors associated with inflammation, including uric acid and glucose.  
Uric acid. Research demonstrates that higher levels of uric acid, an activator that 
promotes inflammation, are linked with poorer levels of cognition among cognitively normal 
older adults (Schretlen et al., 2007; Shao et al., 2016; Suzuki et al., 2016). For example, 
Suzuki et al. used a cross-sectional research design to examine the relationship between 
serum uric acid and risk of ‘cognitive deterioration’ among 228 Japanese adults from Tokyo 
who were an average of 65.45 years old. Suzuki et al., classified an individual as cognitively 
deteriorated if the participant met one of the following three criteria: “(a) Mini-Mental State 
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Examination score <27, (b) Wechsler Memory Scale-Revised Logical Memory story A 
delayed score lower than the cutoffs (education ≥16 years: >11; 10–15 years: >7; 0–9 years: 
>5), and (c) having subjective complaints of forgetfulness and a Clock-Drawing Test score 
<4” (Suzuki et al., p. 582); 64 participants met their criteria for cognitive deterioration. 
Through logistic regressions, they found that individuals who had the highest levels of uric 
acid had the greatest likelihood of having cognitive deterioration. It is important to note that 
Suzuki et al. used the term ‘cognitive deterioration,’ which implies worsening or declining 
over time, however, analyses in their study were cross-sectional; thus, their results should be 
interpreted with caution.   
Alternatively, findings from researchers conducting studies with participants who 
have cognitive impairment demonstrate an inverse relationship: lower levels of uric acid are 
associated with poorer cognition (Euser, Hofman, Westendorp, & Breteler, 2009; Xue et al., 
2017).  Xue et al. investigated the relationship between uric acid and mild cognitive 
impairment (MCI; often the phase between normal cognition and dementia, Xue et al.) 
among 115 older adults from China. There were 58 participants identified with MCI (Mage = 
68.20) and 57 individuals serving as controls without demonstrated MCI (Mage = 68.32). 
Findings from Xue et al. indicated that individuals with lower levels of uric acid were at an 
increased likelihood for MCI. They recommend that slight increases in uric acid may be a 
manner in which individuals could delay MCI and cognitive impairment.   
Glucose. Higher levels of fasting glucose are indicative of diabetes, which is a source 
of inflammation that can lead to cognitive dysfunction (Marseglia et al., 2018). Researchers 
note that higher levels of glucose are associated with poorer levels of cognition among older 
adults (Mortby et al., 2013; Seetharaman, 2016; Yaffe et al., 2009). Marseglia et al., for 
16 
example, examined how diabetes status influenced cognitive trajectories of 793 older adults 
from the Swedish Twin Study. They stratified analyses by diabetes status at baseline (no 
diabetes, yes diabetes, and prediabetes). There were seven waves of data collection spanning 
more than two decades that assessed cognitive domains representative of crystallized and 
fluid abilities, such as verbal abilities, memory, and perceptual speed. Participants were at 
least 50 years old at baseline; those with diabetes (Mage = 67.40) were significantly older than 
those who did not have diabetes (Mage = 63) and participants who had prediabetes (Mage = 
63.40). Marseglia et al. found that those with diabetes exhibited the steepest declines in 
cognition, specifically in the perceptual speed and verbal abilities domains. Though not as 
steep of a decline as participants with diabetes, participants with prediabetes also exhibited 
poorer cognitive performance over time.  
The relationship between activators of inflammation, such as uric acid and glucose, 
and cognition may occur because inflammation affects the physical structure of the brain, 
which leads to brain atrophy (i.e., deterioration of brain tissue) of neuronal regions 
responsible for cognitive processes (Suzuki et al., 2016).  
Dietary fatty acids. Research indicates that certain dietary patterns are protective 
against ADRD (Féart et al., 2009; Loef & Walach, 2013). These dietary patterns are often 
characterized by a high consumption of fresh produce and unsaturated fatty acids, moderate 
intake of alcohol, and low consumption of meat, saturated fatty acids, and dairy (Féart et al., 
2009). Saturated fatty acids (SFA) typically come from animal fats and include meat and 
dairy products; a meta-analysis indicated that diets reflective of greater consumption of SFA 
were positively associated with increased risk for ADRD (Ruan, Tang, Guo, Li, & Li, 2018).  
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There are two types of unsaturated fatty acids, including monounsaturated fatty acids 
(MUFA) and polyunsaturated fatty acids (PUFA); the primary biochemical difference 
between the two is that there is a single double bond in the molecular structure of MUFA 
(Smith & Blumenthal, 2016). Cooking oils are a prominent source of MUFA. Omega-3 and 
omega-6 are exemplars of PUFA. Omega-3s are primarily derived from marine-based 
sources including fatty fish, whereas omega-6s typically come from plant-based sources such 
as nuts and legumes (Smith & Blumenthal). Diets with higher intakes of unsaturated fatty 
acids tend to be associated with greater cognition and may be protective against ADRD (Cao 
et al., 2015; Eskelinen et al., 2008). For example, a meta-analysis of 43 cohort studies 
indicated that diets high in unsaturated fatty acids were associated with a decreased risk of 
dementia (Cao et al.) and the consumption of omega-3 polyunsaturated fatty acids was 
supportive of fluid abilities (Zamroziewicz, Paul, Zwilling, & Barbey, 2018).  
Eskelinen et al. (2008) investigated the relationship between diet and later life 
cognition using 1,449 participants from the Cardiovascular Risk Factors Aging and Dementia 
(CAIDE) study based in Finland. Diet was assessed at midlife, which depending on the 
participant was in 1972, 1977, 1982, or 1987; later life cognition was assessed in 1998. The 
mean age at midlife was 50.20 years and the average age at the follow-up exam was 71.10 
years. Findings demonstrated that participants with greater consumption of PUFA tended to 
have greater levels of later life cognition. Eskelinen et al. indicated that higher levels of SFA 
consumption at midlife were related with poorer levels of global cognition and an increased 
risk for MCI in later life.  
These results may have occurred because diets with greater intakes of SFA tend to be 
higher in cholesterol, which influences inflammation (Zhang et al., 2005); this, in turn, has 
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the potential to increase the amount of amyloid beta peptides in the body (e.g., amino acids 
that make ADRD amyloid beta plaques; Oksman et al., 2006). Thus, there tends to be poorer 
cognition and greater risk for ADRD among individuals who have diets high in SFA.   
Body mass index (BMI). BMI is an indicator of obesity, which is linked to numerous 
health conditions (e.g., cardiovascular disease, cancer, type-2 diabetes, hypertension, 
Akinyemiju et al., 2018; Dixon, 2010). BMI is a computed value that divides a person’s 
weight by his/her height. There are recommended guidelines that correspond to different 
BMI ranges; for example, a BMI value less than 18.50 is considered underweight, a BMI 
greater than 18.50 but less than 25 is considered normal/healthy, BMIs between 25 and 30 
fall in the overweight range, and BMIs greater than 30 are categorized in the obese category 
(CDC, 2017). 
Research findings offer a complex view on the relationship between BMI and 
cognition (e.g., Corley, Gow, Starr, & Deary, 2010; García-Ptacek, Faxén-Irving, 
Čermáková, Eriksdotter, & Religa, 2014; Gunstad et al., 2007) and ADRD (Anstey, 
Cherbuin, Budge, & Young, 2011; García-Ptacek et al.). For example, a meta-analysis 
consisting of 16 articles demonstrated there is a parabolic relationship between midlife BMI 
and risk of ADRD development such that persons with BMIs indicative of being underweight 
and overweight at midlife were at increased risk of ADRD (Anstey et al.). Others, including 
García-Ptacek et al. note that higher BMIs in young and middle adulthood were associated 
with poorer cognition and greater risk for ADRD in later life whereas higher BMIs in later 
life were related with better cognition. 
Sabia, Kivimaki, Shipley, Marmot, and Singh-Manoux (2009) assessed the 
relationship between cognition and changes in BMI using 5,131 participants from the 
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Whitehall II Study. BMI values were computed in early adulthood (~25 years of age), early 
midlife (Wave 1; Mage = 44 years) and late midlife/young-old (Wave 7; Mage = 61 years). 
Cognition was measured using the Mini-Mental State Examination (Folstein, Folstein, & 
McHugh, 1975) in late midlife (i.e., Wave 7). Sabia et al. found that participants who had 
consistently underweight BMIs along with those who had long-term obese BMIs had lower 
levels of cognition at Wave 7.  
Others, including Corley et al. (2010) investigated the relationship between BMI and 
specific cognitive abilities. They studied a sample 1,079 adults who were at least 70 years old 
from the Lothian Birth Cohort 1936 study to assess how BMI was associated with verbal 
ability (i.e., crystallized abilities) as well as processing speed and memory (i.e., fluid 
abilities). Study findings revealed a negative relationship between BMI and verbal abilities; 
however, there were no significant associations between BMI and processing speed nor 
memory in this study. 
A “domino effect” of obesity may help to explain an underlying mechanism 
accounting for the association between high BMIs and an increased likelihood of dementia as 
well as poorer cognition. Among many things, obesity is associated with inflammation and as 
noted above, inflammation can influence brain health and neuronal regions responsible for 
cognitive processes (Garcia-Ptacek et al., 2014).  
Hypertension. Blood pressure, which fluctuates on a daily basis as a response to a 
variety of factors (e.g., stress, diet, genetics), measures the amount of force one’s arterial 
walls endure (Walker, Power, & Gottesman, 2017). Blood pressure is measured using 
systolic (e.g., pressure in blood vessel when one’s heart is beating) and diastolic (e.g., 
pressure in blood vessel between heartbeats) values; guidelines for hypertension are diastolic 
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values of 90 and higher and systolic values of 140 and higher (CDC, 2018). Chronic levels of 
high blood pressure (i.e., hypertension) have negative health implications such as hardened 
arteries, which reduce the amount of oxygenated blood flowing throughout the body (CDC, 
2018; Walker et al.).  
Research suggests that hypertension is a risk factor for cognitive impairment 
(Aronow, 2017; Elias, Elias, Sullivan, Wolf, & Agostino, 2003; Yaffe et al., 2009). Elias et 
al. analyzed data from 1,423 participations from the Framingham Heart Study to assess the 
relationship between hypertension, obesity, and cognition. Blood pressure was observed and 
participants were classified as hypertensive if they had a blood pressure greater or equal to 90 
(diastolic) and 140 (systolic). They stratified analyses by sex and found that men who had a 
BMI indicating obesity and demonstrated hypertension had the poorest cognitive 
performance of all participants. 
Others, including Posner et al. (2002) examined the relationship between 
hypertension, dementia typology (e.g., Alzheimer’s disease, vascular dementia), and 
cognitive performance in a sample of 1,259 older adults who were assessed over a seven-year 
span. Their findings indicated that hypertension was not significantly associated with 
Alzheimer’s disease; however, it was associated with greater risk for vascular dementia 
development. Additionally, hypertension was not related to longitudinal changes in cognitive 
functioning.   
There are a variety of underlying mechanisms for the association between 
hypertension and poor cognition, including that hypertension impacts the physical structure 
and function of blood vessels in the brain and can damage brain white matter (i.e., ischemic 
white matter lesions; Iadecola et al., 2016), which is vital to cognitive health.  
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Physical activity. Research indicates that greater levels of physical activity are 
associated with greater cognitive functioning (Abbott et al., 2004; Voss, Nagamatsu, Liu-
Ambrose, & Kramer, 2011). Abbott et al. investigated the relationship between physical 
activity, as assessed via total miles walked daily, and the risk of dementia among 2,257 men 
from the Honolulu-Asia Aging Study who ranged from 71-93 years. Physical activity was 
measured in 1991 and dementia status was assessed in 1994 and 1997. Results demonstrated 
a negative relationship between activity and dementia such that men who walked the least 
distances were at 1.8 times greater risk for dementia development. 
Furthermore, Tolppanen et al. (2015) explored the relationship between physical 
activity and dementia using data from participants of the Cardiovascular Risk Factors, Aging 
and Dementia study based in Finland, which is a longitudinal study spanning more than three 
decades. Participants were an average of 52 years old at the midlife examination and 76 years 
old at the later life examination. Tolppanen et al. found that individuals who reported 
moderate and lower levels of midlife physical activity tended to have a greater risk of 
dementia development in later life. Participants who had greater physical activity in midlife 
demonstrated a reduced likelihood for dementia.  
Moreover, a literature review by Muiños and Ballesteros (2018) exploring physical 
activity and cognition indicated that physical activity may reduce age-related cognitive 
declines in crystallized abilities and total cognition (e.g., memory, attention, perceptual 
speed). There are multiple factors that can help to explain why physical activity is beneficial 
for cognitive health, including the fact that it helps reduce inflammation and regulate glucose 
levels and blood pressure (Aarsland et al., 2010).  
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Sleep. Sleep is an essential component of memory consolidation, learning, and 
cognition (Stickgold, 2005). Persistent sleep loss can lead to excessive daytime sleepiness 
and impact the health of the hippocampus, which is involved with memory and emotion 
processing as well as autonomic nervous system processes in the brain (Meerlo, Mistlberger, 
Jacobs, Heller, & McGinty, 2009). Thus, poor hippocampal health resulting from inadequate 
sleep may lead to excessive daytime sleepiness, which may in turn result in cognitive 
dysfunction.  
Research demonstrates that excessive daytime sleepiness is negatively associated 
with cognition (Foley et al., 2001; Keage et al., 2012; Ohayon & Vecchierini, 2002; Waller et 
al., 2016). Foley et al. used data from the Honolulu-Asia Aging Study to examine the 
relationship between daytime sleepiness, cognition, and dementia. Participants included 
2,346 men who were between 71-93 years old. Baseline self-reports of daytime sleepiness 
along with performance on a cognition measure and dementia diagnosis were collected in the 
year 1991 and again in 1994. Foley et al. demonstrated that men who reported greater levels 
of excessive daytime sleepiness at baseline had a doubled likelihood of dementia at the 
follow-up exam. They noted that men who reported excessive daytime sleepiness had greater 
declines in cognition than those who did not report excessive daytime sleepiness.  
Others including Ohayon and Vecchierini (2002) investigated the association between 
excessive daytime sleepiness and cognitive domains representative of fluid abilities such as 
attention, concentration, and delayed recall. Data came from telephone interviews of 1,026 
participants over the age of 60 in France. Ohayon and Vecchierini found that participants 
who reported greater levels of daytime sleepiness had poorer performance in fluid abilities, 
including attention, recall, and concentration.  
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Psychosocial factors   
Prior research demonstrates an association between psychosocial factors and 
cognitive health. Particularly relevant psychosocial factors included in the current study are 
depressive symptoms (Kaup et al., 2016) and social support (La Fleur & Salthouse, 2016). 
Depressive symptoms. Depressive symptoms are related to cognitive decline and 
ADRD among older adults (Kaup et al., 2016; Mourao, Mansur, Malloy‐Diniz, Castro Costa, 
& Diniz, 2016; Paterniti, Verdier-Taillefer, Dufouil, & Alperovitch, 2002; Wilson et al., 
2012). For example, Paterniti et al. analyzed data from a sample of 1,003 individuals ranging 
in age from 59 to 71 years to examine the relationship between depressive symptoms and 
cognition. The Center for Epidemiologic Study Depression scale (Radloff, 1977) was 
employed to assess depressive symptoms and the Mini-Mental State Examination (Folstein et 
al., 1975) served as the cognitive assessment tool. Paterniti et al. stratified analyses by 
baseline depressive symptomology of high and low. They found that those who had higher 
levels of depressive symptoms tended to have greater declines in cognition over time than 
participants reporting initially lower levels of depressive symptoms.  
Others, including Ganguli, Du, Dodge, Ratcliff, and Chang (2006) assessed the 
relationship between depressive symptoms and cognition using a population-based sample of 
1,265 individuals who were at least 67 years old and did not have dementia at baseline. They 
stratified analyses by dementia status over the 12 years of data collection; there were 171 
adults who developed dementia (Mage = 77.70) and 1,094 who remained free of dementia 
(Mage = 74.10). Ganguli et al. found that greater levels of depressive symptoms at baseline 
were associated with poorer cognition at baseline for all participants. However, the results 
indicated that depressive symptoms were not significantly associated with longitudinal 
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changes in cognition, regardless of dementia status. Ganguli et al. noted that the lack of 
significant associates in their longitudinal analyses might be due to survivor bias that could 
have occurred in the population-based sample used in their study.   
The general negative relationship between depressive symptoms and cognition may 
be due to a variety of factors. For instance, individuals with greater levels of depressive 
symptoms might have pre-clinical symptoms of major depressive disorder such as difficulty 
in concentrating and lethargy (National Institute of Mental Health, 2019), which may impact 
their ability or interest in completing cognitive tasks that require attention, encoding, and 
processing of information (Joormann & Gotlib, 2010). 
Social support. Social support and engagement are positively associated with 
cognition (Amieva et al., 2010; La Fleur & Salthouse, 2009; Saczynski et al., 2006). A 
systematic review of longitudinal studies focused on social engagement and dementia 
indicated, “an active and socially integrated lifestyle in late life protects against dementia” 
(Fratiglioni, Paillard-Borg, & Winblad, 2004, p. 343).  
Results from a study conducted by Saczynski et al. (2006) assessing how midlife and 
late-life social engagement were related to risk for dementia development for men 
participating in the Honolulu-Asia Aging Study were consistent with the systematic review 
conducted by Fratiglioni et al. (2004). Specifically, Saczynski et al. measured social 
engagement using an index comprised of items measuring marital status, living 
arrangements, participation in groups (e.g., social, political, or community) and social events, 
as well as the existence of friendships from 2,513 men at midlife (assessed in 1968) and late 
life (assessed in 1991). Saczynski et al. demonstrated that participants with lower levels of 
social engagement in later life had an increased risk of dementia (assessed across 1994-
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1997); however, there was no significant dementia risk associated with midlife social 
engagement. They also found that men who demonstrated declines in social engagement 
between midlife and late life had an increased risk for dementia development.   
Others including Barrera (1986) noted that specific facets of social support may be 
more strongly linked with cognition. For instance, while “frequency of contact” was not 
associated with cognition (Amieva et al., 2010), “satisfaction with perceived support” was 
positively related with cognition (La Fleur & Salthouse, 2016; Krueger et al., 2009). 
Furthermore, “anticipated support” (i.e., the belief that others will provide support if needed; 
Krause, 1997) was positively associated with vocabulary performance (i.e., crystallized 
abilities) as well as memory and speed tasks (i.e., fluid abilities; La Fleur & Salthouse, 2016).  
These positive relationships can be attributed to a variety of mechanisms, including 
the fact that social experiences have the ability to reduce stress and inflammation, which are 
often linked with cognitive dysfunction (Fratiglioni et al., 2004; Miller & O’Callaghan, 
2005). Others posit that the cognitive reserve hypothesis may explain the relationship 
between social experiences and cognition as the hypothesis suggests that the lifestyles of 
individuals help reduce risk for diagnosis of dementia. For example, individuals with higher 
levels of education who live engaged lifestyles with greater levels of social and physical 
activity tend to tolerate dementia pathology better than those who do not; thus, they often are 
at reduced risks for dementia and have less severe declines in cognition (Scarmeas & Stern, 
2004). 
Current Study 
Since there is currently no cure for ADRD (Baiyewu, 2018), it would behoove 
researchers in the public health field to identify lifestyle factors protective against cognitive 
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decline and ADRD. By capitalizing on the rich data from the Honolulu-Asia Aging Study, 
the current study aimed to identify life span biopsychosocial factors advantageous to later life 
cognition and protective against ADRD. Namely, this study emphasized cognitive factors of 
crystallized and fluid abilities, which allowed for greater precision in identifying cognitive 
processes pivotal to ADRD, rather than solely using a measure of global cognition often used 
in prior research. In this study, longitudinal methods were used to examine changes over 
time, rather than employing a cross-sectional design in an effort to gain a better 
understanding of changes across the life span. Below are the research aims and hypotheses of 
the current study. 
Aim 1: Determine the relationship between biopsychosocial variables and 
longitudinal cognitive factors. To accomplish this aim, I developed cognitive ability scores 
(i.e. crystallized, fluid, and total cognition scores) via factor analyses, employed growth 
curve models to assess intra-individual changes of the cognitive factors, and investigated 
biopsychosocial predictors of changes in cognitive factors. I hypothesized that participants 
who reported greater levels of biopsychosocial reserve factors protective against cognitive 
decline would demonstrate better cognitive performance over time. This aim is illustrated in 
Figure 2.  
Aim 2: Investigate the association of patterns of change in cognitive factors and 
ADRD (see Figure 3). For this aim, I conducted growth curve mixture modeling followed by 
survival analyses to explore age at ADRD diagnosis. I hypothesized that those who had 
greater declines in their cognitive abilities would have an ADRD diagnosis at an earlier age 
and that men who maintained their cognitive abilities would either not have an ADRD 
diagnosis or would have a later life ADRD diagnosis.   
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Aim 3: Establish the relationship between biopsychosocial factors and ADRD 
through the mediating role of changes in cognitive factors over time (see Figure 4). To do 
this, I tested the indirect effects of cognitive abilities to identify if intercept and linear 
changes in cognitive abilities mediated the relationship between biopsychosocial factors and 
ADRD. I hypothesized that men who had greater levels of protective biopsychosocial factors 
would maintain their crystallized, fluid, and total cognition abilities, which would reduce risk 
of ADRD diagnosis. 
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Figure 2. Model of Aim 1. SFA= saturated fatty acids. MUFA=monounsaturated fatty acids. PUFA=polyunsaturated fatty acids. 
Crys= crystallized abilities. Tcog= total cognition.
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Figure 3. Model of Aim 2. Crys= crystallized abilities. Tcog= total cognition. ADRD=Alzheimer’s disease and related dementias. 
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Figure 4. Model of Aim 3. SFA= saturated fatty acids. MUFA=monounsaturated fatty acids. PUFA=polyunsaturated fatty acids. 
Crys= crystallized abilities. Tcog= total cognition. ADRD=Alzheimer’s disease and related dementias.  
 
 
31 
CHAPTER 3.    METHODOLOGY 
Data Source and Collection Procedures 
This study utilized data from the Kuakini Honolulu-Asia Aging Study (HAAS), a 
longitudinal and prospective study that was established to explore factors of health, genetics, 
and heart disease. The HAAS is one of five studies that branched off the Kuakini Honolulu 
Heart Program. The Kuakini Honolulu Heart Program was established by the Kuakini Health 
System in 1965 with funding from the National Heart, Lung, and Blood Institute to 
investigate health, coronary heart disease, and incidence of stroke in men of Japanese 
ancestry (Kuakini Health System, 2018).  
The HAAS recruited 8,006 Japanese-American men from Oahu, Hawaii by utilizing 
the World War 2 Selective Services Registration file of Japanese-American men born 
between 1900 and 1919. These men were between 45-68 years of age at Exam 1, which 
occurred from 1965-1968 when they volunteered to be in the study. There are currently 12 
exams of data, ranging from 1965 (Mage = 54.40, Rangeage = 45-68) to 2012 (Mage = 93.50, 
Rangeage = 91-106). Over 50 years of the study, data collection procedures primarily entailed 
completing participant examinations at the study center/clinic; however, some examinations 
were completed at participants’ residence (Ceria et al., 2001). Expedited university 
Institutional Review Board approval for the current study was obtained (Appendix A).  
Sample 
Cognition is at the crux of the current study and the HAAS began cognitive testing in 
Exam 4 (1991-1993). Approximately 80 percent of men from Exam 1 survived and 
participated in Exam 4 (White et al., 1996). The average age of the 3,734 men included in 
Exam 4 was 77.83 years old (SD=4.66 years) with ages ranging from 71 to 93 years. Most 
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participants were married (76.50%) or widowed (11.70%). On average, participants had 
approximately eleven years of education (M = 10.47, SD = 3.21 years). Refer to Table 1 for 
participant characteristics.  
Table 1.  Participant characteristics from Exam 4 (N = 3,734) 
Variable Frequency Percent 
Age   
70-75 1,462 39.15 
76-80 1,349 36.13 
81-85 601 16.10 
86-90 290 7.76 
91-95 32 0.86 
Missing 0 0.00 
Years of education    
≤ 12 years 3,058 81.90 
> 12 years 676 18.10 
Missing 0 0.00 
Marital status   
Married 2,857 76.50 
Widowed 437 11.70 
Single, never married 81 2.20 
Divorced 61 1.60 
Separated 12 0.30 
Missing  286 7.70 
It is important to note that each research aim in the current study was progressively 
more selective in inclusion criteria. As a result, three analytic samples were used in the 
current study, all which stemmed from the parent sample of 3,734 men with Exam 4 CASI 
data. Figure B1 in Appendix B provides a consort diagram that details the analytic sample by 
research aim. Figure B2 provides a Venn diagram that illustrates the overlap of the number of 
participants across aims. 
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Measures 
The current study utilized cognition, sociodemographic, and biopsychosocial 
variables to test the research aims; specific measures are noted below. 
Cognition and dementia status   
Cognitive Abilities Screening Instrument (CASI). The CASI is a 39-item measure 
that assesses nine cognitive domains (Teng et al., 1994). Teng et al. categorized CASI items 
into nine domains using face validity. The number of items assigned to each domain by Teng 
and colleagues is as follows: orientation (8 items), short-term memory (7 items), language (6 
items), manipulation/concentration (6 items), long-term memory (5 items), attention (3 
items), judgement/abstraction (2 items), visual construction (1 item), and list-generating 
fluency (1 item). CASI items are summed and scores range from 0 to 100, with higher values 
indicating greater levels of cognition. This measure has high levels of internal consistency 
reliability and validity as items are based on three cognition and dementia screening tests: 
Hasegawa Dementia Screening Scale (HSD; Hasegawa, 1983), Mini-Mental State 
Examination (MMSE; Folstein et al., 1975), and the Modified Mini-Mental State (3MS; 
Teng & Chui, 1987). Table C1 in Appendix C provides a comparison of CASI items to each 
of the parent measures; although many CASI items are identical to the parent measures, some 
items are adaptations and others are not included in the parent measures. For reference, a 
score of 74 on the CASI roughly corresponds to a score of 22 on the MMSE (Abbott et al., 
2004). It is important to note that the CASI may lack sensitivity for ADRD detection (Abbott 
et al.). Computed Cronbach’s α of the 39 CASI items at Exam 4 (baseline CASI exam) in the 
current study was 0.92. 
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Diagnosis of dementia. Dementia screening was a multi-pronged process that 
stemmed from CASI performance and ended with a consensus diagnosis by a panel of 
clinicians. All men who had a CASI score less than 74 who were also 85 years and older 
were selected to be assessed in Phase 2 (White et al., 1996). Phase 2 consisted of a “second 
CASI, neurological examining, and testing of the participant’s hearing and vision” (White et 
al., p. 956) along with gathering information on the participant’s changes in cognition and 
behaviors over ten years assessed via the Informant Questionnaire on Cognitive Decline in 
the Elderly (IQCODE), which was completed by an informant (often the spouse). Men who 
had a CASI score less than 74 or IQCODE scores higher than 3.6 were included in Phase 3, 
which consisted of a “standardized interview and neurologic examination by a neuroscientist 
with advanced training in behavioral neurology and dementia research, as well as the 
neuropsychological test battery from the Consortium to Establish a Registry for Alzheimer's 
Disease (CERAD)” (White et al., p. 956). Participants were further evaluated by a panel of 
clinicians consisting of “the study neurologist and at least 2 other physicians with expertise in 
geriatric medicine and dementia” (White et al., p. 956) who made the final dementia 
diagnosis (Higuchi et al., 2015).  
The panel had access to all participant performance material and used the DSM III 
(American Psychiatric Association, 1987) as the tool to diagnose dementia and the National 
Institute of Neurological and Communicative Disorders and Stroke–Alzheimer’s disease and 
Related Disorders Association (NINCDS-ADRDA; McKhann et al., 1984) guidelines to 
diagnose Alzheimer’s disease. This was a consensus dementia diagnosis by the panel, which 
meant that all panelists came to a consensus about each dementia diagnosis. Data include 
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information on if and when a participant was diagnosed with all-cause dementia across 
Exams 4-12.   
Sociodemographic variables 
Age. Participant age at Exam 4 was noted as a continuous variable.  
Marital status. Marital status was measured using a self-report item reflecting status 
at Exam 4 with response options of single (i.e., never married), married, divorced, widowed, 
and separated.  
Education. A self-reported item assessed years of schooling completed at Exam 4. 
This continuous value was used in the current study. 
Biopsychosocial variables 
APOE. Blood serum was collected and assayed for APOE genetic phenotype using 
standard polymerase chain reaction techniques (Saunders et al., 1996). Participant APOE 
allelic combinations (i.e., ԑ2/ԑ2, ԑ2/ԑ3, ԑ2/ԑ4, ԑ3/ԑ3, ԑ3/ԑ4, and ԑ4/ԑ4) were available and used 
in the current study.  
Associates of inflammation. Percent in milligrams of random serum uric acid was 
collected at Exam 3. Fasting glucose was collected at Exam 4 as mg/dL. These continuous 
variables were used in the current study.    
Dietary fatty acids. Dietary information obtained from a 24-hour dietary collected at 
Exam 1 was coded into the computer program, Nutritionist 4, which is a validated software 
that offers the nutritional breakdown of food (McCullough et al., 1999). This program 
provided information on the nutrition intake of micronutrients (e.g., vitamins, minerals) and 
macronutrients (e.g., proteins, fats, carbohydrates). Intake of saturated fatty acids (SFA), 
monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA) reported in 
grams were used in the current study.  
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BMI. Researchers computed BMI using participant height and weight values that 
were collected at each exam. Computed values at Exam 4 were used in the current study.  
Hypertension. Researchers collected systolic and diastolic measures for seated blood 
pressure at each exam. A dichotomized hypertension variable assessed at Exam 4 was 
available and used in the current study. Participants received a score of 1 (yes) if their blood 
pressure was greater than or equal to 140 (systolic value) over 90 (diastolic value) or if they 
reported taking blood pressure medication.  
Physical activity. A physical activity index was used to assess activity level. 
Participants self-reported the average number of hours per day they spent on five types of 
activities, each with a different level of intensity: no activity (e.g., sleeping or lying down), 
sedentary activity (e.g., sitting, standing), slight activity (activity that does not induce 
sweating, such as walking, golfing), moderate activity (activity that concludes at the onset of 
sweating such as gardening, yoga), and heavy activity (e.g., shoveling, running). A computed 
total physical activity index score for Exam 4 was available and used in the current 
investigation; higher scores indicated greater level of physical activity (Reiff et al., 1967; 
Taaffe et al., 2008). This measure has high levels of validity (Taaffe et al.) as it is similar to 
the physical activity assessments used in the Framingham Heart Study (Kannel & Sorlie, 
1979) as well as the Puerto Rico Heart Study (Garcia-Palmieri, Costas, Cruz-Vidal, Sorlie, & 
Havlik, 1982). 
Sleep.  Daytime sleepiness was measured using one question, “Are you sleepy most 
of the day?” with dichotomous response options 0 (no) / 1 (yes). This item has high levels of 
validity and has been used in other longitudinal studies such as the Cardiovascular Health 
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Study to assess daytime sleepiness (Newman et al., 1997). Participant responses from Exam 
4 were used in this study. 
Depressive symptoms. An 11-item version of the Centers for Epidemiologic Studies 
Depression (CES-D; Eaton, Smith, Ybarra, Muntaner & Tien, 2004) scale assessed 
depressive symptoms. Although this measure is a shortened version of the 20-item version of 
the scale, it is comparable and has high levels of validity (Harada et al., 2012). Participants 
indicated how often they felt a certain way during the span of a week. Sample items include 
“Would you say in the last week, you were bothered by things that usually don’t bother 
you?” and “Would you say in the last week, you did not feel like eating; your appetite was 
poor?” For each item, participants received a score that ranged from 0 (without symptoms) to 
3 (with severe symptoms; Takeshita et al., 2002). Computed total depressive symptom values 
from Exam 4 were available and utilized in the current investigation; higher scores reflected 
greater depressive symptomology. For this measure, a score of 9 or greater indicated 
significant depressive symptoms (Harada et al.; Yanagita et al., 2006). Participant scores at 
Exam 4 ranged from 0 to 26, and the mean depressive symptom score was 3.73 (SD = 3.67). 
This measure has high internal consistency reliability with a reported Cronbach’s α of 0.83 
(Gellis, 2010).  
Social support. Social support measures were collected at Exam 4 using six items 
reflecting anticipated social support (i.e., the belief that others will provide support if needed; 
Krause, 1997). Items were adapted from the Interpersonal Support Evaluation List (Cohen & 
Hoberman, 1983) to assess aspects of social support using response categories ranging from 
1 (definitely true) to 4 (definitely false).  Example items include “When I need suggestions on 
how to deal with a personal problem I know someone I can turn to” and “There is at least one 
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person I know whose advice I really trust.”  In the current study, I reverse coded these items 
for ease of interpretation so that higher response anchors indicated greater levels of support 
and lower response anchors reflected lower levels of support. An average of these items was 
computed and possible scores ranged from 1 to 4, with higher averages reflecting greater 
levels of social support. Cronbach’s α of the six items at Exam 4 in the current study was 
0.73.  This measure has high levels of test-retest and internal reliability as well as high levels 
of validity as evinced by strong correlations with various measures of social support, 
including the Inventory of Socially Supportive Behaviors (Cohen et al., 1985; Sims et al., 
2015).  
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CHAPTER 4.    RESULTS 
This chapter provides results of the current study and is organized by research aim. I 
first provide descriptive statistics on participant performance, address incomplete data, and 
detail analyses conducted for the three aims. Statistical programs SPSS version 23 (IBM 
Corporation, 2014), Mplus version 8.1 (Muthén & Muthén, 2010), and STATA version 15 
(Stata Corporation, 2017) were used to conduct analyses. 
Descriptive Statistics  
Participant CASI performance as well as levels of biopsychosocial variables are noted 
in this subsection.   
CASI performance  
Table 2 provides details on CASI performance across the nine exams that the CASI 
was assessed. The highest mean score was approximately 86 at Exam 4 (M = 85.70, SD = 
9.77) and lowest mean score was 66 (M = 65.53, SD = 23.02) at Exam 12.  
Table 2. CASI performance across exams (N = 3,734) 
Year Exam M SD         N N, not in exam 
1991-1993 Exam 4 85.70 9.77 3,128 606 
1994-1996 Exam 5 81.92 13.13 2,428 1,306 
1997-1999 Exam 6 78.33 16.99 1,842 1,892 
1999-2000 Exam 7 78.33 15.94 1,431 2,303 
2001-2004 Exam 8 75.60 18.51 1,107 2,627 
2003-2005 Exam 9 75.31 18.80 857 2,877 
2007-2009 Exam 10 68.12 23.16 857 2,877 
2009-2010 Exam 11 66.47 22.79 512 3,222 
2011-2012 Exam 12 65.53 23.02 361 3,373 
Note. CASI scores range from 0 to 100.  
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Biopsychosocial variables  
Table 3 below provides details on continuous biopsychosocial variables. The National 
Cholesterol Education Program within the National Institutes of Health (2001) identified 
fasting glucose values of greater than or equal to 110 mg/dL as the threshold linked with 
metabolic syndrome. Based on this guideline, on average, participants in the current study 
demonstrated elevated levels of fasting glucose (M = 113.04, SD = 29.40).  
Using the HAAS, Taffe et al. (2008) employed cut off scores of low (e.g., ≤ 28.70), 
moderate (e.g., 28.80 – 32.40), and high (e.g., ≥ 32.50) physical activity levels. Physical 
activity scores in the current study ranged from 24 to about 70 and the mean score for men 
was 30.82 (SD = 4.62), indicating moderate levels of physical activity on average.  
The mean BMI was 23.44 and that falls within the normal/healthy weight BMI 
category (CDC, 2017). On average, participants had relatively moderate levels of depressive 
symptoms with a mean of 3.73 (SD = 3.67), which is less than the significant depressive 
symptoms criterion score of 9 (Harada et al. 2012; Yanagita et al., 2006).  
It is recommended that individuals have limited amounts of saturated fatty acids (e.g., 
about 13 grams of daily, ~ 6% of calorie intake; Institute of Medicine, 2006). The mean level 
of saturated fat consumption in the current study was higher than the recommended intake. It 
is recommended that about 15-20% of daily caloric intake (e.g., ~44 grams) come from 
monounsaturated fatty acids and between 3-10% of calories come from polyunsaturated fatty 
acids (e.g., 22 grams; Vannice & Rasmussen, 2014). On average participants in the current 
study had relatively less intake of these unsaturated fatty acids than recommended.  
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Table 3. Descriptive statistics for continuous biopsychosocial variables (N = 3,734) 
Variable      M    SD Min   Max N, missing 
Glucose 113.04 29.40 44.00 399.00 165 
Uric acid 62.68 15.42 1.00 140.00 697 
Physical activity index 30.82 4.62 24.00 69.80 301 
BMI 23.44 3.16 12.25 39.34 142 
Depressive symptoms 3.73 3.67 0.00 26.00 540 
Social support 3.59 0.47 1.00 4.00 345 
Saturated fatty acid  33.11 15.56 0.00 129.70 0 
Monounsaturated fatty acid 34.35 15.70 0.00 125.10 0 
Polyunsaturated fatty acid 16.04 9.98 0.00 75.90 0 
Note. BMI = Body mass index. All variables were collected at Exam 4 with the exception 
of uric acid (Exam 3) and dietary fatty acids (Exam 1).  
 
Table 4, which provides participant characteristics for categorical variables, denotes 
that the majority of participants (73.60%) qualified as hypertensive by either reporting their 
consumption of blood pressure medication or having a seated systolic blood pressure greater 
than or equal to 140 and diastolic value of 90 at Exam 4. Less than ten percent of participants 
reported experiencing excessive daytime sleepiness. The majority of participants (70.50%) 
had the APOE-ԑ3/ԑ3 combination. Eight participants had the APOE-ԑ2/ԑ2 allelic 
combination, which is considered protective and places them at a lower risk of ADRD 
development (Qiu et al., 2004) compared to the 16 participants who were at the greatest risk 
for ADRD due to APOE-ԑ4/ԑ4 status (Rawle et al., 2018).  
Table 4. Characteristics for categorical biopsychosocial variables. (N = 3,734) 
Variable Frequency Percent 
Hypertension   
Not hypertensive 985 26.40 
Hypertensive 2,749 73.60 
Missing 0 0.00 
Daytime sleepiness   
No daytime sleepiness 2,935 78.60 
Daytime sleepiness 278 7.40 
Missing   521 14.00 
APOE   
ԑ2/ԑ2 8 0.20 
ԑ2/ԑ3 306 8.20 
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(Table 4 continued)   
Variable Frequency Percent 
ԑ2/ԑ4 38 1.00 
ԑ3/ԑ3 2,633 70.50 
ԑ3/ԑ4 618 16.60 
ԑ4/ԑ4 16 0.40 
Missing  115 3.10 
Note. All variables were collected at Exam 4. 
 
 The associations among the aforementioned biopsychosocial variables and baseline 
CASI performance are detailed in the correlation matrix below, which used listwise deletion 
such that it excluded men who had missing data on any of the variables and resulted in an 
analytic sample of 3,036 men. It is important to note that in an effort to ease the 
interpretation of matrix results, APOE and marital status were dichotomized as presence of 
APOE-ԑ4 allele or not as well as married or not. As noted in Table 5, age was negatively 
associated with BMI (r = -0.22, p < 0.001), indicating that older participants had lower 
BMIs. Variables most strongly correlated with CASI were age (r = -0.37, p < 0.001), 
education (r = 0.38, p < 0.001), physical activity index (r = 0.10, p < .001), and daytime 
sleepiness (r = -0.11, p < 0.001); thus, suggesting that older participants and those with 
excessive daytime sleepiness tended to have poorer CASI performance at Exam 4, whereas 
those with higher levels of education and physical activity had greater CASI performance. 
Glucose levels were positively associated with BMI (r = 0.11, p < 0.001) while the highest 
correlation for BMI was uric acid (r = 0.16, p < 0.001). Not surprisingly, social support was 
associated with marital status (r = 0.12, p < 0.001) and depressive symptoms (r = -0.18,  p < 
0.001) indicating that those who were married tended to have higher levels of social support 
and men with greater levels of depressive symptoms tended to have poorer levels of social 
support. 
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Table 5. Zero-order correlation matrix of biopsychosocial variables, Exam 4 (N = 3,036) 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1. Age 1.00                
2. Married -.13 1.00               
3. Education -.16 .04 1.00              
4. APOE-ԑ4 -.02 -.01 .01 1.00             
5. Glucose -.04 -.01 .03 .02 1.00            
6. Uric acid -.04 -.04 .02 -.02 .03 1.00           
7. Saturated fatty acids -.17 .03 .09 -.02 .02 -.03 1.00          
8. MUFA -.16 .03 .10 -.02 .03 -.02 .93 1.00         
9. PUFA -.10 .00 .01 -.01 .03 -.01 .43 .51 1.00        
10. Body mass index -.22 .04 -.01 -.01 .11 .16 .07 .07 .05 1.00       
11. Hypertension .04 -.03 -.02 .02 .07 .09 -.07 -.08 -.09 .09 1.00      
12. Physical activity -.12 .07 -.04 .02 .00 -.01 .02 .02 .02 .02 .03 1.00     
13. Daytime sleepiness .04 -.02 -.03 -.02 .02 -.02 -.02 -.02 -.02 .02 .01 -.06 1.00    
14. Dep. symp. .02 -.06 -.02 -.02 -.01 -.03 .00 .01 .01 -.06 -.03 -.06 .13 1.00   
15. Social support -.04 .12 .00 .00 .01 .00 .00 -.01 -.03 .04 -.01 .03 -.04 -.18 1.00  
16. CASI -.37 .07 .38 -.03 .01 -.02 .11 .11 .04 .10 .00 .10 -.11 -.11 .05 1.00 
Note. Married [0 (not married)]/1(married)]. APOE [0 (no ԑ4 allele)/1 (at least one ԑ4 allele)]. MUFA= monounsaturated fatty 
acids. PUFA= polyunsaturated fatty acids. Hypertension (0 [a blood pressure less than 140/90]/ 1[blood pressure greater than or 
equal to 140/90 or taking blood pressure medication]). Dep. symp. = depressive symptoms. CASI= total CASI score. All variables 
were from Exam 4 with the exception of SFA, MUFA, PUFA, which were from Exam 1 and uric acid (Exam 3). Bolded values= 
p < 0.01. 
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Aim 1  
The purpose of Aim 1 was to determine the relationship between biopsychosocial 
variables and longitudinal cognitive factors. I hypothesized that participants who had greater 
levels of biopsychosocial factors protective against cognitive decline would have better 
cognitive performance over time. Below is a description of methods used to assess this aim, 
which include addressing incomplete data, conducting factor analysis of the CASI, exploring 
study participation over time to determine missingness, employing growth curve models to 
assess intra-individual changes of the cognitive factors, and investigating biopsychosocial 
predictors of cognitive abilities (e.g., level and change).   
Addressing incomplete CASI data  
There were low levels of incomplete CASI data across the exams indicating that the 
majority of participants responded to all 39 CASI items. Incomplete data were addressed 
using a two-pronged approach. First, I noted the number of participants with incomplete data 
across exams by assessing how many CASI items each participant responded to at each 
exam. The number of participants with any incomplete data (i.e., one or more missing CASI 
items) at each Exam were as follows: Exam 4 (n = 16), Exam 5 (n = 38), Exam 6 (n = 38), 
Exam 7 (n = 28), Exam 8 (n = 34), Exam 9 (n = 25), Exam 10 (n = 33), Exam 11 (n = 26), 
and Exam 12 (n = 13).  
Next, I examined the item responses for these individuals and noticed there were two 
distinct patterns: (a) men who had a large number of incomplete responses (e.g., 38% 
response rate; responded to 15 items) and (b) those who had less incomplete data (e.g., 62% 
response rate; responded to at least 24 items). Upon further investigation of the CASI item 
responses, it became clear that the men who had many incomplete responses also had item 
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responses of 0 for their CASI items; these men received a substituted value of 0. Participants 
who had less instances of incomplete data had greater CASI item scores; these men had 
values substituted using mean substitution.  
Factor analysis of CASI 
After addressing incomplete CASI item-level data, the next step was to factor analyze 
the CASI. Factor analyzing the CASI was a three-pronged process comprised of developing 
cognitive ability factors, conducting confirmatory factor analyses of the CASI to assess fit of 
the factors, and computing total cognitive ability scores.  
Development of crystallized and fluid factors. Crystallized and fluid abilities are at 
the crux of this study. Thirty-nine CASI items were classified as crystallized (n = 22) and 
fluid (n = 17) items. CASI items were categorized as crystallized or fluid based on a variety 
of factors that took work by Teng and colleagues (1994) along with cognitive aging literature 
into account. Specifically, I assessed how items within each CASI domain classified by Teng 
et al. (1994) aligned with cognitive aging theory and literature (e.g., Bendayan et al., 2017; 
Benton et al., 1983; Flanagan & Dixon, 2014; Lima et al., 1991; Niileksela, Reynolds, & 
Kaufman, 2012; Parkin,1999; Raz et al., 2008; Undheim, 1976; Unsworth, 2010).  
For example, in the current study, the crystallized ability category encompassed items 
that Teng et al. labeled long-term memory, orientation, visual construction, 
judgement/abstraction, and language; whereas the fluid category was comprised of items that 
were labeled as short-term memory, attention, manipulation/concentration, and list-
generating fluency domains. Table 6 provides details on CASI items, the cognitive domain it 
was labeled as by Teng et al, its classification as crystallized or fluid for the current study, 
along with literature supporting the categorization. Literature supported the crystallized and 
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fluid classification of all but one item (item 31 in Table 6), which was the only item within 
the visual construction domain identified by Teng et al. Although a visual-spatial reasoning 
factor (Baghaei & Tabatabaee, 2015) would be an ideal cognitive factor/ability to place this 
item in, I classified it as crystallized because in addition to assessing fine motor skills, the 
item measured comprehension following directions, which are learned culture-based abilities. 
Table 6. Classification of crystallized and fluid ability, CASI items 
Number         CASI item Domain Classification Support  
1 Where were you born? 
-city/town/village 
-state 
Long-term 
memory 
Crystallized Flanagan & 
Dixon (2014) 
2 When were you born? 
-year 
-month 
Long-term 
memory 
Crystallized Flanagan & 
Dixon (2014) 
3 When were you born? 
-date 
Long-term 
memory 
Crystallized Flanagan & 
Dixon (2014) 
4 How old are you? Orientation Crystallized Flanagan & 
Dixon (2014) 
5 How many minutes are there in 
an hour? OR 
How many days are there in a 
year? 
Long-term 
memory 
Crystallized Flanagan & 
Dixon (2014) 
6 In what direction does the sun 
set? 
Long-term 
memory 
Crystallized Flanagan & 
Dixon (2014) 
7 I am going to say 3 words for 
you to remember. Repeat them 
after I have said all three. 
1. shirt, brown, honesty  
2. shoes, black, modesty  
3. socks, blue, charity 
Attention Fluid Unsworth (2010) 
8 I shall say some numbers, and 
you repeat what I say 
backwards. For example, if I 
say 1–2, you say 2–1. Ok?  
 
Remember: you repeat what I 
say backwards. 
1–2–3 (If unable, coach for 3 – 
2 – 1, but score 0)  
Concentration/ 
manipulation 
Fluid Undheim (1976) 
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(Table 6 continued)    
Number CASI item Domain Classification Support  
9 Remember: you repeat what I 
say backwards. 
6 – 8- 2   
Concentration/ 
manipulation 
Fluid Undheim (1976) 
 
10 I shall say some numbers, and 
you repeat what I say 
backwards.  
3 – 5 – 2 – 9 
Concentration/ 
manipulation 
Fluid Undheim (1976) 
 
11 What three words did I ask you 
to remember earlier? (3 times) 
 
(3 sec) Spontaneous recall 
(2 sec) After: “one word was 
something to wear” 
After: “Was it X, X or X?” 
Short-term 
memory 
Fluid Unsworth (2010) 
 
12 (3 sec) Spontaneous recall 
(2 sec) After: “one word was 
something to wear” 
After: “Was it X, X or X?” 
Short-term 
memory 
Fluid Unsworth (2010) 
 
13 (3 sec) Spontaneous recall 
(2 sec) After: “one word was 
something to wear” 
After: “Was it X, X or X?” 
Short-term 
memory 
Fluid Unsworth (2010) 
 
14 From 100, take away 3, how 
many? 
Concentration/ 
manipulation 
Fluid Flanagan & 
Dixon (2014) 
15 And take away 3 from that 
equals? 
Concentration/ 
manipulation 
Fluid Flanagan & 
Dixon (2014) 
16 Repeat “and take away 3 again 
equals?” (3times) 
Concentration/ 
manipulation 
Fluid Flanagan & 
Dixon (2014) 
17 What is today’s date? 
-year 
Orientation Crystallized Flanagan & 
Dixon (2014) 
18 What is today’s date? 
-month 
Orientation Crystallized Flanagan & 
Dixon (2014) 
19 What is today’s date? 
-date 
Orientation Crystallized Flanagan & 
Dixon (2014) 
20 What day of the week is it 
today? 
Orientation Crystallized Flanagan & 
Dixon (2014) 
21 What season are we in? Orientation Crystallized Flanagan & 
Dixon (2014) 
22 What state and city are we in? 
 
Orientation Crystallized Flanagan & 
Dixon (2014) 
23 Is this place a hospital, store, 
or home? 
Orientation Crystallized Flanagan & 
Dixon (2014) 
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(Table 6 continued)   
Number CASI item Domain Classification Support  
24 What animals have 4 legs? Tell 
me as many as you can. (30 
sec) 
Word  
fluency 
Fluid Benton et al. 
(1983); Parkin 
(1995; 1999) 
25 (Cue card – introduction to 
similarities) an orange and a 
banana are both fruit 
 
-An arm and a leg are both...?  
*Body parts, limbs, extremities  
*Long, bend, muscles, bones, 
etc.  
*Incorrect; DK; tells difference  
 
-Laughing and crying are 
both...? 
*Expressions of 
feelings/emotions  
*Other correct answer  
*Incorrect; DK; tells difference  
 
-Eating and sleeping are 
both...? 
*Necessary bodily functions  
*Other correct answer  
*Incorrect; DK; tells difference 
Abstraction/ 
judgement 
Crystallized Niileksela, 
Reynolds, & 
Kaufman (2012); 
Bendayan et al. 
(2017) 
26 What actions would you take if 
you saw your neighbor’s house 
catching fire? (Prompt “what 
else might you do?” Once 
only, if necessary) 
 
-What actions would you take 
if you lost a borrowed 
umbrella?  
* inform/apologize  
* replace/compensate  
 
-What would you do if you 
found an envelope that was 
sealed, addressed and had a 
new stamp? 
*Mail  
*Try to locate the owner  
*Inappropriate action 
Abstraction/ 
judgement 
Crystallized Lima et al. 
(1991) 
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(Table 6 continued) 
   
Number CASI item Domain Classification Support  
27 Repeat exactly what I say: 
“He would like to go home.” 
Attention Fluid Raz et al. (2008) 
 
28 Now repeat … (3 sec) 
“this yellow circle is heavier 
than blue square” 
Attention Fluid Raz et al. (2008) 
 
29 Please do this: 
(point to statement “raise your 
hand”) 
Language  Crystallized Kaufman, 
Kaufman, & 
McLean (1995); 
Niileksela, 
Reynolds, & 
Kaufman (2012) 
30 Let me have a sample of your 
handwriting. Please write: “he 
would lie to go home” 
Language Crystallized McGrew (2009) 
31 Please copy this: the pentagon 
shape 
Visual  
construction 
Crystallized Support for 
visual-spatial 
ability: Baghaei 
& Tabatabaee 
(2015) 
32 Take this paper with your L 
(R) hand, fold it in half, and 
hand it back to me.  
Language Crystallized Kaufman, 
Kaufman, & 
McLean (1995); 
Niileksela, 
Reynolds, & 
Kaufman (2012) 
 
33 What three words did I ask you 
to remember earlier? (3 times) 
(3 sec) Spontaneous recall 
(2 sec) After: “one word was 
something to wear” 
After: “Was it X, X or X?” 
Short-term 
memory 
Fluid Unsworth (2010) 
34 (3 sec) Spontaneous recall 
(2 sec) After: “one word was 
something to wear” 
After: “Was it X, X or X?” 
Short-term 
memory 
Fluid Unsworth (2010)  
35 (3 sec) Spontaneous recall 
(2 sec) After: “one word was 
something to wear” 
After: “Was it X, X or X?” 
Short-term 
memory 
Fluid Unsworth (2010) 
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(Table 6 continued)    
Number CASI item Domain Classification Support  
36 What do we call this part of the 
face/body? 
*Brow/forehead  
*Jaw/chin  
*Shoulder  
*Elbow  
*Wrist 
Language Crystallized Kaufman, 
Kaufman, & 
McLean (1995); 
Niileksela, 
Reynolds, & 
Kaufman (2012) 
 
37 What is this? (show one at a 
time, any order ok) (show 
item: 2 sec for answer; if 
unable, place in hand: 4 sec for 
answer)  
*Spoon  
*Coin  
Language Crystallized Kaufman, 
Kaufman, & 
McLean (1995); 
Niileksela, 
Reynolds, & 
Kaufman (2012) 
 
38 What is this? (show one at a 
time, any order ok) (show 
item: 2 sec for answer; if 
unable, place in hand: 4 sec for 
answer)  
*Toothbrush  
*Key  
*Comb 
Language Crystallized Kaufman, 
Kaufman, & 
McLean (1995); 
Niileksela, 
Reynolds, & 
Kaufman (2012) 
 
39 Remember these 5 objects! 
(wait for 5 sec.; cover, then 
ask) 
-What 5 objects did I just show 
you?  
Spoon coin toothbrush key 
comb 
Short-term 
memory 
Fluid Unsworth (2010) 
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Next, the internal consistencies of the crystallized and fluid ability items were 
computed at each exam. As noted in Table 7, Cronbach’s alphas were relatively high across 
the nine exams. The alphas for crystallized abilities ranged from a low of 0.88 at Exams 4, 5, 
and 7 to a high of 0.92 at Exam 10. The lowest alpha for fluid abilities was 0.85 at Exams 4, 
5, and 7 to a high alpha value of 0.90 at Exam 10.  
Table 7. Alphas of crystallized and fluid abilities across exams 
Exam       N Crystallized abilities Fluid abilities 
Exam 4 3,706 0.88 0.85 
Exam 5 2,680 0.88 0.85 
Exam 6 1,978 0.90 0.86 
Exam 7 1,518 0.88 0.85 
Exam 8 1,175 0.89 0.88 
Exam 9 907 0.90 0.87 
Exam 10 545 0.92 0.90 
Exam 11 378 0.91 0.89 
Exam 12 251 0.91 0.89 
 
Confirmatory factor analysis of CASI.  The next step was to conduct confirmatory 
factor analyses (CFA) to assess whether the a-priori proposed two-factor structure of 
crystallized and fluid abilities fit the data well. For this, I created parcels of average 
crystallized and fluid items instead of using individual scores for the 39 CASI items in the 
CFA. There are a number of advantages to item parceling compared to using raw items, 
namely the fact that there are stronger model fit indices and factor solutions resulting from 
parcels because there are fewer parameters in the model (Little, Cunningham, Shahar, & 
Widaman, 2002; Little, Rhemtulla, Gibson, & Schoemann, 2013). Six parcels were created 
from the 39 items and no weights were used—three parcels each, for crystallized and fluid 
abilities. To do this, I performed a factor analysis fitting a one-factor solution to the 39 items, 
rank-ordered the items by loadings, and computed parcel scores by averaging items of a 
parcel.  
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Subsequently, CFAs of the CASI at each exam were conducted to assess if the two-
factor solution of crystallized and fluid abilities fit the data well. Specifically, I fit the three 
crystallized parcels to a crystallized factor and fit the three fluid parcels to a fluid factor 
within the same model. This parcel development and factor analysis procedure was 
performed for each CASI assessment across nine exams with CASI data (i.e., Exams 4-12).  
The factor analysis fit indices noted in Table 8, demonstrate that the two-factor 
solution fit the data relatively well. For example, model fit ranged from χ2(8) = 471.99 with a 
comparative fit index (CFI) of 0.97 and root mean square error of approximation (RMSEA) 
of 0.12 at Exam 4 to a χ2 (8) = 26.16 with a CFI of 0.98 and RMSEA of 0.09 at Exam 12. Fit 
indices across exams met the goodness of fit cutoff values recommended by Hu and Bentler 
(1999) as the CFIs were near 0.95 and RMSEAs were approximately 0.06. 
Table 8. Confirmatory factor analysis fit indices and correlations between two factors across 
exams 
 Fit indices  
Exam N df χ2 CFI RMSEA FF r 
Exam 4 3,706 8 471.99 0.97 0.12 0.06 0.86 
Exam 5 2,680 8 341.40 0.97 0.12 0.06 0.87 
Exam 6 1,978 8 181.36 0.98 0.10 0.04 0.88 
Exam 7 1,518 8 390.54 0.94 0.17 0.12 0.88 
Exam 8 1,175 8 122.85 0.98 0.11 0.05 0.86 
Exam 9 907 8 128.82 0.97 0.12 0.07 0.89 
Exam 10 545 8 44.35 0.99 0.09 0.04 0.89 
Exam 11 378 8 9.35 0.99 0.02 0.01 0.90 
Exam 12 251 8 26.16 0.98 0.09 0.05 0.90 
Note. FF= Maximum likelihood fit function. r = standardized correlations between the two 
factors; all were significant (p < 0.001).  
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A closer look at the standardized model results from the factor analysis for Exam 4 is 
illustrated in Figure 5 and indicates that the parcels loaded onto the factors well—the lowest 
loading was 0.82 and highest loading was 0.89. The correlation between the two factors was 
relatively high, (r = 0.86, p < 0.001). This loading pattern along with the high correlation 
between the two factors was consistent across exams (see the last column of Table 8 for 
correlations between the two factors along with Figures D1 through D8 in Appendix D for 
standardized CFA results for Exams 5 through 12).  
 
Figure 5. Standardized confirmatory factor analysis model results for Exam 4. Crys = 
crystallized abilities. Fluid = fluid abilities (N = 3,706).  
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Total crystallized and fluid scores. Next, total scores were created. Specifically, two 
total scores per participant per exam were computed—a total crystallized and a total fluid 
score. These total scores were used in the remaining analyses and were computed through the 
summation of respective crystallized and fluid parcels (i.e., total crystallized score was 
computed by adding the three crystallized parcels together). In an effort to obtain a measure 
of overall cognition, I also computed a total cognition score, which was a summation of the 
total crystallized and fluid values at each exam.  
Table 9 provides descriptive statistics of the crystallized, fluid, and total cognition 
values across Exams 4-12. The average crystallized ability score ranged from M = 8.72 (SD = 
1.31) at Exam 4 to M = 7.22 (SD = 2.14) at Exam 12 whereas fluid abilities ranged from M= 
6.58 (SD = 1.70) at Exam 4 to M = 4.75 (SD = 2.30) at Exam 12.  
In an effort to assess whether there were significant differences in crystallized 
performance and fluid performance over time, which would help in warranting conducting 
growth curve analyses, I examined if there were significant differences in the means of 
crystallized and fluid abilities over time. A repeated measures ANOVA demonstrated a 
significant effect of time on both crystallized abilities F (1.39, 2681.22) = 475.45, p < 0.001 
and fluid abilities F (1.87, 3616.49) = 617.26, p < 0.001.  
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Table 9. Descriptive statistics for cognitive abilities across exams 
   Crystallized abilities Fluid abilities Total cognition 
Exam    N  
N, not in 
exam M SD 
Obs. 
Max 
Hyp. 
Max M SD 
Obs. 
Max 
Hyp. 
Max M SD 
Obs. 
Max 
Hyp. 
Max 
Exam 4 3,706 28 8.72 1.31 9.88 9.88 6.58 1.70 8.90 8.90 15.31 2.85 18.78 18.78 
Exam 5 2,680 1,054 8.45 1.39 9.73 9.73 6.42 1.76 9.07 9.07 14.88 2.98 18.80 18.80 
Exam 6 1,978 1,756 8.26 1.58 9.68 9.68 6.03 1.85 8.97 8.97 14.30 3.25 18.65 18.65 
Exam 7 1,518 2,216 8.60 1.48 10.01 10.01 5.98 1.81 8.97 8.97 14.59 3.10 18.81 18.81 
Exam 8 1,175 2,559 8.04 1.71 9.68 9.68 5.77 2.06 9.20 9.20 13.84 3.57 18.57 18.57 
Exam 9 907 2,827 8.00 1.74 9.68 9.68 5.59 2.01 8.90 8.90 13.60 3.58 18.44 18.44 
Exam 10 545 3,189 7.40 2.21 9.68 9.68 4.94 2.22 8.87 8.87 12.35 4.27 18.40 18.40 
Exam 11 378 3,356 7.26 2.18 9.61 9.61 4.80 2.22 8.73 8.90 12.07 4.22 18.05 18.51 
Exam 12 251 3,483 7.22 2.14 9.73 9.73 4.75 2.30 8.77 8.93 11.98 4.26 18.04 18.66 
Note. Obs. Max = observed maximum. Hyp. Max = hypothetical maximum. Maximum values differing across exams is due to 
the rank-order and item-level parcel classification procedure conducted in the one-factor factor analysis at each exam. 
Participants scored the hypothetical maximum for all exams except for Exams 11 and 12 (fluid abilities and total cognition). The 
minimum score for all cognitive abilities was 0.  
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Exploring study participation over time  
Due to the nature of missing data in longitudinal studies, it was important to examine 
aspects of missingess, including investigating the type of missingness present in the current 
study (e.g., missing at random, missing not a random, missing completely at random; Enders, 
2001). To do so, I noted which exams participants had total crystallized and fluid scores for 
and used this information to categorize men into groups of participation. Groups were 
mutually exclusive such that an individual was classified into just one group. These groups of 
participation are noted in Table 10. Of the 3,734 men, 23.70% participated in just Exam 4 
whereas 5.28% of men participated across Exams 4-12.  
Table 10. Groups of participation  
 
Growth curve modeling requires participants to have a minimum of three time points 
of data to examine changes over time (Wickrama, Lee, O’Neal, & Lorenz, 2016). Because 
men in Groups 1 (participation in only Exam 4), 2 (participation in only Exams 4 and 5), and 
10 (other; participation in Exam 4, skipped Exam 5, and participated in following exams) did 
not meet this requisite, they were excluded from further analyses.  
Next, I plotted crystallized and fluid means by participation group in an effort to 
Group Exams of participation Frequency Percent 
1 4 885 23.70 
2 4 and 5 665 17.81 
3 4-6 486 13.02 
4 4-7 479 12.83 
5 4-8 213 5.70 
6 4-9 338 9.05 
7 4-10 127 3.40 
8 4-11 95 2.54 
9 4-12 197 5.28 
10 Other 221 5.92 
Missing  28 0.75 
Total  3,734 100.00 
Note. Men in Group 10 (i.e., Other) participated in Exam 4, skipped Exam 5, and 
participated in following exams.  
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examine how participation may have influenced performance. Figure 6 illustrates crystallized 
scores by participation group and it seems that men who participated in Exams 4-12 tended 
to have the greatest performance over time. A similar pattern related to participation group 
emerged for fluid abilities and is depicted in Figure 7.  
 
Figure 6. Average crystallized performance over time by participation group. Lines represent 
average levels of performance among different participation groups. 
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Figure 7. Average fluid performance over time by participation group. Lines represent 
average levels of performance among different participation groups. 
 
Figures 6 and 7 illustrate that although there were general declines in cognition; 
performance seemed to vary as a function of participation group. In order to further 
investigate potential differences in participants based on group of participation, analyses of 
variance tests (ANOVAs) were conducted to examine if groups differed on biopsychosocial 
variables. Results from eight ANOVAs demonstrated significant differences in the following 
variables based on participation group: years of education F(9, 3696) = 16.11, p < 0.001; age 
F(9, 3696) = 62.61, p < 0.001; uric acid F(9, 3680) = 2.34, p = 0.012; glucose F(9, 3539) = 
2.91, p = 0.002; physical activity index F(9, 3410) = 12.95, p < 0.001; BMI F(9, 3580) = 
14.08, p < 0.001; depressive symptoms F(9, 3184) = 3.28, p = 0.001; and CASI score at 
Exam 4 F(9, 3696) = 68.71, p < 0.001. All analyses favored men who participated in HAAS 
1
2
3
4
5
6
7
8
9
10
4 5 6 7 8 9 10 11 12
Av
er
ag
e 
Fl
ui
d 
Pe
rfo
rm
an
ce
Exam
Exams 4-6 Exams 4-7 Exams 4-8 Exams 4-9
Exams 4-10 Exams 4-11 Exams 4-12
59 
 
across Exams 4-12. The aforementioned analyses suggest that missingness was not at random 
and that the Full Information Maximum Likelihood (FIML) function in Mplus would not be 
an acceptable method of data analysis. Thus, the following analyses were restricted to men 
who, at a minimum, participated in Exams 4 through 6 (i.e., men in Groups 3-9; N = 1,935).  
Participant descriptives of these 1,935 men are presented in Table 11.  
Analyses were employed to test for demographic differences between two mutually 
exclusive groups: (a) 3,734 men who had CASI data at Exam 4 and (b) 1,799 men who did 
not have CASI data across Exams 4-6 [e.g., 3,734 minus 1,935 (number of men who had data 
across Exams 4-6) equals 1,799 men]. Findings demonstrated that there were significant 
differences in age, t (5,531) = 10.01, p < 0.001 and education, t (5,531) = 5.88, p < 0.001. 
Additionally, there was a significant difference in marital status between these groups, χ2 (1, 
N = 5,247) = 129.19, p < 0.05. These analyses indicated that the subsample of 3,734 men 
were significantly younger and had more years of education than the 1,799 men without 
CASI data; furthermore, a greater proportion of the men from the 3,734 subsample were 
married compared to the 1,799 men without CASI data. 
 
 
 
 
 
 
 
60 
 
Table 11. Participant biopsychosocial characteristics of men with cognitive data across 
Exams 4-6 (N = 1,935) 
Variable  M SD Min Max Missing 
Age 76.58 3.94 71.00 92.00 0 
Education 10.95 3.15 2.00 24.00 0 
Glucose  112.06 26.33 44.00 298.00 35 
Uric acid 62.50 15.17 1.00 122.00 183 
Saturated fatty acid  33.78 15.54 0.00 129.70 0 
Monounsaturated fatty acid 35.12 15.77 0.00 125.10 0 
Polyunsaturated fatty acid 16.18 9.95 0.00 75.90 0 
BMI 23.87 2.99 14.62 39.34 41 
Physical activity index 31.39 4.68 24.00 69.80 64 
Depressive symptoms 3.51 3.56 0.00 25.00 126 
Social support 3.61 0.45 1.00 4.00 77 
Variable  N, Yes  % Yes  Missing   
Married 1,624 82.70 59   
APOE, presence of at least one ԑ4 375 19.10 10   
Hypertensive 1,431 72.90 0   
Daytime sleepiness 150 7.60 125   
Note. All variables were collected at Exam 4 with the exception of uric acid 
(Exam 3) and dietary fatty acids (Exam 1).  
 
Average crystallized and fluid performance by age 
To gain a better understanding of crystallized and fluid performance at Exam 4, I 
explored plots of mean performance in relation to age of the 1,935 identified men. Doing so 
provided a cross-sectional snapshot of performance at an inter-individual level. Figure 8 
illustrates how average crystallized and fluid performance mapped onto participant age at 
Exam 4 and it seems that the oldest participants had the poorest crystallized and fluid 
performance.  
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Figure 8. Age and average crystallized and fluid performance, Exam 4 (N = 1,935). 
Average crystallized and fluid performance by age, APOE, and education  
 The relationships between age and known associates of ADRD, including APOE and 
education were also investigated. This was examined using age categories (rather than 
individual ages) as the X-axis variable because it would deter against spikes in trend lines 
that might have resulted from sparse data at specific ages. Thus, the relationship among 
cognitive factors, age categories, and the presence of APOE-ԑ4 was explored. I grouped 
APOE by the lack of an ԑ4 allele (i.e., ԑ2/ԑ2, ԑ2/ԑ3, ԑ3/ԑ3) compared to the presence of at 
least one ԑ4 allele (i.e., ԑ2/ԑ4, ԑ3/ԑ4, ԑ4/ԑ4) since the presence of an ԑ4 allele is associated 
with an increased likelihood of ADRD (Deary et al., 2002). Figure 9 depicts how crystallized 
performance was comparable for participants with and without the APOE-ԑ4 allele. It seems 
as if participants in the oldest age group (88+ years) who had an APOE-ԑ4 allele had the 
lowest average fluid performance. There was a significant main effect of age on both crystallized 
Crystallized Abilities 
Fluid Abilities 
62 
 
abilities at Exam 4 (β = -0.22, p < 0.001) and fluid performance at Exam 4 (β = -0.32, p < 0.001). 
There was no support of a main effect of APOE-ԑ4 nor interaction of age X APOE-ԑ4 for either 
cognitive ability.  
 
Figure 9. Age and average crystallized and fluid performance by APOE-ԑ4, Exam 4 (N = 
1,935). 
 The relationship between age categories and cognitive abilities by education was 
examined and is illustrated in Figure 10. From this graphic, it seems as if the youngest 
participants had the greatest performance, regardless of education status. From a visual 
inspection of Figure 10, it also seems as if men in the oldest age group (88+) who had less 
than or equal to 12 years of education had the lowest levels of fluid performance. There was a 
significant main effect of age on crystallized abilities at Exam 4 (β = -0.27, p < 0.001). Findings 
indicated that education significantly moderated the relationship between age and fluid performance 
at Exam 4 (β = 1.20, p = 0.001). 
Crystallized Abilities 
Fluid Abilities 
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Figure 10. Age and average crystallized and fluid performance by education, Exam 4 (N = 
1,935).  
Investigating biopsychosocial associates of cognitive change via growth curve models  
Next, I examined biopsychosocial predictors of cognitive abilities (e.g., level and 
change) using growth curve models (GCM) to identify protective and risk factors of 
cognition. All predictors used in analyses were collected at Exam 4 with the exception of 
dietary variables that were collected at Exam 1 and random serum uric acid, which was 
collected at Exam 3. I conducted separate analyses for crystallized, fluid, and total cognition.  
Of the 1,935 participants who had cognition data across Exams 4-6, a total of 1,780 
participants were included in the analytic sample of Aim 1 as these men had responses for the 
15 biopsychosocial variables. The biopsychosocial characteristics of the 1,780 men included 
in this analytic sample are noted in Table 12 and the zero-order correlation matrix is provided 
in Table 13. Analyses were employed to test for demographic differences between two 
Crystallized Abilities 
Fluid Abilities 
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mutually exclusive groups: (a) 3,734 men who had CASI data at Exam 4 and (b) 1,954 men 
who were not included in the Aim 1 analytic sample [e.g., 3,734 minus 1,780 (Aim 1 analytic 
sample) equals 1,954 men].  Findings demonstrated that there were significant differences in 
age, t (5,686) = 9.75, p < 0.001 and education, t (5,868) = 5.82, p < 0.001. Additionally, there 
was a significant difference in marital status between these groups, χ2 (1, N = 5,116) = 7.37, 
p < 0.001. These analyses indicated that the subsample of 3,734 men were significantly 
younger and had more years of education than the 1,954 men not included in the Aim 1 
analytic sample; furthermore, a greater proportion of the men from the 3,734 subsample were 
married compared to the 1,954 men not included in the Aim 1 analytic sample. 
Table 12. Participant characteristics for Aim 1 analytic sample (N = 1,780) 
Variable  M SD Min Max 
Age 76.38 3.79 71.00 92.00 
Education 11.04 3.14 2.00 24.00 
Glucose  112.24 26.02 65.00 298.00 
Uric acid 62.50 15.17 1.00 122.00 
Saturated fatty acid  34.02 15.54 0.00 129.70 
Monounsaturated fatty acid 35.36 15.78 0.00 125.10 
Polyunsaturated fatty acid 16.34 10.06 0.00 75.90 
BMI 23.91 2.97 14.69 39.34 
Physical activity index 31.53 4.67 24.70 69.80 
Depressive symptoms 3.51 3.56 0.00 25.00 
Social support 3.61 0.44 1.00 4.00 
Variable  N, Yes  % Yes    
Married 1,527 85.79   
APOE, presence of at least one ԑ4 343 19.27   
Hypertensive 1,307 73.43   
Daytime sleepiness 145 8.15   
Note. All biopsychosocial variables were collected at Exam 4 with the exception of uric 
acid (Exam 3) and dietary fatty acids (Exam 1).  
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Table 13. Zero-order correlation matrix of biopsychosocial variables and cognitive abilities, Aim 1 (N = 1,780) 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. Age 1.00                 
2. Married -.11 1.00                               
3. Education -.14 .02 1.00                             
4. APOE -.03 -.03 .02 1.00                           
5. Glucose -.04 -.03 .02 .04 1.00                         
6. Uric acid -.04 -.04 .01 .00 .04 1.00                      
7. SFA -.15 .02 .09 -.01 .00 -.02 1.00                    
8. MUFA -.15 .02 .09 -.01 .01 -.01 .92 1.00                   
9. PUFA -.09 .00 .00 .00 .01 .00 .42 .50 1.00                 
10. BMI -.15 .03 -.03 -.01 .14 .16 .08 .08 .04 1.00               
11. Hypertension .04 -.02 .01 .03 .08 .08 -.05 -.06 -.07 .09 1.00             
12. PAI -.04 .04 -.06 .00 .01 -.01 -.01 .01 .02 -.01 .04 1.00           
13. Sleep .03 -.01 -.02 -.02 .00 -.04 .01 -.01 -.02 .01 .01 -.05 1.00         
14. Dep. symp. .00 -.05 -.04 -.02 -.03 -.04 -.03 -.02 -.02 -.04 -.03 -.06 .13  1.00      
15. Social support -.02 .06 .00 -.02 -.01 .00 .00 .00 -.03 .04 .00 .01 -.05 -.19  1.00    
16. Crys, Exam 4 -.21 .03 .39 .01 -.01 -.04 .11 .11 .03 .03 -.01 .03 -.05 -.08 .01 1.00   
17. Fluid, Exam 4 -.30 .05 .29 -.01 .01 -.01 .10 .11 .04 .07 -.02 .03 -.04 -.09 .01 .56 1.00 
Note. Married [0 (not married)]/1(married)]. APOE [0 (no ԑ4 allele)/1 (at least one ԑ4 allele)]. SFA= saturated fatty acids. MUFA= 
monounsaturated fatty acids. PUFA= polyunsaturated fatty acids. BMI= body mass index. Hypertension (0 [a blood pressure less than 140/90]/ 
1[blood pressure greater than or equal to 140/90 or taking blood pressure medication]). PAI= physical activity index. Sleep= daytime sleepiness. 
Dep. symp. = depressive symptoms. Crys, Exam 4= crystallized performance at Exam 4. Fluid, Exam 4= fluid performance at Exam 4. All 
variables were from Exam 4 with the exception of SFA, MUFA, PUFA, which were from Exam 1 and uric acid (Exam 3). Bolded values = p < 
0.01. 
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The remainder of analyses for Aim 1 are organized in subsections representing each 
of the cognitive abilities (i.e., crystallized, fluid, and total cognition). Within each subsection, 
I provide information on average changes in performance across Exams 4-6. I then highlight 
results from the GCM analyses that identified biopsychosocial predictors of cognition.  
Crystallized abilities performance. First, I examined crystallized performance of 
the 1,780 men in the Aim 1 analytic sample at a descriptive level. Table 14 provides the 
means, standard deviations, and range of scores of these men. There was an average decline 
of 0.37 points in crystallized performance from Exam 4 to Exam 5 and a decline of 0.39 
points between Exam 5 and Exam 6, resulting in an average decline of 0.76 points across 
Exams 4-6. Next, I calculated the average annual slope between Exam 4 and 6. There was an 
approximate eight-year span across Exams 4-6, spanning from 1991 (start of Exam 4) to 
1999 (end of Exam 6; refer to Table 2 for CASI exam years). As such, there was an average 
annual decline in 0.10 points in crystallized abilities [e.g., 0.76 (average decline) divided by 
8 (number of years between Exams 4-6)]. Figure 11 depicts the crystallized ability 
trajectories of a random sample of 255 men.  
Table 14. Average crystallized abilities performance for Aim 1 analytic sample (N =1,780) 
Variable  M SD Min Max 
Crystallized abilities, Exam 4 9.12 0.55 5.75 9.88 
Crystallized abilities, Exam 5 8.75 0.80 0.00 9.73 
Crystallized abilities, Exam 6 8.36 1.47 0.00 9.68 
Note. Average annual decline of 0.10 points in crystallized abilities. Cohen’s d between 
Exam 4 and 5 was 0.53, indicating a medium effect size. Cohen’s d between Exam 5 and 6 
was 0.32, indicating a small effect size. Cohen’s d from Exam 4-6 was 0.68, indicating a 
medium effect size (Cohen, 1988). 
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Figure 11. Intra-individual performance trajectories of crystallized abilities from Aim 1 
analytic sample (N = 255). 
Growth curve model of crystallized abilities. Next, a growth curve model assessing 
biopsychosocial associates of crystallized abilities was conducted to identify cognitive risk 
and protective factors. The measurement model had excellent fit to the data: χ2 (11) = 0; the 
CFI was 1 and RMSEA was 0. The variance for the intercept was 0.26 (p < 0.001) and the 
variance for the slope was 0.19 (p < 0.001). This allowed me to run the causal model with 
biopsychosocial predictors, which also fit the data well, χ2 (15) = 66.81, CFI = 0.97, RMSEA 
= 0.04. As noted in Table 15, the intercept term was significantly and positively associated 
with education (β = 0.50, p < 0.001) and physical activity (β = 0.06, p = 0.05) demonstrating 
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that those with greater levels of education and physical activity tended to have higher levels 
of crystallized abilities at baseline. The intercept term was significantly and negatively 
associated with age (β = -0.17, p < 0.001), depressive symptoms (β = -0.08, p = 0.01), and 
uric acid (β = -0.07, p = 0.01) indicating that older participants, those with greater depressive 
symptoms at Exam 4, and higher levels of uric acid at Exam 3 tended to have lower 
crystallized performance at baseline. 
There was an average annual decline in crystallized abilities of 0.10 points (refer to 
Table 14). Four variables were significantly associated with this slope, including education (β 
= 0.09, p = 0.01), suggesting that participants with greater levels of education tended to have 
less steep declines in their crystallized performance over time. The crystallized linear slope 
term was significantly and negatively associated with age (β = -0.24, p < 0.001), the presence 
of an APOE-ԑ4 allele (β = -0.14, p < 0.001), and depressive symptoms (β = -0.14, p < 0.001). 
This indicated that older participants and those with greater reported depressive symptoms at 
baseline along with those who had less protective APOE alleles had steeper declines in their 
crystallized abilities.1 Significant standardized results are shown in Figure 12.  
 
 
 
 
 
 
 
                                                 
1 Given the dual nature of the APOE-ԑ2/ԑ4 genotype (Lu, Bian, Zhang, & Wen, 2014) and the recommendation of a 
clinician collaborator, I re-ran the analysis excluding men with ԑ2/ԑ4 (n=21). Results remained the same. 
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Table 15. Biopsychosocial associates of crystallized abilities intercept and change (N 
=1,780) 
  Intercept   Linear slope 
Variable b S.E. β p b S.E. β p 
Age -0.02 0.00 -0.17 < .001 -0.03 0.00 -0.24 < .001 
Marital status -0.01 0.03 -0.01 0.700 0.01 0.04 0.01 0.790 
Education 0.07 0.00 0.50 < .001 0.01 0.00 0.09 0.010 
APOE-ԑ4 0.00 0.03 0.00 0.970 -0.14 0.03 -0.14 < .001 
Glucose 0.00 0.00 -0.02 0.390 0.00 0.00 -0.05 0.150 
Uric acid 0.00 0.00 -0.07 0.010 0.00 0.00 -0.04 0.240 
SFA 0.00 0.00 0.00 0.990 0.00 0.00 -0.09 0.350 
MUFA 0.00 0.00 0.07 0.340 0.00 0.00 0.04 0.670 
PUFA 0.00 0.00 -0.02 0.470 0.00 0.00 -0.04 0.270 
BMI 0.00 0.00 0.02 0.520 0.00 0.01 0.02 0.600 
Hypertension -0.01 0.03 -0.01 0.730 0.01 0.03 0.01 0.690 
PAI 0.01 0.00 0.06 0.050 0.00 0.00 -0.03 0.450 
Daytime sleep -0.04 0.04 -0.03 0.330 -0.07 0.05 -0.05 0.140 
Depressive sym. -0.01 0.00 -0.08 0.010 -0.02 0.00 -0.14 < .001 
Social support -0.02 0.03 -0.02 0.560 0.00 0.03 0.00 0.960 
Note. SFA= saturated fatty acids. MUFA= monounsaturated fatty acids. PUFA= 
polyunsaturated fatty acids. BMI= body mass index. PAI= physical activity index. 
Daytime sleep= daytime sleepiness. Depressive sym. = depressive symptoms. Married [0 
(not married)]/1(married)]. APOE [0 (no ԑ4 allele)/1 (at least one ԑ4 allele)]. Hypertension 
[0 (a blood pressure less than 140/90)/ 1(blood pressure greater than or equal to 140/90 or 
taking blood pressure medication)]. All variables were from Exam 4 with the exception of 
SFA, MUFA, PUFA, which were from Exam 1 and uric acid (Exam 3). Standardized 
correlation between intercept and linear term was 0.47 (p = 0.003).    
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Figure 12. Significant standardized associations among biopsychosocial variables and the intercept as well as linear slope of 
crystallized abilities. Crys at 4, 5, and 6= crystallized abilities performance at Exams 4, 5, and 6 (N = 1,780). 
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Fluid abilities performance. Next, I investigated fluid abilities. Table 16 provides 
descriptive statistics of fluid abilities performance of men in the Aim 1 analytic sample. 
There was an average decline of 0.36 points in fluid performance from Exam 4 to Exam 5 
and a decline of 0.67 points between Exam 5 and Exam 6, resulting in an average decline of 
1.03 points across Exams 4-6. There was an average annual decline in 0.13 points in fluid 
abilities across the eight years between Exams 4 and 6 [e.g., 1.03 (average decline) divided 
by 8 (number of years between Exams 4-6)]. Figure 13 illustrates the intra-individual 
changes in the fluid abilities using a random sample of 255 men.  
Table 16. Average fluid abilities performance for Aim 1 analytic sample (N = 1,780) 
Variable  M SD Min Max 
Fluid abilities, Exam 4 7.17 1.15 2.30 8.90 
Fluid abilities, Exam 5 6.81 1.41 0.00 9.07 
Fluid abilities, Exam 6 6.14 1.78 0.00 8.97 
Note. Average annual decline of 0.13 points in fluid abilities. Cohen’s d between Exam 4 
and 5 was 0.28, indicating a small effect size. Cohen’s d between Exam 5 and 6 was 0.41, 
indicating a small effect size. Cohen’s d from Exam 4-6 was 0.69, indicating a medium 
effect size (Cohen, 1988).  
 
 
Figure 13. Intra-individual fluid abilities performance trajectories of a random sample of 
men from Aim 1 analytic sample (N = 255). 
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Growth curve model of fluid abilities. The GCM measurement model for fluid 
abilities fit the data well: χ2 (11) = 0, CFI = 1 and RMSEA = 0. The variance for the intercept 
was 0.92 (p < 0.001) and the variance for the slope was 0.14 (p < 0.001). The causal model 
also fit the data well: χ2 (15) = 16.61, the CFI was 0.99 and RMSEA was 0.01. Several 
significant results for the fluid intercept term parallel the crystallized intercept term findings 
noted above. For example, as noted in Table 17, the fluid intercept term was significantly and 
positively associated with education (β = 0.34, p < 0.001) while being significantly and 
negatively related to age (β = -0.31, p < 0.001) and depressive symptoms (β = -0.11, p < 
0.001). A trend was observed between the fluid abilities intercept term and the following 
variables: uric acid (β = -0.05, p = 0.07), MUFA (β = 0.13, p = 0.09), and BMI (β = 0.05, p = 
0.08).  
The average annual slope of fluid abilities was -0.13 points (see Table 16). The fluid 
abilities slope was significantly and positively associated with education (β = 0.09, p = 0.04) 
and marital status (β = 0.09,  p= 0.03) indicating that men with greater levels of education 
and those who were married tended to have less steep declines in fluid performance over 
time. As shown in Figure 14, the slope of fluid abilities was significantly and negatively 
associated with age (β = -0.27, p < 0.001), glucose (β= -0.10, p = 0.01), the presence of an 
APOE-ԑ4 allele (β = -0.14, p < 0.001), depressive symptoms (β = -0.08, p = 0.06), and 
daytime sleepiness (β = -0.08, p = 0.04).  
These results indicate that older participants, those who had higher levels of glucose, 
men who had an APOE-ԑ4 allele, those who reported greater levels of depressive symptoms, 
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as well as men who had reported greater levels of daytime sleepiness tended to exhibit 
steeper declines in their fluid abilities over time.2  
Table 17 . Biopsychosocial associates of fluid abilities intercept and change (N = 1,780) 
  Intercept   Linear slope 
Variable b S.E. β p b S.E.  β p 
Age -0.07 0.01 -0.31 < .001 -0.03 0.01 -0.27 < .001 
Marital status 0.05 0.07 0.02 0.500 0.11 0.05 0.09 0.030 
Education 0.10 0.01 0.34 < .001 0.01 0.01 0.09 0.040 
APOE-ԑ4 -0.06 0.06 -0.03 0.320 -0.14 0.04 -0.14 < .001 
Glucose 0.00 0.00 -0.01 0.670 -0.00 0.00 -0.10 0.010 
Uric acid -0.00 0.00 -0.05 0.070 -0.00 0.00 -0.03 0.470 
SFA -0.00 0.00 -0.05 0.450 0.00 0.00 -0.02 0.880 
MUFA 0.01 0.00 0.13 0.090 0.00 0.00 0.02 0.860 
PUFA -0.00 0.00 -0.04 0.190 -0.00 0.00 -0.03 0.510 
BMI 0.02 0.01 0.05 0.080 0.00 0.01 0.03 0.530 
Hypertension -0.01 0.06 -0.00 0.910 0.00 0.04 0.00 0.990 
PAI 0.01 0.01 0.04 0.140 0.00 0.00 -0.03 0.430 
Daytime sleep -0.09 0.09 -0.03 0.300 -0.12 0.06 -0.08 0.040 
Depressive sym. -0.03 0.01 -0.11 < .001 -0.01 0.01 -0.08 0.060 
Social support -0.05 0.06 -0.02 0.410 0.03 0.04 0.03 0.520 
Note. SFA= saturated fatty acids. MUFA= monounsaturated fatty acids. PUFA= 
polyunsaturated fatty acids. BMI= body mass index. PAI= physical activity index. 
Daytime sleep= daytime sleepiness. Depressive sym. = depressive symptoms. Married [0 
(not married)]/1(married)]. APOE [0 (no ԑ4 allele)/1 (at least one ԑ4 allele)]. Hypertension 
[0 (a blood pressure less than 140/90)/ 1(blood pressure greater than or equal to 140/90 or 
taking blood pressure medication)]. All variables were from Exam 4 with the exception of 
SFA, MUFA, PUFA, which were from Exam 1 and uric acid (Exam 3). Standardized 
correlation between intercept and linear term was 0.50 (p = 0.006).    
                                                 
2 Given the dual nature of the APOE-ԑ2/ԑ4 genotype (Lu et al., 2014) and the recommendation of a clinician 
collaborator, I re-ran the analysis excluding men with ԑ2/ԑ4 (n = 21). The results primarily remained the same, 
however, associates of the slope changed: marital status and glucose were no longer significant and depressive 
symptoms went from a trend (p = 0.06) to significant (p < 0.001). 
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Figure 14. Significant standardized associations among biopsychosocial variables and the intercept as well as linear slope in fluid 
abilities. Solid lines=significant relationships p ≤ 0.05. Dashed lines= observed trends (0.06 ≤ p ≤ 0.10). Fluid at 4, 5, and 6= fluid 
abilities performance at Exams 4, 5, and 6 (N =1,780). 
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Total cognition performance. Descriptive information of total cognition 
performance is noted in Table 18. There was an average decline of 0.73 points in total 
cognition performance from Exam 4 to Exam 5 and a decline of 1.07 points between Exam 5 
and Exam 6, resulting in an average decline of 1.80 points in total cognition across Exams 4-
6. There was an average annual decline in 0.23 points in total cognition across the eight years 
between Exams 4 and 6 [e.g., 1.80 (average decline) divided by 8 (number of years between 
Exams 4-6)]. Figure 15 illustrates the intra-individual changes in the total cognition using a 
random sample of 255 men from the Aim 1 analytic sample.  
Table 18. Average total cognition performance for Aim 1 analytic sample (N = 1,780) 
Variable  M SD Min Max 
Total cognition, Exam 4 16.29 1.53 9.28 18.78 
Total cognition, Exam 5 15.56 2.04 0.00 18.80 
Total cognition, Exam 6 14.49 3.07 0.00 18.65 
Note. Average annual decline of 0.23 points in crystallized abilities. Cohen’s d between 
Exam 4 and 5 was 0.40, indicating a small effect size. Cohen’s d between Exam 5 and 6 
was 0.41, indicating a small effect size. Cohen’s d from Exam 4-6 was 0.74, indicating a 
medium effect size (Cohen, 1988).  
 
 
Figure 15. Intra-individual total cognition performance trajectories of a random sample of 
men from Aim 1 analytic sample (N = 255). 
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Growth curve model of total cognition. The measurement model for total cognition 
had excellent fit to the data: χ2 (11) = 0, CFI = 1, and RMSEA = 0. The variance for the 
intercept was 1.92 (p < 0.001) and the variance for the slope was 0.60 (p < 0.001). The causal 
model also fit the data well: χ2 (15) = 33.63, the CFI was 0.99 and RMSEA was 0.02. 
Analysis indicated several significant findings in relation to associates of the intercept and 
linear terms of total cognition that noted in Table 19. Specifically, the intercept term was 
significantly and positively associated with education (β = 0.42, p < 0.001) and a trend was 
observed between total cognition and physical activity index (β = 0.05, p = 0.07) indicating 
that men with greater levels of education and perhaps those with greater levels of physical 
activity tended to have higher levels of total cognitive performance at baseline. The intercept 
term was significantly and negatively associated with age (β = -0.28, p < 0.001), depressive 
symptoms (β = -0.11, p < 0.001), and uric acid (β = -0.06, p = 0.02), suggesting that older 
men, men with greater depressive symptoms, and those with higher levels of inflammation as 
measured through uric acid tended to demonstrate lower levels of total cognition 
performance at baseline.  
The average annual slope of total cognition was -0.23 (refer to Table 18). This slope 
was significantly and positively associated with education (β = 0.09, p = 0.01) signifying that 
men with greater levels of education tended to have less steep declines in total cognition 
performance over time. A trend was observed between marital status and the linear term (β = 
0.06, p = 0.08). As illustrated in Figure 16, the total cognition slope was significantly and 
negatively associated with age (β = -0.27, p < 0.001), glucose (β = -0.08, p = 0.02), the 
presence of an APOE-ԑ4 allele (β = -0.15, p < 0.001), depressive symptoms (β = -0.12, p < 
0.001), and daytime sleepiness (β = -0.09, p = 0.01). This indicates that there were steeper 
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declines in total cognition for older participants, those who had at least one APOE-ԑ4 allele, 
and participants with greater levels of glucose, depressive symptoms, and daytime 
sleepiness.3  
Table 19. Biopsychosocial associates of total cognition intercept and change (N = 1,780). 
  Intercept   Linear slope 
Variable b S.E. β p b S.E.  β p 
Age -0.09 0.01 -0.28 < .001 -0.05 0.01 -0.27 < .001 
Marital status 0.03 0.09 0.01 0.760 0.14 0.08 0.06 0.080 
Education 0.16 0.01 0.42 < .001 0.02 0.01 0.09 0.010 
APOE-ԑ4  -0.06 0.08 -0.02 0.450 -0.28 0.07 -0.15 < .001 
Glucose -0.00 0.00 -0.02 0.540 -0.00 0.00 -0.08 0.020 
Uric acid -0.01 0.00 -0.06 0.020 -0.00 0.00 -0.04 0.260 
SFA -0.00 0.01 -0.04 0.600 -0.00 0.01 -0.07 0.480 
MUFA 0.01 0.01 0.11 0.120 0.00 0.01 0.06 0.570 
PUFA 0.00 0.00 -0.04 0.220 -0.00 0.00 -0.05 0.240 
BMI 0.02 0.01 0.04 0.120 0.01 0.01 0.03 0.510 
Hypertension -0.02 0.07 -0.01 0.800 0.02 0.06 0.01 0.720 
PAI 0.01 0.01 0.05 0.070 -0.00 0.01 -0.02 0.500 
Daytime sleep -0.12 0.12 -0.03 0.320 -0.26 0.10 -0.09 0.010 
Depressive sym. -0.04 0.01 -0.11 < .001 -0.03 0.01 -0.12 < .001 
Social support -0.07 0.07 -0.02 0.360 0.05 0.06 0.03 0.480 
Note. SFA= saturated fatty acids. MUFA= monounsaturated fatty acids. PUFA= 
polyunsaturated fatty acids. BMI= body mass index. PAI= physical activity index. 
Daytime sleep= daytime sleepiness. Depressive sym. = depressive symptoms. Married [0 
(not married)]/1(married)]. APOE [0 (no ԑ4 allele)/1 (at least one ԑ4 allele)]. Hypertension 
[0 (a blood pressure less than 140/90)/ 1(blood pressure greater than or equal to 140/90 or 
taking blood pressure medication)]. All variables were from Exam 4 with the exception of 
SFA, MUFA, PUFA, which were from Exam 1 and uric acid (Exam 3). Standardized 
correlation between intercept and linear term was 0.59 (p < 0.001).  
 
 
 
 
  
  
 
                                                 
3 Given the dual nature of the APOE-ԑ2/ԑ4 genotype (Lu et al., 2014) and the recommendation of a clinician 
collaborator, I re-ran the analysis excluding men with ԑ2/ԑ4 (n = 21). Results indicated uric acid and depressive 
symptoms were no longer significantly associated with the intercept term. Marital status, glucose, and social support 
were now significantly associated with the total cognition intercept. APOE, glucose, sleepiness, and depressive 
symptoms were no longer associated with the slope. BMI was associated with total cognition slope (p < 0.001).  
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Figure 16. Significant standardized associations among biopsychosocial variables and the intercept as well as linear slope in total 
cognition. Solid lines=significant relationships p ≤ 0.05. Dashed lines= observed trends (0.06 ≤ p ≤ 0.10). Tcog at 4, 5, and 6= 
total cognition performance at Exams 4, 5, and 6 (N =1,780). 
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Aim 2 
In this aim, I investigated the association of patterns of change in cognitive factors 
and ADRD. I hypothesized that men who demonstrated greater declines in their cognitive 
abilities would have an ADRD diagnosis at an earlier age and that men who maintained their 
cognitive abilities would either not have an ADRD diagnosis or would have a later life 
diagnosis. To do this, I conducted growth curve mixture models followed by survival 
analyses to explore time to ADRD diagnosis.  
Growth curve mixture models  
Growth curve mixture models (GCMM) were used to identify classes/patterns of 
cognitive performance over time for men who had, at minimum, cognition data across Exams 
4-6 (N = 1,935). Data from the 1,935 men were used for the GCMM.  
There are a variety of factors to take into consideration when deciding the optimal 
number of classes for a GCMM analysis, including examining fit indices such as the sample 
size adjusted Bayesian Information Criterion (i.e., adjusted BIC) and entropy values. Lower 
adjusted BICs indicate a better model fit (Feldman et al., 2009; Wickrama, Lee, O’Neal, & 
Lorenz, 2016). Entropy values range from 0 to 1 and assess the accuracy of class 
membership; larger entropy values translate into stronger class separation (Feldman et al.; 
Nagin, 2005; Wickrama et al.).  
First, I conducted GCMM of crystallized abilities. In addition to noting two fit 
indices, Table 20 provides information on the intercept, linear change terms, and class counts 
for five tested models. The five-class model fit the data well, adjusted BIC = 11,651.61, 
entropy = 0.96. Interestingly, there was a consistent pattern in terms of the number of 
participants per class across the tested models such that there was always one class that 
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consisted of the majority of participants that was characterized by a greater intercept term 
with a relatively small linear change term. For example, this modal group was Class 3 in the 
tested three class solution (n = 1,751), Class 3 in the four class solution (n = 1,648), and 
Class 5 in the five class solution (n = 1,650).  
Table 20. Crystallized abilities growth curve mixture model fit, intercept and linear terms, 
and class counts (N = 1,935) 
1 class | Adjusted BIC = 13,754.16    
Class 1      
Intercept 9.08      
Linear -0.39      
N per class 1,935      
2 classes | Adjusted BIC = 12,550.95 | Entropy = 0.99   
Class 1 2     
Intercept 9.10 8.65     
Linear -0.29 -3.06     
N per class 1,869 66     
3 classes | Adjusted BIC=12,051.26 | Entropy = 0.96   
Class 1 2 3    
Intercept 8.61 8.40 9.15    
Linear -3.40 -1.21 -0.23    
N per class 49 135 1,751    
4 classes | Adjusted BIC = 11,781.95 | Entropy = 0.96    
Class 1 2 3 4   
Intercept 8.61 8.54 9.18 8.51   
Linear -3.86 -0.89 -0.20 -2.16   
N per class 37 207 1,648 43   
5 classes | Adjusted BIC = 11,651.61 | Entropy = 0.96   
Class 1 2 3 4 5  
Intercept 8.66 8.57 7.15 8.79 9.18  
Linear -3.91 -2.22 -0.32 -1.00 -0.20  
N per class 37 40 37 171 1,650  
 
Figure 17 illustrates the differences among crystallized classes from the five-class 
solution. As can be seen from the graphic, men in two classes [e.g., Classes 3 (Moderate and 
maintain) and 5 (High and maintain)] seemed to maintain relatively stable in their 
crystallized performance, the difference being that men in Class 5 had greater intercepts than 
men in Class 3. On the other hand, men from three classes [e.g., Classes 1 (Moderately-high 
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and greatest-risk of drop), 2 (Moderately-high and high-risk of drop), and 4 (Moderately-high 
and low-risk of drop)] had noticeable declines. Men in the Moderately-high and greatest-risk 
of drop class seem to be at the greatest risk as they have moderately high intercepts but the 
steepest declines over time.   
 
Figure 17. Growth curve mixture model classes over time, crystallized abilities. N = 1,935. 
 
Next, I conducted GCMM of fluid abilities. Table 21 provides results from the tested 
five-class solutions. It is important to note that findings from these GCMM analyses 
produced warning messages indicating the fluid abilities linear and intercept terms for 
Classes 2-5 were highly correlated. The Class 1 solution did not have any warning messages 
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and it fit the data well; as such, this class solution was used in the current study. Figure 18 
illustrates the change in the one-class solution across Exams 4-6.  
Table 21. Fluid abilities growth curve mixture model fit, intercept and linear terms, and class 
counts (N=1,935) 
1 class | Adjusted BIC = 18,586.28    
Class 1      
Intercept 7.14      
Linear -0.49      
N per class 1,935      
2 classes | Adjusted BIC = 18,230.339 | Entropy = 0.88   
Class 1 2     
Intercept 6.01 7.28     
Linear -1.73 -0.36     
N per class 195 1,740     
3 classes | Adjusted BIC = 18,010.22 | Entropy = 0.87   
Class 1 2 3    
Intercept 7.48 4.89 6.69    
Linear - 0.40 - 0.30 - 2.19    
N per class 1,615 205 115    
4 classes | Adjusted BIC = 17,903.71 | Entropy = 0.86    
Class 1 2 3 4   
Intercept 7.59 5.43 6.83 3.87   
Linear - 0.40 - 0.13 -2.06 -1.16   
N per class 1,506 254 135 40   
5 classes | Adjusted BIC = 17,848.05 | Entropy = 0.83   
Class 1 2 3 4 5  
Intercept 5.35 4.07 6.91 7.62 6.98  
Linear -0.05 -1.21 -1.32 -0.33 -2.82  
N per class 229 52 209 1,400 45  
Note. Statistical output noted warning messages pertaining to high correlations between the 
intercept and linear terms for the Classes 2-5 structure solutions; thus, the 1 class solution 
was used in the current study. 
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Figure 18. Growth curve mixture model classes over time, fluid abilities. N = 1,935. 
Subsequently, I conducted GCMM of total cognition. Results from five tested models 
are presented in Table 22. Although the entropy value for the three class solution was slightly 
higher than that of the five class solution, the adjusted BIC was lowest for the five class 
solution; Nylund, Asparouhov, and Muthén (2007) note that the adjusted BIC is a pivotal 
indicator for deciding the number of classes, thus, the five class solution was selected. Figure 
19 illustrates the differences among classes. Similar to the crystallized GCMM results, two 
classes [e.g., Classes 1 (Moderate and maintain) and 5 (High and maintain)] seemed to 
maintain relatively stable in their total cognition performance over time whereas men in three 
classes [e.g., Classes 2 (Low and drop), 3 (Moderately-high and greatest-risk of drop), and 4 
(Moderately-high and low-risk of drop)] had declines.   
 
 
0
1
2
3
4
5
6
7
8
9
10
4 5 6
Fl
ui
d 
Pe
rfo
rm
an
ce
 
Exam
84 
 
Table 22. Total cognition growth curve mixture model fit, intercept and linear terms, and 
class counts (N = 1,935) 
1 class | Adjusted BIC = 23,084.91      
Class 1       
Intercept 16.22       
Linear -0.85       
N per class 1,935       
2 classes | Adjusted BIC = 22,262.24 | Entropy = 0.98  
Class 1 2      
Intercept 16.28 14.83      
Linear -0.68 -4.96      
N per class 1,847 88      
3 classes | Adjusted BIC = 21,950.83 | Entropy = 0.94    
Class 1 2 3     
Intercept 16.42 14.63 14.87     
Linear -0.56 -2.46 -5.96     
N per class 1,709 174 52     
4 classes | Adjusted BIC =21,834.69 | Entropy = 0.91    
Class 1 2 3 4    
Intercept 15.05 12.84 14.89 16.62    
Linear -2.73 -0.41 -6.10 -0.60    
N per class 145 112 51 1,627    
5 classes| Adjusted BIC = 21,679.23 | Entropy = 0.90    
Class 1 2 3 4 5   
Intercept 13.63 10.67 15.43 15.52 16.76   
Linear -0.34 -2.78 -6.07 -2.56 -0.59   
N per class 187 31 46 142 1,529   
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Figure 19. Growth curve mixture model classes over time, total cognition. N = 1,935. 
Survival analysis 
Next, survival analyses, specifically Cox proportional hazards regressions, were 
employed to investigate age at ADRD diagnosis using the GCMM classes as predictors. 
Specifically, Class 5 was the reference group for crystallized abilities and total cognition 
survival analyses. Age at either ADRD diagnosis or last CASI exam was the time scale. The 
event was whether the participant was diagnosed with ADRD or not. Of the 1,935 
participants with CASI data across Exams 4-6, a total of 599 men had an ADRD diagnosis 
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across Exams 4-12 (see Table 23). Of the 599 men who had an ADRD diagnosis, 191 men 
had a diagnosis across Exams 4-6.  
Table 23. Number of participants diagnosed with ADRD at each exam 
Exam  Frequency Percent Hazard rate (%) 
Exam 4 23 3.84 0.61 
Exam 5 63 10.52 2.32 
Exam 6 105 17.53 5.27 
Exam 7 51 8.51 3.34 
Exam 8 107 17.86 9.07 
Exam 9 66 11.02 7.26 
Exam 10 85 14.19 15.45 
Exam 11 71 11.85 18.68 
Exam 12 28 4.67 11.11 
Total  599 100.00  
 
It is important to note that for the survival analyses, the dependent variable was 
ADRD diagnosis across Exams 7-12 because the GCMM classes of changes in cognition 
(across Exams 4-6) were the predictor variables. There was left truncation of participants 
who had an ADRD diagnosis between Exams 4-6 (n = 191). Of the 1,935 men who had 
CASI data across Exams 4-6, 191 men were excluded from the survival analyses, resulting in 
an analytic sample of 1,744 men. Of these men, 408 experienced the event (i.e., 23% had a 
diagnosis of ADRD between Exams 7-12), whereas 1,336 were right-censored, as they did 
not have an ADRD diagnosis. Table 24 provides descriptive statistics of biopsychosocial 
variables for the 1,744 men. Tables 25 and 26 provide correlation matrices for men who had 
dementia across Exams 7-12 and those who did not have a dementia, respectively.  
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Analyses were employed to test for demographic differences between two mutually 
exclusive groups: (a) 3,734 men who had CASI data at Exam 4 and (b) 1,990 men who were 
not included in the Aim 2 analytic sample [e.g., 3,734 minus 1,744 (Aim 2 analytic sample) 
equals 1,990 men]. Findings demonstrated that there were significant differences in age, t 
(5,722) = 10.32, p < 0.001 and education, t (5,722) = 5.51, p < 0.001. Additionally, there was 
a significant difference in marital status between these groups, χ2 (1, N = 5,183) = 7.14, p < 
0.05. These analyses demonstrated that the subsample of 3,734 men were significantly 
younger and had more years of education than the 1,990 men not included in the Aim 2 
analytic sample; furthermore, a greater proportion of the men from the 3,734 subsample were 
married compared to the 1,990 men not included in the Aim 2 analytic sample. 
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Table 24. Participant biopsychosocial characteristics for Aim 2 analytic sample (N=1,744) 
 Dementia, Exams 7-12 | N= 408 No Dementia | N=1,336 
Variable  M SD Min Max Missing M SD Min Max Missing 
Age 76.18 3.56 71.00 89.00 0 76.28 3.70 71.00 92.00 0 
Education 11.00 3.25 2.00 21.00 0 11.04 3.10 3.00 24.00 0 
Glucose  112.37 28.30 65.00 298.00 5 111.95 25.51 44.00 296.00 18 
Uric acid 61.71 15.28 1.00 116.00 24 62.88 15.10 1.00 122.00 107 
Saturated fatty acid  33.09 14.75 0.00 129.70 0 34.28 15.59 0.00 120.50 0 
Monounsaturated fatty acid 33.94 14.45 0.00 83.40 0 35.81 15.98 0.00 125.10 0 
Polyunsaturated fatty acid 15.65 9.93 0.00 75.90 0 16.42 9.89 0.00 67.30 0 
BMI 24.11 2.92 16.57 37.64 2 23.87 2.98 14.62 39.34 6 
Physical activity index 31.40 4.55 24.70 51.10 8 31.47 4.70 24.10 69.80 29 
Depressive symptoms 3.48 3.29 0.00 18.00 12 3.37 3.43 0.00 25.00 68 
Social support 3.64 0.42 1.83 4.00 7 3.61 0.45 1.00 4.00 30 
Variable  N, Yes  % Yes Missing    N, Yes  % Yes Missing    
Married 352 86.30 8.00   1,120 83.60 26.00   
APOE, presence of at least one ԑ4 93 22.80 2.00   223 16.70 3.00   
Hypertensive 309 75.70 0.00   977 73.00 0.00   
Daytime sleepiness 34 8.30 14.00   92 6.90 68.00   
Note. All variables were collected at Exam 4 with the exception of uric acid (Exam 3) and dietary fatty acids (Exam 1). 
Hypertensive = blood pressure greater than or equal to 140/90 or taking blood pressure medication.  
 
 
 
 
 
 
89 
Table 25. Zero-order correlation matrix of biopsychosocial variables and cognitive abilities, Aim 2 men with dementia exam 7-12 
(listwise deletion N=384) 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. Age 1.00                 
2. Married -.10 1.00                              
3. Education -.13 -.04 1.00                            
4. APOE -.03 .06 .05 1.00                          
5. Glucose .08 -.07 .06 .05 1.00                        
6. Uric acid -.01 .01 .02 -.03 .07 1.00                      
7. SFA -.12 .04 .12 .06 .01 -.10 1.00                    
8. MUFA -.14 .04 .10 .03 .01 -.07 .90 1.00                  
9. PUFA -.11 -.09 -.06 .02 .05 .02 .39 .49 1.00                
10. BMI -.10 .10 .03 .06 .10 .06 .18 .19 .10 1.00              
11. Hypertension .07 -.06 .00 .06 .09 .05 -.06 -.08 -.09 .08 1.00            
12. PAI -.06 .05 .02 -.03 -.04 -.08 .01 .02 -.01 -.04 .04 1.00          
13. Sleep -.01 .03 .01 -.03 -.03 -.09 -.02 -.01 -.08 .05 -.04 -.05 1.00        
14. Dep. symp. -.02 -.06 .01 -.04 .01 .03 -.12 -.10 -.03 -.04 .03 .01 .18 1.00      
15. Social support .07 .03 -.05 .00 .07 .01 .06 .05 .04 .06 -.01 .00 -.08 -.20 1.00    
16. Crys, Exam 4 -.24 .06 .44 .06 -.05 -.06 .17 .17 .06 .01 -.03 .03 -.02 -.02 -.07 1.00  
17. Fluid, Exam 4 -.32 .07 .31 .04 -.04 -.09 .13 .16 .11 .07 -.04 .01 .02 -.10 -.10 .49 1.00 
Note. Married [0 (not married)]/1(married)]. APOE [0 (no ԑ4 allele)/1 (at least one ԑ4 allele)]. SFA= saturated fatty acids. MUFA= 
monounsaturated fatty acids. PUFA= polyunsaturated fatty acids. BMI= body mass index. Hypertension (0 [a blood pressure less than 140/90]/ 
1[blood pressure greater than or equal to 140/90 or taking blood pressure medication]). PAI= physical activity index. Sleep= daytime sleepiness. 
Dep. symp. = depressive symptoms. Crys, Exam 4= crystallized performance at Exam 4. Fluid, Exam 4= fluid performance at Exam 4. All 
variables were from Exam 4 with the exception of SFA, MUFA, PUFA, which were from Exam 1 and uric acid (Exam 3). Bolded values= p < 
0.01. 
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Table 26. Zero-order correlation matrix of biopsychosocial variables and cognitive abilities, Aim 2 men without dementia exam 7-12 
(listwise deletion N=1,232) 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. Age 1.00                 
2. Married -.09 1.00                              
3. Education -.12 .06 1.00                            
4. APOE -.05 -.06 .03 1.00                          
5. Glucose -.07 -.04 .01 .03 1.00                        
6. Uric acid -.04 -.06 .00 .00 .04 1.00                      
7. SFA -.14 .01 .07 -.03 .00 .00 1.00                    
8. MUFA -.14 .02 .07 -.01 .02 .00 .92 1.00                  
9. PUFA -.07 .01 .02 -.01 .00 .01 .41 .50 1.00                
10. BMI -.17 .00 -.07 -.01 .13 .17 .07 .07 .05 1.00              
11. Hypertension .06 .00 .01 .03 .08 .10 -.07 -.07 -.08 .09 1.00            
12. PAI -.02 .05 -.09 .02 .04 .01 -.02 .00 .03 -.01 .04 1.00          
13. Sleep .04 -.04 -.01 -.04 .01 -.02 .01 .00 .00 -.01 .02 -.04 1.00        
14. Dep. symp. -.01 -.03 -.05 -.04 -.03 -.06 .00 .01 -.01 -.03 -.04 -.07 .08 1.00      
15. Social support -.02 .06 .02 .00 -.03 -.01 .00 -.01 -.05 .02 .00 .00 -.03 -.18 1.00    
16. Crys, Exam 4 -.16 .02 .40 .03 -.01 -.06 .11 .10 .05 -.01 -.02 .01 -.05 -.09 .01 1.00  
17. Fluid, Exam 4 -.24 .04 .28 .05 .04 -.02 .09 .09 .02 .03 -.02 .00 -.02 -.07 .01 .52 1.00 
Note. Married [0 (not married)]/1(married)]. APOE [0 (no ԑ4 allele)/1 (at least one ԑ4 allele)]. SFA= saturated fatty acids. MUFA= 
monounsaturated fatty acids. PUFA= polyunsaturated fatty acids. BMI= body mass index. Hypertension (0 [a blood pressure less than 140/90]/ 
1[blood pressure greater than or equal to 140/90 or taking blood pressure medication]). PAI= physical activity index. Sleep= daytime sleepiness. 
Dep. symp. = depressive symptoms. Crys, Exam 4= crystallized performance at Exam 4. Fluid, Exam 4= fluid performance at Exam 4. All 
variables were from Exam 4 with the exception of SFA, MUFA, PUFA, which were from Exam 1 and uric acid (Exam 3). Bolded values= p < 
0.01. 
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The unadjusted survival function of ADRD diagnosis is depicted in Figure 20 and it 
demonstrates that 50% of participants would have an ADRD diagnosis near 95 years of age.  
 
Figure 20. Base, unadjusted survival function for ADRD diagnosis. N = 1,744. 
First, survival analyses were conducted using crystallized abilities GCMM classes. 
The proportional hazards assumption for crystallized classes and ADRD diagnosis was met 
and tested using Schoenfeld’s residuals global test (p = 0.16; Schoenfeld, 1982) indicating 
that the effect of class was constant with age (i.e., the effect of being in a certain class was 
proportional for all ages). Results indicated that there were no significant GCMM class-based 
risk ratios related to ADRD diagnosis (Table 27).4 Although not significant, men of the 
Moderately-high and low-risk of drop class (i.e., Class 4), had the greatest risk of ADRD 
across the classes with a hazard ratio (HR) of 1.31. Figure 21 illustrates the approximate 
median age of survival by crystallized GCMM class. At approximately age 95, 50% of men 
in the High and maintain class (i.e., Class 5; reference group) would be diagnosed with 
                                                 
4 Given the dual nature of the APOE-ԑ2/ԑ4 genotype (Lu et al., 2014) and the recommendation of a clinician 
collaborator, I re-ran the analysis excluding men with ԑ2/ԑ4 (n =21); results remained the same. 
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ADRD whereas 50% of men in the Moderately-high and high-risk of drop class (i.e., Class 2) 
would have ADRD at 100 years old.  
Table 27. Cox proportional hazards of ADRD diagnosis by crystallized abilities growth 
curve mixture model classes (N = 1,744) 
GCMM class Hazard ratio 95% CI p 
Class 1 | Moderately-high and greatest-risk of drop 0.00 0.00 9.95 0.92 
Class 2 | Moderately-high and high-risk of drop 0.38 0.05 2.72 0.33 
Class 3 | Moderate and maintain 0.77 0.36 1.64 0.50 
Class 4 | Moderately-high and low-risk of drop 1.31 0.89 1.94 0.16 
Note. Reference group is GCMM Class 5, High and maintain.* p < 0.05 
 
 
Figure 21. Survival function for ADRD diagnosis, crystallized growth curve mixture model 
classes. Plateaus in class trend lines are due to data sparsity (N = 1,744). 
 
Due to the fact that results of the GCMM analysis indicated a one-class solution fit 
fluid abilities performance, there was no variability in classes; thus, no survival analysis was 
conducted for fluid abilities.  
Next, survival analysis of ADRD using total cognition GCMM classes was 
conducted. The proportional hazards assumption for total cognition classes and ADRD 
diagnosis was met and tested using Schoenfeld’s residuals global test (p = 0.69; Schoenfeld, 
Crystallized Class 
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1982), indicating the effect of being in a certain class is proportional for all ages. Results are 
noted in Table 28 and indicate that the risk of a ADRD diagnosis was 1.64 times greater for 
men in the Moderately-high and low-risk of drop class (i.e., Class 4) compared to men in the 
High and maintain class (i.e., Class 5), p = 0.02.5 Figure 22 illustrates the survival function 
by total cognition GCMM classes. Median survival age (i.e., the age at which 50% of 
participants would have an ADRD diagnosis) varied across classes; for example, median 
survival age for men in the Moderately-high and low-risk of drop class (i.e., Class 4) was 
approximately 92 years.  
Table 28. Cox proportional hazards of ADRD diagnosis by total cognition growth curve 
mixture model classes (N = 1,744) 
GCMM class Hazard ratio 95% CI    p 
Class 1 | Moderate and maintain 1.06 0.78 1.43 0.68 
Class 2 | Low and drop 0.00 0.00 3.51 0.94 
Class 3 | Moderately-high and greatest-risk of drop 0.00 0.00 5.41 0.93 
Class 4 | Moderately-high and low-risk of drop 1.64* 1.08 2.50 0.02 
Note. Reference group is GCMM Class 5. * p < 0.05 
 
 
Figure 22. Survival function for ADRD diagnosis, total cognition growth curve mixture 
model classes. Plateaus in class trend lines due to data sparsity. Note that lines for Classes 2 
and 3 are overlapping (N = 1,744).  
                                                 
5 Given the dual nature of the APOE-ԑ2/ԑ4 genotype (Lu et al., 2014) and the recommendation of a clinician 
collaborator, I re-ran the analysis excluding men with ԑ2/ԑ4 (n = 21); results remained the same. 
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Post-hoc analyses. Below I describe two sets of post-hoc analyses. First, I conducted 
a follow-up analysis on the significant total cognition GCMM survival analysis results. Next, 
I assessed the survival function using a two-class model of Maintainers and Decliners of 
crystallized and total cognition GCMM classes.  
A further examination of total cognition results: Testing a two-class solution. Due 
to the fact that participants in total cognition GCMM Class Moderately-high and low-risk of 
drop (i.e., Class 4) were at an increased risk for ADRD and the number of participants in 
each class was unequal (i.e., see “N per class” in Table 22), an investigation of the survival 
function using fewer groups was warranted. I conducted the total cognition survival analysis 
again; however, this time I collapsed the groups to test a two-group model: GCMM Class 
Moderately-high and low-risk of drop (i.e., Class 4) versus a group with all other 
participants. Results indicated that participants not in the Moderately-high and low-risk of 
drop class were at a significantly reduced risk for ADRD diagnosis than participants in the 
Moderately-high and low-risk of drop class (HR = 0.60, p = 0.02, 95% CI: 0.40 to 0.91). 
Figure 23 shows the survival function of this two-class model and illustrates how median age 
of survival differed between the two classes. For example, median survival age for Class 4 
was approximately 92 years compared to 95 years for those in the other group, which was 
comprised of participants from total cognition GCMM Classes 1, 2, 3, and 5.  
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Figure 23. Survival function for two-class model of total cognition (Class 4 versus other 
classes; N = 1,744). 
Testing a two-class model of Maintainers and Decliners. In an effort to gain more 
concrete understanding of ADRD survival using indicators beyond the GCMM class labels as 
identifiers, I reran the original survival analyses using a two-class model. Specifically, I 
collapsed the GCMM classes into two groups of Maintainers (participants from Class 5) and 
Decliners (participants from Classes 1-4) because Class 5 participants had the greatest 
intercepts with the smallest slopes (i.e., they seemed to maintain their crystallized abilities 
and total cognition), whereas the other classes had noticeable declines and lower intercepts 
(refer to Tables 20 and 22).  
Results indicated that neither Maintainers nor Decliners of crystallized abilities were 
at greater risk for time to ADRD (HR = 1.38, 95% CI: 0.73 to 1.46, p = 0.85). Similarly, 
using total cognition, findings indicated that neither group was at an increased risk for time to 
ADRD (HR = 1.09, 95% CI: 0.85 to 1.41, p = 0.47). Figures 24 and 25 illustrate these 
survival curves. Figure 24 depicts the survival curves for the crystallized classes and in 
general, it seems that Maintainers were slightly (but not significantly) older than Decliners 
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when they were diagnosed with ADRD. This pattern held true for the total cognition (Figure 
25); however, there seemed to be a slightly more pronounced protective effect for 
Maintainers in the model using total cognition class compared to the crystallized abilities 
classes. 
 
Figure 24. Survival function for two-class model of crystallized abilities classes (Maintainers 
versus Decliners; N = 1,744). 
 
Figure 25. Survival function for two-class model of total cognition (Maintainers versus 
Decliners; N = 1,744). 
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Aim 3 
In Aim 3, I investigated the relationship between biopsychosocial factors and ADRD 
through the mediating role of the level (i.e., intercept) and change (i.e., linear slope) of 
cognitive ability (crystallized, fluid, and total cognition). I hypothesized that men who had 
higher levels of biopsychosocial protective factors would maintain their crystallized, fluid, 
and total cognition abilities, which would reduce risk of an ADRD diagnosis.  
Biopsychosocial variables noted in Aim 1 were used. Mediation was assessed using 
the intercept (performance at Exam 4) and linear changes (across Exams 4 through 6) in 
cognitive abilities and conducted with bootstrapping methods utilizing bias-corrected 
confidence intervals. The dichotomous outcome variable in this aim was ADRD diagnosis 
(Exams 7-12). Similar to Aim 2, this analysis excluded men who had an ADRD diagnosis 
across Exams 4 through 6.  
Of the 1,935 men who had cognition data across Exams 4-6, 1,744 did not have an 
ADRD diagnosis across Exams 4-6. Of the 1,744 men, 1,616 had responses for the 15 
biopsychosocial variables (128 men were missing biopsychosocial variables). As a result, the 
analytic sample for this aim included 1,616 men. Participant descriptive statistics for this 
analytic sample are provided in Table 29 and a zero-order correlation matrix is noted in 
Table 30. Analyses were employed to test for demographic differences between two mutually 
exclusive groups: (a) 3,734 men who had CASI data at Exam 4 and (b) 2,118 men who were 
not included in the Aim 3 analytic sample [e.g., 3,734 minus 1,616 (Aim 3 analytic sample) 
equals 2,118 men]. Findings demonstrated that there were significant differences in age, t 
(5,850) = 9.78, p < 0.001 and education, t (5,850) = 5.52, p < 0.001. Additionally, there was a 
significant difference in marital status between these groups, χ2 (1, N= 5,280) = 7.76, p < 
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0.05. These analyses indicated that the subsample of 3,734 men were significantly younger 
and had more years of education than the 2,118 men not included in the Aim 3 analytic 
sample; furthermore, a greater proportion of the men from the 3,734 subsample were married 
compared to the 2,118 men not included in the Aim 3 analytic sample. 
Table 29. Participant biopsychosocial characteristics for Aim 3 analytic sample (N = 1,616) 
Variable  M SD Min Max 
Age 76.16 3.61 71.00 92.00 
Education 11.11 3.14 2.00 24.00 
Glucose  112.13 25.95 65.00 298.00 
Uric acid 62.60 15.14 1.00 122.00 
Saturated fatty acid  34.15 15.45 0.00 129.70 
Monounsaturated fatty acid 35.50 15.72 0.00 125.10 
Polyunsaturated fatty acid 16.29 9.98 0.00 75.90 
BMI 23.97 2.95 15.30 39.34 
Physical activity index 31.54 4.67 24.70 69.80 
Depressive symptoms 3.40 3.40 0.00 25.00 
Social support 3.62 0.43 1.00 4.00 
Variable  N, Yes % Yes   
Married 1,396 86.40   
APOE, presence of at least one ԑ4 293 18.10   
Hypertensive 1,185 73.30   
Daytime sleepiness 123 7.60   
Note. All biopsychosocial variables were collected at Exam 4 with the exception of uric 
acid (Exam 3) and dietary fatty acids (Exam 1).  
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Table 30. Zero-order correlation matrix of biopsychosocial variables and cognitive abilities, Aim 3 (N = 1,616) 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. Age 1.00                 
2. Married -.10 1.00                              
3. Education -.13 .04 1.00                            
4. APOE -.04 -.03 .03 1.00                          
5. Glucose -.04 -.05 .02 .03 1.00                        
6. Uric acid -.04 -.05 .01 -.01 .05 1.00                      
7. SFA -.13 .02 .08 -.01 .00 -.02 1.00                    
8. MUFA -.14 .02 .07 -.01 .01 -.01 .92 1.00                  
9. PUFA -.08 -.01 .00 -.01 .01 .01 .41 .50 1.00                
10. BMI -.15 .03 -.05 .01 .13 .14 .09 .09 .05 1.00              
11. Hypertension .05 -.01 .01 .04 .09 .08 -.07 -.08 -.08 .09 1.00            
12. PAI -.02 .05 -.06 .01 .02 -.01 -.01 .00 .02 -.01 .04 1.00          
13. Sleep .03 -.02 -.01 -.04 .00 -.04 .01 .00 -.02 .00 .01 -.04 1.00        
14. Dep. symp. -.02 -.04 -.04 -.04 -.02 -.04 -.02 -.01 -.01 -.03 -.02 -.05 .11 1.00      
15. Social support .00 .06 .01 .00 -.01 -.01 .01 .00 -.04 .03 .00 .00 -.04 -.19 1.00    
16. Crys, Exam 4 -.18 .03 .41 .03 -.02 -.06 .12 .12 .05 .00 -.02 .01 -.04 -.08 -.01 1.00  
17. Fluid, Exam 4 -.25 .05 .29 .04 .01 -.04 .10 .11 .05 .04 -.03 .01 -.01 -.08 -.02 .51 1.00 
Note. Married [0 (not married)]/1(married)]. APOE [0 (no ԑ4 allele)/1 (at least one ԑ4 allele)]. SFA= saturated fatty acids. MUFA= 
monounsaturated fatty acids. PUFA= polyunsaturated fatty acids. BMI= body mass index. Hypertension (0 [a blood pressure less than 140/90]/ 
1[blood pressure greater than or equal to 140/90 or taking blood pressure medication]). PAI= physical activity index. Sleep= daytime sleepiness. 
Dep. symp. = depressive symptoms. Crys, Exam 4= crystallized performance at Exam 4. Fluid, Exam 4= fluid performance at Exam 4. All 
variables were from Exam 4 with the exception of SFA, MUFA, PUFA, which were from Exam 1 and uric acid (Exam 3). Bolded values= p < 
0.01. 
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Crystallized abilities performance 
Average crystallized performance at Exam 4, 5, and 6 is noted in Table 31. There was 
an average decline of 0.30 points in crystallized performance from Exam 4 to Exam 5 and a 
decline of 0.24 points between Exam 5 and Exam 6, resulting in an average decline of 0.54 
points across Exams 4-6. There was an approximate eight-year span across Exams 4-6 from 
1991 (start of Exam 4) to1999 (end of Exam 6; refer to Table 2 for CASI exam years); thus 
there was an average annual decline in 0.07 points in crystallized abilities [e.g., 0.54 (average 
decline) divided by 8 (number of years between Exams 4-6)]. Refer to Figure 26 for a graph 
of crystallized abilities performance trajectories of a random sample of 255 men.  
Table 31. Average crystallized abilities performance for Aim 3 analytic sample (N = 1,616) 
Variable  M SD Min Max 
Crystallized, Exam 4 9.15 0.52 5.75 9.87 
Crystallized, Exam 5 8.85 0.65 0.00 9.73 
Crystallized, Exam 6 8.61 1.07 0.00 9.67 
Note. Average annual decline of 0.07 points in crystallized abilities. Cohen’s d between 
Exam 4 and 5 was 0.51, indicating a medium effect size. Cohen’s d between Exam 5 and 6 
was 0.27, indicating a small effect size. Cohen’s d from Exam 4-6 was 0.64, indicating a 
medium effect size (Cohen, 1988). 
 
 
Figure 26. Intra-individual crystallized abilities performance trajectories of a random sample 
of men from Aim 3 analytic sample; men in this analytic sample did not have ADRD 
diagnoses across Exams 4-6 (N = 255). 
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Testing mediation via crystallized abilities. Next, I tested for mediation using the 
intercept and linear changes (across Exams 4 through 6) in crystallized abilities. The 
measurement model had excellent fit to the data: χ2 (1) = 0.37, CFI= 1, and RMSEA= 0. The 
variance for the intercept was 0.25 (p < 0.001) and the variance for the slope was 0.08 (p = 
0.02). The causal model also fit the data well: χ2 (16) = 34.97, the CFI was 0.99 and RMSEA 
was 0.03.  
Results indicated that age (β = -0.14, p < 0.001), depressive symptoms (β = -0.09, p = 
0.008), and uric acid (β = -0.08, p = 0.003) were significantly and negatively associated with 
the intercept term of crystallized abilities. Education (β = 0.48, p < 0.001) on the other hand 
was positively associated with the intercept term. These results demonstrate that older men, 
those with greater depressive symptoms, and uric acid tended to have poorer crystallized 
performance at baseline whereas those who had higher levels of education were likely to 
have greater levels of crystallized performance at baseline (Figure 27). 
The average annual slope in crystallized abilities for the Aim 3 analytic sample was    
-0.07 (refer to Table 31). As noted in Table 32, variables significantly and negatively 
associated with the slope of crystallized abilities included age (β = -0.27, p = 0.002) and uric 
acid (β = -0.15, p = 0.03). Trends were observed for the relationships between presence of 
APOE-ԑ4 (β = -0.11, p = 0.09) and the slope along with BMI (β = -0.11, p = 0.09) and the 
slope. Education (β = 0.16, p = 0.006) was positively associated with the crystallized abilities 
slope. These results indicate that older participants and those who reported greater depressive 
symptoms at baseline tended to have steeper declines in their crystallized abilities over time 
whereas those with greater levels of education were likely to have less steep declines in 
crystallized performance over time. 
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None of the 15 biopsychosocial variables had a significant direct association with 
ADRD diagnosis. However, there was an observed trend between presence of APOE-ԑ4 (β = 
0.08, p = 0.09) and ADRD diagnosis along with MUFA and ADRD diagnosis (β = -0.20, p = 
0.07), suggesting the potential that participants who had an APOE-ԑ4 allele had a greater 
likelihood of ADRD development across Exams 7-12 whereas those with greater MUFA 
dietary intake had a decreased risk of ADRD development.  
Furthermore, ADRD diagnosis across Exams 7-12 was negatively but not 
significantly associated with both the intercept (β = -0.20, p = 0.69) and slope (β = -0.36, p = 
0.83) of crystallized abilities.  
In regards to the indirect effects portion of the model, results indicated that neither the 
intercept nor slope of crystallized abilities significantly mediated any of the relationships 
between the biopsychosocial variables and ADRD (all total indirect p values > 0.426).6
                                                 
6 Given the dual nature of the APOE-ԑ2/ԑ4 genotype (Lu et al., 2014) and the recommendation of a clinician 
collaborator, I re-ran the analysis excluding men with ԑ2/ԑ4 (n =13); results remained the same. 
 
 
103 
 
Table 32. Biopsychosocial associates of crystallized intercept term and slope as well as ADRD (N = 1,616)  
 Intercept term Linear slope  ADRD  
Variable b S.E. β p b S.E. β p b S.E.  β p 
Age -0.02 0.00 -0.14 <.001 -0.01 0.00 -0.27 0.002 -0.01 0.03 -0.03 0.724 
Marital status -0.02 0.03 -0.01 0.643 0.01 0.03 0.03 0.651 0.12 0.13 0.04 0.325 
Education 0.07 0.00 0.48 <.001 0.01 0.00 0.16 0.006 0.02 0.02 0.05 0.526 
APOE-ԑ4  0.03 0.03 0.02 0.362 -0.05 0.03 -0.11 0.093 0.22 0.13 0.08 0.098 
Glucose 0.00 0.00 -0.03 0.354 0.00 0.00 -0.10 0.435 0.00 0.00 0.00 0.958 
Uric acid 0.00 0.00 -0.08 0.003 0.00 0.00 -0.15 0.025 0.00 0.00 -0.06 0.284 
SFA 0.00 0.00 0.06 0.300 0.00 0.00 -0.18 0.182 0.01 0.01 0.12 0.314 
MUFA 0.00 0.00 0.03 0.721 0.00 0.00 0.13 0.348 -0.01 0.01 -0.20 0.066 
PUFA 0.00 0.00 0.01 0.830 0.00 0.00 0.01 0.822 0.00 0.01 0.00 0.932 
Body mass index 0.00 0.01 -0.01 0.721 -0.01 0.00 -0.11 0.088 0.02 0.02 0.06 0.289 
Hypertension -0.01 0.03 -0.01 0.704 0.01 0.02 0.01 0.842 0.03 0.09 0.01 0.707 
Physical activity 0.00 0.00 0.03 0.188 0.00 0.00 -0.04 0.558 0.00 0.01 -0.01 0.820 
Daytime sleepiness -0.04 0.05 -0.03 0.433 -0.08 0.05 -0.14 0.119 0.07 0.28 0.02 0.805 
Depressive symptoms -0.01 0.00 -0.09 0.008 0.00 0.00 -0.09 0.144 0.00 0.01 0.01 0.845 
Social support  -0.03 -0.03 -0.04 -0.216 -0.02 0.02 -0.05 0.417 0.12 0.10 0.05 0.228 
Note. SFA= saturated fatty acids. MUFA= monounsaturated fatty acids. PUFA= polyunsaturated fatty acids. Married [0 (not 
married)]/1(married)]. APOE [0 (no ԑ4 allele)/1 (at least one ԑ4 allele)]. Hypertension [0 (a blood pressure less than 140/90)/ 
1(blood pressure greater than or equal to 140/90 or taking blood pressure medication)]. All biopsychosocial variables were 
from Exam 4 with the exception of dietary variables from Exam 1 and uric acid (Exam 3). Linear change in cognition was 
assessed using Exams 4-6. Binary variable, ADRD diagnosis, used Exams 7-12. 
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Figure 27. Significant standardized associations among biopsychosocial variables, crystallized intercept term, linear slope in 
crystallized abilities, and ADRD. Solid lines=significant relationships p ≤ 0.05. Dashed lines= observed trends (0.06 ≤ p ≤ 0.10). 
Crys at 4, 5, and 6= crystallized performance at Exams 4, 5, and 6. ADRD= Alzheimer’s disease and related dementias diagnosis 
across Exams 7-12 (N = 1,616). 
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Fluid abilities performance 
Next, I investigated fluid abilities performance; descriptive statistics of fluid abilities are 
noted in Table 33. There was an average decline of 0.27 points in fluid performance from Exam 
4 to Exam 5 and a decline of 0.55 points between Exam 5 and Exam 6, resulting in an average 
decline of 0.82 points across Exams 4-6. There was an average annual decline in 0.10 points in 
fluid abilities over the eight-year span [e.g., 0.82 (average decline) divided by 8 (number of years 
between Exams 4-6)]. Figure 28 illustrates the intra-individual changes in fluid abilities of a 
random sample of 255 men.  
Table 33. Average fluid abilities performance for Aim 3 analytic sample (N = 1,616) 
Variable  M SD Min Max 
Fluid abilities, Exam 4 7.28 1.05 3.17 8.90 
Fluid abilities, Exam 5 7.01 1.20 0.00 9.07 
Fluid abilities, Exam 6 6.46 1.44 0.00 8.97 
Note. Average annual decline of 0.10 points in fluid abilities. Cohen’s d between Exam 4 and 
5 was 0.23, indicating a small effect size.  Cohen’s d between Exam 5 and 6 was 0.42, 
indicating a small effect size. Cohen’s d from Exam 4-6 was 0.65, indicating a medium effect 
size (Cohen, 1988). 
 
 
Figure 28. Intra-individual fluid abilities performance trajectories of a random sample of men 
from Aim 3 analytic sample; men in this analytic sample did not have ADRD diagnoses across 
Exams 4-6 (N = 255). 
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Testing mediation via fluid abilities. Next, I conducted analyses to examine if fluid 
abilities mediated the relationship between biopsychosocial variables and ADRD. The 
measurement model had excellent fit to the data: χ2 (1) = 0.46, CFI=1, and RMSEA= 0. The 
variance for the intercept was 0.67 (p < 0.001) and the variance for the slope was 0.05 (p = 0.21). 
The causal model also fit the data well: χ2 (16) = 16.15, the CFI was 1 and RMSEA = 0.002. As 
noted in Table 34, age (β = -0.27, p < 0.001), depressive symptoms (β = -0.11, p = 0.002), and 
uric acid (β = -0.07, p = 0.022) were significantly and negatively associated with the intercept 
term of fluid abilities. Education (β = 0.36, p < 0.001) was positively associated with the fluid 
abilities intercept term. 
The annual average slope of fluid abilities was -0.10 (Table 33). The slope of fluid 
abilities was negatively associated with age (β = -0.30, p = 0.001). There was a trend between 
APOE-ԑ4 (β = -0.14, p = 0.068) and the linear term along with glucose (β = -0.16, p = 0.057) 
and the slope (see Figure 29). Education (β = 0.20, p = 0.007) was positively associated with the 
fluid abilities slope. These results indicate that older participants tended to have steeper declines 
in their fluid abilities over time while men with greater levels of education were likely to have 
less steep declines in fluid abilities over time.   
There were no significant direct associations with ADRD diagnosis (all p values > 
0.330). ADRD diagnosis across Exams 7-12 was not significantly associated with the intercept 
term (β = -0.21, p = 0.68) nor the slope term (β = 0.05, p = 0.93) of fluid abilities.  
Results indicated that neither the intercept nor slope significantly mediated any 
relationship between biopsychosocial variables and ADRD (all total indirect p values > 0.486).7
                                                 
7 Given the dual nature of the APOE-ԑ2/ԑ4 genotype (Lu et al., 2014) and the recommendation of a clinician collaborator, I 
re-ran the analysis excluding men with ԑ2/ԑ4 (n = 13); results remained the same. 
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Table 34. Biopsychosocial associates of fluid intercept term and slope as well as ADRD (N = 1,616) 
 Intercept term Linear slope  ADRD  
Variable b S.E. β p b S.E. β p b S.E.  β p 
Age -0.06 0.01 -0.27 <.001 -0.02 0.01 -0.30 0.001 -0.01 0.03 -0.05 0.598 
Marital status 0.05 0.07 0.02 0.520 0.08 0.05 0.12 0.121 0.12 0.26 0.04 0.652 
Education 0.09 0.01 0.36 <.001 0.01 0.01 0.20 0.007 0.02 0.03 0.06 0.542 
APOE-ԑ4  0.08 0.06 0.04 0.225 -0.08 0.04 -0.14 0.068 0.27 0.33 0.10 0.418 
Glucose 0.00 0.00 0.01 0.864 0.00 0.00 -0.16 0.057 0.00 0.00 0.01 0.906 
Uric acid 0.00 0.00 -0.07 0.022 0.00 0.00 -0.08 0.213 0.00 0.00 -0.06 0.337 
Saturated fatty acids 0.00 0.00 -0.03 0.696 0.00 0.00 0.02 0.926 0.01 0.01 0.12 0.437 
MUFA 0.01 0.00 0.11 0.143 0.00 0.00 0.03 0.876 -0.01 0.01 -0.19 0.271 
PUFA 0.00 0.00 -0.01 0.682 0.00 0.00 0.02 0.824 0.00 0.01 0.00 0.993 
Body mass index 0.00 0.01 0.01 0.654 0.00 0.01 -0.01 0.846 0.02 0.02 0.07 0.330 
Hypertension -0.03 0.05 -0.01 0.638 0.01 0.03 0.01 0.858 0.02 0.14 0.01 0.863 
Physical activity 0.00 0.01 0.02 0.477 0.00 0.00 -0.01 0.881 0.00 0.01 -0.01 0.931 
Daytime sleepiness -0.02 0.10 -0.01 0.815 -0.08 0.07 -0.10 0.235 0.12 0.35 0.03 0.732 
Depressive symptoms -0.02 0.01 -0.11 0.002 0.00 0.00 0.01 0.881 0.00 0.03 0.00 0.968 
Social support  -0.08 0.06 -0.04 0.179 0.01 0.03 0.01 0.832 0.11 0.16 0.05 0.496 
Note. MUFA= monounsaturated fatty acids. PUFA= polyunsaturated fatty acids. Married [0 (not married)]/1(married)]. APOE 
[0 (no ԑ4 allele)/1 (at least one ԑ4 allele)]. Hypertension [0 (a blood pressure less than 140/90)/ 1(blood pressure greater than or 
equal to 140/90 or taking blood pressure medication)]. All biopsychosocial variables were from Exam 4 with the exception of 
dietary variables from Exam 1 and uric acid (Exam 3). Linear change in cognition was assessed using Exams 4-6. Binary 
variable, ADRD diagnosis, used Exams 7-12. 
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Figure 29. Significant standardized associations among biopsychosocial variables, fluid intercept term, linear slope in fluid 
abilities, and ADRD. Solid lines=significant relationships p ≤ 0.05. Dashed lines= observed trends (0.06 ≤ p ≤ 0.10). Fluid at 4, 5, 
and 6= fluid performance at Exams 4, 5, and 6. ADRD= Alzheimer’s disease and related dementias diagnosis across Exams 7-12 
(N = 1,616). 
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Total cognition performance 
Descriptive statistics of total cognition performance are noted in Table 35. There was an 
average decline of 0.56 points in total cognition performance from Exam 4 to Exam 5 and a 
decline of 0.78 points between Exam 5 and Exam 6, resulting in an average decline of 1.34 
points in total cognition across Exams 4-6. Eight years lapsed between Exams 4-6, resulting in 
an average annual decline in 0.17 points in total cognition [e.g., 1.34 (average decline) divided 
by 8 (number of years between Exams 4-6)]. Figure 30 illustrates the total cognition performance 
trajectories of a random sample of 255 men.  
Table 35. Average total cognition performance for Aim 3 analytic sample (N = 1,616) 
Variable  M SD Min Max 
Total cognition, Exam 4 16.44 1.39 9.28 18.78 
Total cognition, Exam 5 15.88 1.65 0.00 18.80 
Total cognition, Exam 6 15.10 2.19 0.00 18.65 
Note. Average annual decline of 0.17 points in total cognition. Cohen’s d between Exam 4 and 
5 was 0.37, indicating a small effect size.  Cohen’s d between Exam 5 and 6 was 0.40, 
indicating a small effect size. Cohen’s d from Exam 4-6 was 0.73, indicating a large effect size 
(Cohen, 1988). 
 
 
Figure 30. Intra-individual total cognition performance trajectories of a random sample of men 
from Aim 3 analytic sample; men in this analytic sample did not have ADRD diagnoses across 
Exams 4-6 (N = 255). 
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Testing mediation via total cognition. Lastly, mediation of total cognition was tested 
using the intercept and linear slope. The measurement model had excellent fit to the data: χ2 (1) = 
0.65, CFI = 1, and RMSEA = 0. The causal model also fit the data well: χ2 (16) = 22.78, the CFI 
was 1 and RMSEA was 0.02. The variance for the intercept was 1.52 (p < 0.001) and the 
variance for the slope was 0.24 (p = 0.05). As noted in Table 36, age (β = -0.24, p < 0.001), uric 
acid (β = -0.08, p = 0.006), and depressive symptoms (β = -0.11, p = 0.001) were significantly 
and negatively associated with the intercept term of total cognition. Education (β = 0.43, p < 
0.001) was positively associated with the intercept term. 
The average annual slope of total cognition was -0.17 (Table 35). As illustrated in Figure 
31, age (β = -0.29, p < 0.001), presence of APOE-ԑ4 (β = -0.12, p = 0.05), and uric acid (β = -
0.12, p = 0.046) were negatively associated with the slope. Education, on the other hand, was 
positively associated with the slope term (β = 0.19, p = 0.002). These results indicate that older 
men, those with an APOE-ԑ4 allele, and men with higher levels of uric acid had steeper declines 
in total cognition while men with higher levels of education tended to have less steep declines in 
total cognition performance over time.  
There were no significant direct associations with ADRD diagnosis (all p values > 
0.433). ADRD diagnosis across Exams 7-12 was negatively but not significantly associated with 
the intercept (β = -0.17, p = 0.794) and positively associated with the slope (β = 0.01, p= 0.994) 
of total cognition. Furthermore, neither the intercept nor slope significantly mediated the 
relationships between biopsychosocial variables and ADRD (all total indirect p values > 0.60).8 
                                                 
8 Given the dual nature of the APOE-ԑ2/ԑ4 genotype (Lu et al., 2014) and the recommendation of a clinician collaborator, I 
re-ran the analysis excluding men with ԑ2/ԑ4 (n = 13); results remained the same. 
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Table 36. Biopsychosocial associates of total cognition intercept term and slope as well as ADRD (N = 1,616) 
 Intercept term Linear slope  ADRD  
Variable b S.E. β p b S.E. β p b S.E.  β p 
Age -0.07 0.01 -0.24 <.001 -0.03 0.01 -0.29 <.001 -0.01 0.03 -0.05 0.677 
Marital status 0.03 0.09 0.01 0.771 0.10 0.07 0.09 0.143 0.13 0.28 0.04 0.655 
Education 0.15 0.01 0.43 <.001 0.02 0.01 0.19 0.002 0.02 0.05 0.07 0.634 
APOE-ԑ4  0.10 0.08 0.04 0.206 -0.12 0.06 -0.12 0.050 0.24 0.45 0.09 0.590 
Glucose 0.00 0.00 -0.01 0.821 0.00 0.00 -0.13 0.152 0.00 0.01 0.00 0.984 
Uric acid -0.01 0.00 -0.08 0.006 0.00 0.00 -0.12 0.046 0.00 0.01 -0.06 0.466 
Saturated fatty acids 0.00 0.00 0.01 0.924 0.00 0.00 -0.08 0.561 0.01 0.01 0.13 0.433 
MUFA 0.01 0.01 0.08 0.221 0.00 0.00 0.09 0.481 -0.01 0.01 -0.19 0.168 
PUFA 0.00 0.00 -0.01 0.828 0.00 0.00 0.00 0.939 0.00 0.01 0.00 0.978 
Body mass index 0.00 0.01 0.00 0.889 -0.01 0.01 -0.05 0.417 0.02 0.03 0.07 0.455 
Hypertension -0.04 0.07 -0.01 0.607 0.01 0.05 0.02 0.792 0.03 0.23 0.01 0.908 
Physical activity 0.01 0.01 0.03 0.299 0.00 0.00 -0.01 0.823 0.00 0.01 -0.01 0.928 
Daytime sleepiness -0.05 0.13 -0.01 0.731 -0.18 0.12 -0.13 0.124 0.10 0.39 0.03 0.794 
Depressive symptoms -0.04 0.01 -0.11 0.001 0.00 0.01 -0.03 0.614 0.00 0.02 0.00 0.975 
Social support  -0.11 0.07 -0.04 0.119 -0.01 0.05 -0.01 0.912 0.11 0.14 0.05 0.433 
Note. MUFA= monounsaturated fatty acids. PUFA= polyunsaturated fatty acids. Married [0 (not married)]/1(married)]. APOE 
[0 (no ԑ4 allele)/1 (at least one ԑ4 allele)]. Hypertension [0 (a blood pressure less than 140/90)/ 1(blood pressure greater than or 
equal to 140/90 or taking blood pressure medication)]. All biopsychosocial variables were from Exam 4 with the exception of 
dietary variables from Exam 1 and uric acid (Exam 3). Linear change in cognition was assessed using Exams 4-6. Binary 
variable, ADRD diagnosis, used Exams 7-12. 
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Figure 31. Significant standardized associations among biopsychosocial variables, total cognition (Tcog) intercept term, linear 
slope in total cognition, and ADRD. Solid lines=significant relationships p ≤ 0.05. Dashed lines= observed trends (0.06 ≤ p ≤ 
0.10). Tcog at 4, 5, and 6= total cognition performance at Exams 4, 5, and 6. ADRD= Alzheimer’s disease and related dementias 
diagnosis across Exams 7-12 (N = 1,616). 
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CHAPTER 5.    DISCUSSION 
The current study focused on the identification of life span biopsychosocial factors 
protective against cognitive decline and dementia. The rationale for the study stemmed from 
the fact that there is currently is no cure for dementia (Baiyewu, 2018); thus, it would 
behoove the public health field to identify factors associated with cognitive health so that 
individuals could modify their lifestyles across their life spans in an effort to strengthen 
identified reserves advantageous to cognitive health.  
In this chapter, I describe how findings from the current study connect with prior 
literature, discuss results in a theoretical context, note study limitations along with 
recommendations for future research, and conclude with study implications.  
Synopsis of Biopsychosocial Associates 
Aims 1 and 3 pertained to the relationship between biopsychosocial factors and 
cognition (average level and change). The primary difference between these aims was that in 
Aim 3, I conducted mediation analyses to examine if cognitive performance indirectly 
explained the relationship between biopsychosocial factors and ADRD, whereas in Aim 1, I 
examined biopsychosocial associates of cognition. A summary table denoting the directional 
association between significant biopsychosocial factors and each cognitive ability for Aims 1 
and 3 is noted in Table 37. From this table, one can glean that age, presence of APOE-ԑ4, 
associates of inflammation (e.g., uric acid and glucose), and depressive symptoms were 
negatively associated with cognition. Education was consistently positively associated with 
cognition in the current study.  
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Table 37. Significant biopsychosocial associates of cognitive abilities for Aims 1 and 3 
 Aim 1 Aim 3 
 Crystallized Fluid Total cognition Crystallized Fluid Total cognition 
Variable Int. Slope Int. Slope Int. Slope Int. Slope Int. Slope Int. Slope 
Age (-) (-) (-) (-) (-) (-) (-) (-) (-) (-) (-) (-) 
Marital status    (+)         
Education (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) 
APOE-ԑ4   (-)  (-)  (-)      (-) 
Glucose    (-)  (-)       
Uric acid (-)    (-)  (-) (-) (-)  (-) (-) 
PAI (+)            
Daytime sleep    (-)  (-)       
Depressive sym. (-) (-) (-)  (-) (-) (-)  (-)  (-)  
Note. Int. = intercept. Married [0 (not married)]/1(married)]. APOE-ԑ4 [0 (no ԑ4 allele)/1 (at least one ԑ4 allele)]. PAI= physical 
activity index. Daytime sleep= daytime sleepiness. Depressive sym. = depressive symptoms. All biopsychosocial variables were 
from Exam 4 with the exception of uric acid (Exam 3). (-) = significant negative association. (+) = significant positive association. 
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Aim 1  
The purpose of Aim 1 was to determine the relationship between biopsychosocial 
influences and longitudinal cognitive factors. The hypothesis that participants who had 
higher levels of biopsychosocial factors protective against cognitive decline would have less 
steep declines in cognitive performance over time was supported.  
Biopsychosocial protective factors from Aim 1 
Results that addressed the hypothesis for this aim came from the growth curve model 
analyses. These results elucidated a handful of biopsychosocial variables consistently 
associated with both the intercept and linear terms across the three analyses (i.e., crystallized, 
fluid, total cognition).  
In regards to protective factors, education, physical activity, and marital status were 
beneficial for cognition. Specifically, higher levels of education were consistently protective 
against declines in all analyses—for both baseline and linear changes. The protective effects 
of education support the cognitive reserve hypothesis, which posits that individuals with 
higher levels of education tend to have greater levels of cognition and can tolerate dementia 
pathology better than those who do not. As such, individuals with more education tend to 
have reduced risks for dementia and less severe declines in cognition (e.g., Davey et al., 
2010; Scarmeas & Stern, 2004; Sharp & Gatz, 2011; Stern, 2012; Tucker & Stern, 2011).   
Furthermore, greater levels of physical activity reported at Exam 4 were significantly 
associated with greater levels of crystallized performance. This is in line with a review article 
by Muiños and Ballesteros (2018), which noted that physical activity may reduce cognitive 
declines that are age-related and reflective of cognitive domains representative of crystallized 
abilities and total cognition (e.g., memory, attention, perceptual speed). This may be due to 
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the fact that physical activity helps reduce inflammation and regulates glucose and blood 
pressure, which is beneficial for cognitive health (Aarsland et al., 2010).  
Another protective factor was marital status, such that being married at Exam 4 was 
associated with a greater fluid performance at Exam 4. Though having a spouse has been 
considered a protective factor against declines in cognition (Fincham, 1994) and dementia 
development (Fan et al., 2015), the current study uniquely supported this connection with 
fluid abilities. An underlying mechanism that could help explain the link between being 
married and cognitive health is that having a spouse may facilitate communication, 
engagement, and cognitive-stimulation (Mousavi-Nasab et al., 2012).  
Biopsychosocial risk factors from Aim 1 
Age, depressive symptoms, and uric acid were significantly associated with poorer 
cognitive performance at baseline (i.e., intercept term) across the three analyses in Aim 1. 
Negative associates of the cognition slope across the three analyses were age, presence of the 
APOE-ԑ4, and depressive symptoms, indicating that older men, those with greater levels of 
depressive symptoms, and men with at least one APOE-ԑ4 allele had steeper declines in 
cognition over time.  
An underlying mechanism for the negative relationship between age and cognition 
may be that in general, as individuals progress through their lives, they tend to experience 
declines in speed of information processing along with reductions in cognitive attentional 
resources (Glisky, 2007).  
The negative association between depressive symptoms and cognition is in line with 
literature (e.g., Kaup et al., 2016; Mourao, Mansur, Malloy‐Diniz, Castro Costa, & Diniz, 
2016; Paterniti, Verdier-Taillefer, Dufouil, & Alperovitch, 2002; Wilson et al., 2012). A 
possible explanation for the negative relationship between depressive symptoms and 
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cognition is that individuals with greater levels of depressive symptoms might have pre-
clinical symptoms (National Institute of Mental Health, 2019), which may impact their 
ability or interest in completing cognitive tasks (Joormann & Gotlib, 2010). 
The uric acid findings support prior literature that indicates that greater levels of uric 
acid are not beneficial for cognitive health (e.g., Molshatzki et al., 2015; Kono et al., 2010; 
Schretlen et al., 2007; Shao et al., 2016; Suzuki et al., 2016). This negative relationship may 
occur because inflammation can impact the physical structure of the brain and deteriorate 
brain tissue, thus leading to poor cognitive performance (Suzuki et al.). Furthermore, findings 
regarding the presence of the APOE-ԑ4 allele and cognition support extant literature as the 
current study also demonstrated a negative effect of the APOE-ԑ4 allele on cognitive change  
(e.g., Deary et al., 2002; Hofer et al., 2002; Rawle et al., 2018; Smith, 2000).  
Some variables were significantly and negatively associated with the linear decline in 
specific cognitive abilities. For example, greater levels of glucose at baseline along with 
reports of excessive daytime sleepiness were both risk factors for linear declines in fluid 
abilities and total cognition. These findings are in line with prior literature on glucose and 
cognition (Mortby et al., 2013) as well as daytime sleepiness cognition (Foley et al., 2001). 
The mechanism underlying the relationship between daytime sleepiness and cognition may 
stem from the fact that persistent sleep loss (which leads to excessive daytime sleepiness) can 
impact brain regions necessary for cognition (e.g., hippocampus is essential for memory 
processes; Meerlo et al., 2009). 
It is important to note that in addition to being in line with extant literature, which 
often focuses on global cognition, results from the current study extend and contribute to the 
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cognitive aging field by providing novel insights into risk and protective factors of 
crystallized and fluid performance as well as total cognition, at both baseline and over time. 
Considerations  
The development of crystallized and fluid scores and factoring the CASI were 
intricate processes that laid the foundation for all analyses in the current study. I used 
empirically- and theoretically-grounded methods when factoring the CASI while preserving 
the nine domains that were identified by Teng et al. (1994). The number of items assigned to 
domains by Teng et al. was unequal in that there were domains with only one item (e.g., 
visual construction) and other domains with eight items (e.g., orientation). Even though the 
Cronbach’s alphas of the crystallized and fluid items in the current study were relatively high 
(see Table 7) and the fit indices of the two factor model over time were good (refer to Table 
8), one could argue that certain CASI items could be included in the opposite ability scale 
(e.g., a fluid item could arguably be classified as a crystallized item). Of the 39 CASI items, 
one item (e.g., “Please copy this: the pentagon shape”) uniquely falls into this category as it 
was classified as crystallized in the current study; however, literature supporting this item 
being classified as another ability (e.g., visual-spatial ability) also exists (Baghaei & 
Tabatabaee, 2015; Kaufman, Kaufman, & McLean, 1995).   
Investigating changes over time in cognition (Tables 14, 16, and 18) allowed for a 
better understanding of average performance in each cognitive ability at each exam as well as 
over time. Doing this also allowed for the identification of the slope and determination that 
the three cognition terms had average annual declines ranging from 0.10 to 0.23. Further, the 
intra-individual trajectories depicted in Figures 11, 13, and 15 demonstrated that although 
average annual slopes were declining, the picture was complex since not everyone 
experienced declines in performance across exams.   
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Aim 2  
The goal of the second aim was to investigate the association of patterns of change in 
cognitive factors and ADRD. The hypothesis that men who had greater declines in their 
cognitive abilities would have an ADRD diagnosis at an earlier age and that men who 
maintain their cognitive abilities would either not have an ADRD diagnosis or would have a 
later life diagnosis was supported. This aim was investigated through two sets of analyses, 
including GCMM to identify classes of cognitive performance followed by survival analyses 
to determine age to ADRD diagnosis.  
The GCMM fit indices indicated that a five-class solution fit the data well for both 
crystallized performance and total cognition. In general, the High and maintain class (i.e., 
Class 5) had the largest class counts, greatest intercept terms, and the smallest slopes. The 
GCMM classes were used as predictors in the survival analyses to examine age at ADRD 
diagnosis. I assessed ADRD diagnosis between Exams 7-12; thus, individuals with an ADRD 
diagnosis between Exams 4-6 were excluded from the analyses. Cox proportional hazards 
models indicated that men in total cognition GCMM Class Moderately-high and low-risk of 
drop (i.e., Class 4) were at an increased risk of an earlier life ADRD diagnosis compared to 
men in GCMM Class 5 (reference class). A post-hoc analysis further investigating this 
significant relationship was performed with a two-class model (i.e., Class 4 versus a group 
consisting of all other classes) and results indicated that men in total cognition GCMM Class 
4 were still at a significantly greater risk for ADRD diagnosis at a younger age compared to 
other participants.  
In an effort to gain a more tangible understanding of results, beyond using identifiers 
of GCMM class, I conducted survival analyses using collapsed classes of Maintainers and 
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Decliners. Findings demonstrated that although one group was not at a significantly greater 
risk for ADRD, those in the Maintainer group would have been diagnosed with ADRD at a 
slightly older age than Decliners (refer to Figures 24 and 25).  
Considerations 
GCMM results indicated a one-class model fit fluid abilities well. When performing 
the analysis, I conducted tests of increasing class solutions for fluid abilities and found that 
the linear and intercept terms were highly correlated. A possible reason as to why this 
occurred could be that in this sample, there may be less variation/patterns for fluid 
performance when compared to crystallized performance. In other words, everyone declined 
in fluid abilities but there might have been multiple patterns of change for crystallized 
abilities as evidenced through the five GCMM classes. An alternative explanation is that 
cognitive dedifferentiation (e.g., structure of cognitive abilities coalesce in old age; Baltes et 
al., 1980; de Frias et al., 2007) could have already occurred in men of the Aim 2 analytic 
sample and their cognitive performance may be manifesting itself in the crystallized abilities 
GCMM solution. For example, results from the factor analyses noted in Table 8 elucidated 
that the crystallized and fluid factors were significantly correlated with each other (r > 0.86) 
suggesting support for dedifferentiation. 
Aim 3  
Aim 3 focused on investigating the relationship between biopsychosocial factors and 
ADRD through the mediating role of the level (i.e., intercept) and change (i.e., linear slope) 
of cognition (crystallized, fluid, and total cognition). To accomplish this aim, I examined 
cognitive performance at each exam as well as explored changes over time at a descriptive 
level; then, I performed three mediation analyses using bootstrap sampling. The hypothesis 
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was not supported since there were no significant indirect effects by any of the cognitive 
abilities.  
Similar to Aim 1, the investigation of cognitive changes over time (Tables 31, 33, and 
35) in Aim 3 allowed for a richer understanding of average performance at each exam as well 
as over time. This also allowed for the determination of the slope and average annual decline. 
Moreover, the intra-individual trajectories illustrated in Figures 26, 28, and 30 indicated that 
although the average annual slopes were declining, most men seemed to maintain their levels 
of performance, others improved across exams, and some men declined over time. 
Findings from Aim 3 analyses demonstrated that age, uric acid, and depressive 
symptoms were negatively associated with the intercept terms across the three cognitive 
abilities indicating that older men, those with greater levels of inflammation measured by 
uric acid, and men with higher levels of depressive symptoms tended to have poorer levels of 
cognition at baseline. On the other hand, education was consistently positively associated 
with the intercept terms of the three cognitive abilities indicating that those with greater 
levels of education tended to have greater levels of cognition. These results are in line with 
prior research (Harrington et al., 2018; Schretlen et al., 2007; Shao et al., 2016; Suzuki et al., 
2016; Stern, 2012; Tucker & Stern, 2011; Xue et al., 2017) and with findings from Aim 1 of 
the current study (refer to Table 37). 
In general, the same set of variables were associated with cognition performance over 
time. Specifically, age, education, and depressive symptoms were associated with the 
crystallized abilities slope indicating that older men and those with greater levels of 
depressive symtoms at baseline had steeper declines in crystallized performance across 
Exams 4-6 whereas those with higher levels of education at baseline had less steep declines 
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in crystallized abilities over time. Additionally, results demonstrated that those who were 
older at baseline tended to have steeper declines in fluid performance and men who had 
greater levels of education had less steep declines in fluid abilities over time. Furthermore, 
older men, those who had an APOE-ԑ4 allele, and men with greater levels of uric acid at 
baseline tended to have steeper declines in total cognition over time whereas those with 
higher levels of education had less steep declines in total cognition. 
Though there were no significant direct associates of ADRD across the three 
analyses, there were trends between presence of APOE-ԑ4 and ADRD as well as MUFA and 
ADRD in the crystallized abilities mediation analysis. These findings are consistent with 
prior research and offer insight for the potential that those with at least one APOE-ԑ4 allele 
may be at an increased risk for ADRD (Rawle et al., 2018) whereas those with greater 
MUFA intake may have at a reduced likelihood for ADRD (Spencer, Korosi, Layé, Shukitt-
Hale, & Barrientos, 2017).  
Considerations  
The lack of significant associates of ADRD along with lack of mediation by any of 
the cognitive abilities in the current study may be the result of a variety of factors, including 
time between exams. Further, analyses used Exam 4 cognition values as the intercept term to 
assess ADRD across Exams 7-12.  
Another possibility pertains to the influence of CASI items on ADRD. In general, one 
would anticipate that higher levels of cognitive performance reduces the risk of developing 
ADRD; thus a negative association between cognition and ADRD is expected. Although not 
significant, the negative relationships between the cognition intercept terms (crystallized, 
fluid, and total cognition) and ADRD for Aim 3 were in line with this expectation. 
Relationships between two of the cognition linear terms and ADRD, however, were not in 
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line with expectation: though not significant, there was a positive association between the 
fluid abilities linear term and ADRD as well as between the total cognition linear term and 
ADRD. Because there were linear declines in all cognition factors over time (see Tables 31, 
33, and 35 in Chapter 4), these non-significant positive associations suggest the notion that 
men who had less steep declines in their fluid abilities and total cognition were more likely to 
develop ADRD, which is perplexing.  
To further investigate and potentially disentangle this issue, I conducted 39 logistic 
regression analyses to determine how performance on each of the CASI items at Exam 6 (the 
most proximal exam to ADRD diagnosis across Exams 7-12) associated with ADRD across 
Exams 7-12 (see Appendix E). As noted in Table E1 in Appendix E, of the 39 CASI items, 
22 items had negative betas (i.e., higher scores on 22 items were associated with a reduced 
likelihood of ADRD development) and 17 items had positive betas (i.e., higher scores on 17 
items were associated with greater likelihood of ADRD development). These positive and 
negative betas demonstrate that a high score on each CASI item is not necessarily associated 
with a reduced likelihood of ADRD. Furthermore, only nine of the 39 items were uniquely 
predictive of ADRD. Thus, it seems as if higher scores on CASI items are not necessarily 
associated with a reduced likelihood of ADRD and that only 23% of the CASI items at Exam 
6 in the Aim 3 analytic sample were significantly predictive of later life ADRD.  
Therefore, the positive and non-significant relationship between the fluid abilities 
linear term and ADRD along with total cognition and ADRD may be due to the sub-optimal 
psychometric properties of the CASI along with how individual CASI items uniquely 
associate (and do not predict) with ADRD. It would be advantageous to further investigate 
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the relationship between CASI performance and ADRD using other HAAS exams, and more 
importantly, in diverse populations. 
Theoretical Perspectives 
The empirical results of the current study can be viewed from a theoretical 
perspective. The biopsychosocial framework, for example, urges the integration of multiple 
factors, including biological and psychosocial forces when addressing health (Engel, 1980; 
Kail & Cavanaugh, 2010).The current study aimed to identify biological and psychosocial 
associates of cognitive performance and ADRD. For example, variables consistently 
associated with cognition (level and/or change) across Aims 1 and 3 included age, education, 
associates of inflammation (e.g., uric acid, glucose), presence of APOE-ԑ4, and depressive 
symptoms. Other factors such as physical activity were associated with the crystallized 
intercept term in Aim 1, whereas marital status, glucose, and excessive daytime sleepiness 
were significantly associated with the fluid alibies slope in Aim 1. Because these 
biopsychosocial factors are, for the most part, modifiable, individuals have the ability to 
make changes to their lives that may be advantageous for their cognitive health.  
Furthermore, the emphasis of intra-individual changes and inter-individual 
differences of the life span theory (Baltes, 1987; Baltes et al., 1999) was applied through the 
investigation of average intercept and slopes as well as depictions of intra-individual 
performance trajectories in the Figures of Aims 1 and 3 along with inter-individual 
differences in average performance over time through the GCMM classes in Aim 2. 
Investigating cognitive changes in Aim 1 (refer to Tables 14, 16, and 18) and Aim 3 (refer to 
Tables 31, 33, and 35) demonstrated that on average, there were declines in all cognitive 
abilities; it also allowed for the identification of the average annual slope for each cognitive 
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ability. Although on average, slopes were declining, it is important to note that the figures 
presented in respective aims illustrated that not all men experienced declines in performance 
across Exams 4-6 (Figures 11, 13, and 15 for Aim 1; Figures 26, 28, and 30 for Aim 3).  
Moreover, the GCMM results from Aim 2 identified different classes of performance 
trajectories (i.e., inter-individual differences; Tables 20-22). Average performance of men in 
these classes was illustrated in Figures 17-19, which demonstrated that some classes had 
dramatic declines in performance over time, whereas men in other classes had steadier levels 
of performance over time. These GCMM classes, which demonstrate inter-individual 
performance, were used as predictors in survival analyses and results indicated that men in 
total cognition GCMM Class 4 were at an increased risk for ADRD diagnosis at a younger 
age than the reference class (i.e., GCMM Class 5).  It would be advantageous to investigate 
participant characteristics of men within each of the GCMM classes to help disentangle 
findings. For example, examining and comparing the biopsychosocial qualities of men in 
total cognition GCMM Class 4 to other classes could help in identify characteristics that 
might place men at a greater risk of ADRD.  
Findings also seem to support the dedifferentiation hypothesis of cognitive aging, 
which posits that the structure of cognitive abilities merge in old age such that there are age 
related increases in the association of cognitive abilities in later life (Baltes et al., 1980; de 
Frias et al., 2007; Hülür et al., 2015; Tucker-Drob, 2009; Wilson et al., 2012). Support for the 
dedifferentiation hypothesis was exhibited by the high correlations between the crystallized 
and fluid abilities factors (refer to Table 8). Further support for this hypothesis may be 
demonstrated through the lack of multiple class solutions for the fluid abilities GCMM 
analysis in Aim 2, suggesting the possibility that both abilities already coalesced for men and 
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cognitive performance was demonstrated through the crystallized GCMM classes. The 
associations between crystallized and fluid abilities in the current study is in line with the 
coupling of crystallized and fluid abilities by Hülür et al., (2015) that supports the 
dedifferentiation hypothesis of cognitive aging (Baltes et al., 1980; de Frias et al., 2007; 
Tucker-Drob, 2009; Wilson et al., 2012).  
The common cause hypothesis of cognitive aging posits that there is an underlying 
neurobiological mechanism that is responsible for age-related declines in cognition and 
sensorimotor functioning (Christensen, Mackinnon, Korten, & Jorm, 2001; Kiely & Anstey, 
2017; Lindenberger & Baltes, 1994). This hypothesis suggests there are concurrent declines 
in sensory (e.g., vision, hearing, balance) and cognitive functioning stemming from increased 
age such that the association between both types of functioning increases over time (Kiely & 
Anstey, 2017; Ritchie, Tucker-Drob, Starr, & Deary, 2016).  Results from the correlation 
matrix seem to support this hypothesis since age at Exam 4 was negatively correlated with 
Exam 4 physical activity (which requires high levels of sensorimotor functioning) and CASI 
(refer to Table 5). That being noted, it would behoove researchers to integrate sensory 
measures to better assess the common cause hypothesis of cognitive aging.  
Practical interpretation of results: A focus on slopes 
Discussion points thus far have emphasized the mechanical and statistical 
perspectives of the intercept and slope. The intercept and slope could also be viewed from a 
cognitive aging lens, which would offer a more practical interpretation of results. For 
example, there was an average annual decline of 0.10 points in crystallized abilities for Aim 
1 (Table 14). As noted in Table 15, age (β = -0.24), education (β = 0.09), presence of APOE-
ԑ4 (β = -0.14), and depressive symptoms (β = -0.14) were significantly associated with these 
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linear changes indicating that there were steeper declines in crystallized abilities for men who 
were older, had an APOE-ԑ4 allele, and who reported greater levels of depressive symptoms.  
The depressive symptoms finding could be viewed from an applied lens. For instance, 
men who were one standard deviation above the mean in depressive symptoms had a faster 
average annual decline in crystallized performance of 0.24 points (e.g., -0.10 [average annual 
slope in crystallized performance] plus -0.14 [β for depressive symptoms]). A possible 
explanation for this might be that individuals with greater depressive symptoms might have 
pre-clinical symptoms of difficulty in concentrating (National Institute of Mental Health, 
2019), which may impact their ability or interest in accomplishing cognitive tasks (Joormann 
& Gotlib, 2010).  
Men with higher levels of education, on the other hand, had less steep declines in 
crystallized abilities, with an average annual decline of 0.01 points (e.g., -0.10 [average 
annual slope in crystallized performance] plus 0.09 [β for education]). This supports the 
cognitive reserve hypothesis that suggests that greater levels of education can help buffer 
against poor cognitive health and ADRD (Sharp & Gatz, 2011; Stern, 2012; Tucker & Stern, 
2011; Vallesi, 2016).  
Limitations and Future Directions 
This study is not without limitations. The CASI was developed by Teng et al. (1994) 
who relied on face validity to categorize items into nine domains. This measure was at the 
core of the current study as it was used to develop the crystallized, fluid, and total cognition 
scores. It seems that the CASI may not be sensitive to crystallized and fluid abilities and that 
the two factors may lack discriminant validity and possibly change in factor structure with 
age. Because the CASI is a screening tool, it does a relatively sub-optimal job of thoroughly 
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assessing specific constructs and cognition domains compared to other measures. For 
example, measures stemming from cognition theoretical frameworks such as the Cattell-
Horn-Carroll theory provide insight on the structure of intelligence and distinguish between 
fluid and crystallized factors, while also noting specific cognitive abilities at both the broad 
and narrow level (Carroll, 1997; Cattell, 1971; Horn & Blankson, 2005; Willis, Dumont, & 
Kaufman, 2012). Furthermore, it is important to note that CASI items have high levels of 
internal reliability, meaning that if participants perform poorly on one item, they will likely 
perform poorly on other items (and the inverse), resulting in either ceiling or floor effects. 
These are pivotal issues since one could argue that the conclusions of a study are only as 
valid as the validity of the measures used in the study. As such, it is recommended that future 
research use measures that are more sensitive to crystallized and fluid abilities. For example, 
the NIH Toolbox Cognition Battery in Adults assesses cognitive domains of “language, 
executive function, episodic memory, processing speed, and working memory” (Heaton et 
al., 2014, p.1) and has been factor analyzed to support three composite scores of crystallized, 
fluid, and total cognition abilities (Heaton et al.). Otherwise, future research could use 
multiple measures to assess each ability.  
Further study limitations relate to psychometrics. A few variables utilized in the 
current study, including depressive symptoms and physical activity, used computed 
composite scores that were available in the data. Thus, the reliability of these variables was 
not assessed using participants in the current study. That being noted, the measures were 
validated in other studies and using composite measures in the current study allowed for 
measurement consistency with other HAAS publications.  
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Moreover, one could argue that the inconsistent analytic samples across the aims may 
be problematic. Although analytic samples varied across the aims, justification on why/how 
many participants were excluded was provided in respective aims and noted in the consort 
diagram and Venn diagram in Appendix B. Furthermore, descriptive statistics for each 
analytic sample along with information on if that analytic sample was demographically 
different than the 1,935 men who had data across Exams 4-6 were noted in respective aims.  
 Taking the results, noted limitations, and my experiences with this study into 
account, I have a few recommendations for future research. First, it would be advantageous 
to explore how changes in biopsychosocial variables that were collected at three HAAS 
exams were associated with changes in cognition (i.e., curves predicting curves). Doing so 
would provide a more dynamic investigation of the relationship rather than using stagnant 
biopsychosocial variables collected at one exam, which was done in the current study. Future 
research could explore how changes in BMI (collected at every exam), for example, are 
associated with changes in cognitive factors (collected at Exam 4 and onward).  
Moreover, it would behoove researchers to thoroughly examine aspects of intra-
individual variability and inter-individual differences over time. The current study assessed 
these life span concepts using average levels of performance via intercept and slope rather 
than investigating cognitive performance trajectories at the individual level. Although 
Figures 11, 13, 15, 26, 28, and 30 in Aims 1 and 3 provided illustrations of intra-individual 
trajectories of random samples of men, key analyses were conducted using average levels of 
performance. Assessing intra-individual variability, for example, would allow for an acute 
examination of variability and group performance over time, which may be informative for 
researching ADRD development since greater levels of cognitive performance variance over 
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time is thought to be a precursor for ADRD diagnosis (Bielak et al., 2010; Christensen, 2001; 
Gorus et al., 2008; Hultsch et al., 2000).   
Additionally, future research could center analyses on time of death and work 
backwards to explore changes in performance in an effort to gain a more sensitive assessment 
related to mortality and very late life health. By doing so, researchers could test the terminal 
decline and terminal drop hypothesis of cognitive aging that posits that there is a gradual 
decline in cognitive performance several years prior to death (i.e., terminal decline) and a 
rapid drop in cognitive performance that is more proximal to death (i.e., terminal drop; Berg, 
1996; Gerstorf & Ram, 2013; Hassing et al., 2002; Kleemeier, 1962; Margrett, Schofield, 
Martin, Poon, Masaki, & Willcox, 2019; Piccinin, Muniz, Matthews, & Johansson, 2011; 
Riegel & Riegel, 1972; Small, Fratiglioni, von Strauss, & Bäckman, 2003; Thorvaldsson, 
Hofer, Berg, & Johansson, 2006).  
It is pivotal to use a whole-person wellness perspective when assessing healthy aging 
across the life span that acknowledges the dynamic nature of multiple facets of life; thus, the 
incorporation of specific health variables may be informative for future research. For 
instance, it could be advantageous to include clinical measures of health available in the 
HAAS as they may be useful in explaining potential mediation effects or used as stratifying 
variables to test for statistical moderation. These measures range from health behaviors (e.g., 
smoking and alcohol usage) to a lifetime diagnosis of chronic illnesses (e.g., stroke, 
cardiovascular disease); utilization of such variables may shed light on potential effects not 
examined in the current study.  
Future research could also explore aspects of epigenetics and inflammation at a 
cellular level (e.g., trained immunity) in an effort to better understand building reserves at a 
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micro-level (Netea et al., 2016). In line with this, future work could also investigate 
interactions between genes and environments to elucidate how specific genetic factors may 
influence underlying relationships; for example, researchers could examine how the 
relationship between depressive symptoms and level as well as change in each cognitive 
ability varies as a function of APOE status.   
Furthermore, future work may disentangle the relationship between cognition and 
aspects of age, cohort, and period (Brailean et al., 2018; Salthouse, 2013; Schaie & Caskie, 
2005) as this was not explicitly assessed in the current study. Although age at Exam 4 was 
consistently associated with cognitive performance in the current study, it is by nature, tied to 
cohort and period effects. As such, future research may wish to explore how performance 
varies by birth cohort over time in an effort to parse out the intricacies of age, cohort, and 
period effects.  
Lastly, it may be useful to include all individuals in analyses, including those with 
missing data. Given the fact that the current study used a truncated sample of participants 
who had data across Exams 4-6 to assess intra-individual changes in cognitive abilities, one 
could argue that the models are missing a large number of older adults. It may be important 
to include the excluded participants as their lack of participation may be tied to their health 
and cognition, perhaps their ADRD status.  
Implications and Conclusions 
This study has many strengths, namely the fact that it innovatively contributes to the 
cognitive aging and public health fields by identifying how biopsychosocial factors, which 
are both behavior- and psychosocial-focused, are associated with cognitive ability 
performance over time, and how these in turn play a role in dementia development. The 
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novelty of examining crystallized and fluid abilities as well as total cognition contributes to 
the research. The identification of classes from GCMM along with the survival analyses 
elucidated how different classes of performance within these abilities were associated with 
time to ADRD. Due to the fact that this study utilized longitudinal data spanning close to 50 
years from a sample of Japanese-American men from Oahu, Hawaii, it allows for high levels 
of reliability and validity to similar samples, which is often a limitation of studies with 
heterogeneous samples. In addition, the HAAS allows for better estimates of parameters 
compared to studies in populations with multiple races in ethnicities. Of course, the one 
caveat is that these results may have limited levels of external validity. 
Findings offer opportunities for intervention, particularly through cognitive training 
and maintenance. For instance, in the factor analysis of the CASI, I noted which of the nine 
cognitive domains an item belonged to and used the domains to develop the crystallized and 
fluid scales. If an individual is experiencing cognitive declines in one of the cognitive factors 
noted in this study, they could partake in cognitive training focusing on building and/or 
maintaining their crystallized and/or fluid abilities (Ball et al., 2002; Butler et al., 2018). For 
example, they could engage in training programs that focus on cognitive domains specific to 
a certain ability; those who are having issues with their fluid abilities may wish to focus on 
training modules related to building their short-term memory, attention, 
manipulation/concentration, and list-generating fluency domains.  
Overall, five biopsychosocial factors consistently associated with cognitive 
performance (i.e., level and/or change) in the current study were age, education, associates of 
inflammation (uric acid, glucose), APOE status, and depressive symptoms. Three of these are 
modifiable (e.g., education, associates of inflammation, and depressive symptoms) meaning 
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that individuals could adjust their lives to influence these factors in an effort to have a 
beneficial impact on their cognitive health, particularly since there is currently no cure for 
ADRD. For example, individuals could strengthen their education biopsychosocial factor by 
engaging in lifelong learning programs to have cognitive stimulation, learn about a variety of 
topics they are interested in, as well as have socioemotional and physical development (Obhi, 
Hardy, & Margrett, 2019). Doing so may also help reduce their levels of depressive 
symptoms because they would be interacting with other individuals in a relaxed educational 
setting. Furthermore, individuals could address associates of inflammation by reducing their 
levels of uric acid and/or glucose through a variety of mechanisms, including diet 
modification (Phinney, 2005) and engagement in physical activity (Booth, Roberts, & Laye, 
2012). For example, individuals could modify their diet, which may have a “domino effect” 
on their uric acid levels, which in turn, may influence their cognition and overall health. 
The three research aims of the current study focused on identifying life span 
protective factors of cognitive decline and ADRD using longitudinal data from the HAAS. 
Hypotheses were partially supported such that findings indicated that participants who had 
greater levels of biopsychosocial factors protective against cognitive decline had slower 
declines in performance on cognitive tasks over time (Aim 1) and men who had earlier 
cognitive declines tended to have a diagnosis of ADRD (Aim 2). However, there was no 
support for mediation of crystallized abilities on the relationship among the biopsychosocial 
variables and ADRD (Aim 3). Practically speaking, the public health implications of this 
study encourage the building of reserves across the life span, which for the most part are 
modifiable factors, particularly since there currently is no cure for ADRD. This premise is 
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applicable to the vast majority of individuals as the reserves of healthy cognitive aging 
identified in this study are behavior-based. 
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APPENDIX A.    UNIVERSITY IRB APPROVAL 
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APPENDIX B.    AIM-SPECIFIC CONSORT DIAGRAM  
 
Figure B1. Consort diagram of analytic sample for each research aim. For further details on missingess, refer to participant descriptive 
statistics noted in Tables 11, 12, 24, and 29 in Chapter 4.  
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Figure B2. Venn diagram illustrating the overlap of the number of participants across aims. For example, 164 men were only in Aim 1 
whereas 131 men were only in Aim 2. None of the men were only in Aim 3, indicating that all men in Aim 3 were included in either 
Aims 1 or 2. A total of 1,613 participants were in all three analytic samples. 
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APPENDIX C.    COMPARISON OF COGNITIVE ABILITIES SCREENING INSTRUMENT (CASI) TO 3 MEASURES  
Table C1. Item-level comparison of the CASI (Teng et al., 1994) to the Hasegawa Dementia Screening Scale (HSD; Hasegawa, 1983), 
Mini-Mental State Exam (MMSE; Folstein et al., 1975), and the Modified Mini-Mental State Examination (3MS; Teng & Chui, 1987) 
Number CASI item CASI domain HSD (1983) MMSE (1975) 3MS (1987) 
1 Where were you born? 
-city/town/village 
-state 
Long-term 
memory 
Where is your 
birthplace? 
N/A 
 
 
Where were you born? 
-town 
-state 
2 When were you born? 
-year 
-month 
Long-term 
memory 
N/A N/A Date of birth? 
-year 
-month 
3 When were you born? 
-date 
Long-term 
memory 
N/A N/A Date of birth? 
-date 
4 How old are you? Orientation N/A N/A N/A 
5 How many minutes are there 
in an hour? OR 
How many days are there in 
a year? 
Long-term 
memory 
N/A N/A N/A 
6 In what direction does the 
sun set? 
Long-term 
memory 
N/A N/A N/A 
7 I am going to say 3 words for 
you to remember. Repeat 
them after I have said all 
three. 
1. shirt, brown, honesty  
2. shoes, black, modesty  
3. socks, blue, charity 
Attention N/A Registration 
Name 3 objects: 1 second to say 
each. Then ask the patient all 3 
after you have said them. 
Give 1 point for each correct 
answer. Then repeat them until he 
learns all 3. Count trials and 
record. 
Registration 
I am going to say 3 words 
for you to remember. 
Repeat them after I have 
said all three. 
1. shirt, brown, honesty 
2. shoes, black, modesty 
3. socks, blue, charity 
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(Table C1 continued)     
Number CASI item CASI domain HSD (1983) MMSE (1975) 3MS (1987) 
8 I shall say some numbers, 
and you repeat what I say 
backwards. For example, if I 
say 1–2, you say 2–1. Ok?  
 
Remember: you repeat what I 
say backwards. 
1–2–3 (If unable, coach for 3 
– 2 – 1, but score 0)  
Concentration/ 
manipulation 
Name these 
numbers in 
reverse order: 
6-8-2 
3-5-2-9 
N/A N/A 
9 Remember: you repeat what I 
say backwards. 
6 – 8- 2   
Concentration/ 
manipulation 
Name these 
numbers in 
reverse order: 
6-8-2 
3-5-2-9 
N/A N/A 
10 I shall say some numbers, 
and you repeat what I say 
backwards.  
3 – 5 – 2 – 9 
Concentration/ 
manipulation 
Name these 
numbers in 
reverse order: 
6-8-2 
3-5-2-9 
N/A N/A 
11 What three words did I ask 
you to remember earlier? (3 
times) 
 
(3 sec) Spontaneous recall 
(2 sec) After: “one word was 
something to wear” 
After: “Was it X, X or X?” 
Short-term 
memory 
N/A Recall 
Ask for the 3 objects repeated 
above. Give 1 point for each 
correct. 
First Recall 
What three words did I ask 
you to remember earlier? (3 
times) (3 sec) Spontaneous 
recall 
(2 sec) After: “one word 
was something to wear” 
After: “Was it X, X or X?” 
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(Table C1 continued)     
Number CASI item CASI domain HSD (1983) MMSE (1975) 3MS (1987) 
12 (3 sec) Spontaneous recall 
(2 sec) After: “one word was 
something to wear” 
After: “Was it X, X or X?” 
Short-term 
memory 
N/A Recall 
Ask for the 3 objects repeated 
above. Give 1 point for each 
correct. 
First Recall 
What three words did I ask 
you to remember earlier? (3 
times) (3 sec) Spontaneous 
recall 
(2 sec) After: “one word 
was something to wear” 
After: “Was it X, X or X?” 
13 (3 sec) Spontaneous recall 
(2 sec) After: “one word was 
something to wear” 
After: “Was it X, X or X?” 
Short-term 
memory 
N/A Recall 
Ask for the 3 objects repeated 
above. Give 1 point for each 
correct. 
First Recall 
What three words did I ask 
you to remember earlier? (3 
times) (3 sec) Spontaneous 
recall 
(2 sec) After: “one word 
was something to wear” 
After: “Was it X, X or X?” 
14 From 100, take away 3, how 
many? 
Concentration/ 
manipulation 
Subtract 7 
from 100, 
then 7 from 
93 
Attention/Calculation Serial 7’s. 
1 pt for each correct. Stop after 5 
answers. Alternatively spell 
“world” backwards. 
N/A 
15 And take away 3 from that 
equals? 
Concentration/ 
manipulation 
Subtract 7 
from 100, 
then 7 from 
93 
Attention/Calculation Serial 7’s. 
1 pt for each correct. Stop after 5 
answers. Alternatively spell 
“world” backwards. 
N/A 
16 Repeat “and take away 3 
again equals?” (3times) 
Concentration/ 
manipulation 
Subtract 7 
from 100, 
then 7 from 
93 
Attention/Calculation Serial 7’s. 
1 pt for each correct. Stop after 5 
answers. Alternatively spell 
“world” backwards. 
N/A 
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(Table C1 continued)     
Number CASI item CASI domain HSD (1983) MMSE (1975) 3MS (1987) 
17 What is today’s date? 
-year 
Orientation What is the 
date today? 
Orientation 
What is the (year) (date) (day) 
(month)? 
Temporal Orientation 
What is the 
-year 
-month 
-day of month 
18 What is today’s date? 
-month 
Orientation What is the 
date today? 
What is the date today? Orientation 
What is the (year) (date) 
(day) (month)? 
19 What is today’s date? 
-date 
Orientation What is the 
date today? 
Orientation 
What is the (year) (date) (day) 
(month)? 
Temporal Orientation 
What is the 
-year 
-month 
-day of month 
20 What day of the week is it 
today? 
Orientation N/A N/A Temporal Orientation 
What day of the week is it? 
21 What season are we in? Orientation N/A Orientation 
What is the (season)? 
Temporal Orientation 
What season are we in? 
22 What state and city are we 
in? 
 
Orientation Where are 
you? 
Orientation 
Where are we: (state) (county) 
(town) (hospital) (floor)? 
Spatial Orientation 
What is the 
-state 
-county 
-city/town 
Are we in a hospital or 
office building or home? 
23 Is this place a hospital, store, 
or home? 
Orientation Where are 
you? 
Orientation 
Where are we: (state) (county) 
(town) (hospital) (floor)? 
Spatial Orientation 
What is the 
-state 
-county 
-city/town 
Are we in a hospital or 
office building or home? 
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(Table C1 continued) 
    
Number CASI item CASI domain HSD (1983) MMSE (1975) 3MS (1987) 
24 What animals have 4 legs? 
Tell me as many as you can. 
(30 sec) 
Word 
fluency 
N/A N/A Four-legged animals 
What animals have 4 legs? 
25 (Cue card – introduction to 
similarities) an orange and a 
banana are both fruit 
 
-An arm and a leg are both...?  
*Body parts, limbs, 
extremities  
*Long, bend, muscles, bones, 
etc.  
*Incorrect; DK; tells 
difference  
 
-Laughing and crying are 
both...? 
*Expressions of 
feelings/emotions  
*Other correct answer  
*Incorrect; DK; tells 
difference  
 
-Eating and sleeping are 
both...? 
*Necessary bodily functions  
*Other correct answer  
*Incorrect; DK; tells 
difference 
Abstraction/ 
judgement 
N/A N/A Similarities 
In what way are X and Y 
alike? 
-an arm and a leg 
-laughing and crying 
-eating and sleeping 
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(Table C1 continued) 
Number CASI item CASI domain HSD (1983) MMSE (1975) 3MS (1987) 
26 What actions would you take 
if you saw your neighbor’s 
house catching fire? (Prompt 
“what else might you do?” 
Once only, if necessary) 
 
-What actions would you 
take if you lost a borrowed 
umbrella?  
* inform/apologize  
* replace/compensate  
 
-What would you do if you 
found an envelope that was 
sealed, addressed and had a 
new stamp? 
*Mail  
*Try to locate the owner  
*Inappropriate action 
Abstraction/ 
judgement 
N/A N/A N/A 
27 Repeat exactly what I say: 
“He would like to go home.” 
Attention N/A Language 
Repeat the following “No ifs, 
ands or buts.” 
Repetition 
Repeat what I say: 
-I would like to go 
home/out 
Now repeat 
-No ifs, ands, or buts 
28 Now repeat … (3 sec) 
“this yellow circle is heavier 
than blue square” 
Attention N/A Language 
Repeat the following “No ifs, 
ands or buts.” 
Repetition 
Repeat what I say: 
-I would like to go 
home/out 
Now repeat 
-No ifs, ands, or buts 
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(Table C1 continued)     
Number CASI item CASI domain HSD (1983) MMSE (1975) 3MS (1987) 
29 Please do this: 
(point to statement “raise 
your hand”) 
Language N/A Language 
Read and obey the following: 
Close your eyes 
Read and obey 
Please read and do what 
this says: 
-close your eyes 
30 Let me have a sample of your 
handwriting. Please write: 
“he would lie to go home” 
Language N/A Language 
Write a sentence 
Writing 
Please write: 
-I would like to go home 
31 Please copy this: the 
pentagon shape 
Visual 
construction 
N/A Language 
Copy design 
Copying pentagons 
Please copy this shape 
32 Take this paper with your L 
(R) hand, fold it in half, and 
hand it back to me.  
Language N/A Language 
Follow a 3-stage command: 
“Take a paper in your right hand, 
fold it in half, and put it on the 
floor” 
3-stage command 
Take this paper with your 
left hand (for a left handed 
person say right hand), fold 
it in half, and hand it back 
to me 
33 What three words did I ask 
you to remember earlier? (3 
times) 
(3 sec) Spontaneous recall 
(2 sec) After: “one word was 
something to wear” 
After: “Was it X, X or X?” 
Short-term 
memory 
N/A N/A Second recall 
What three words did I ask 
you to remember earlier? (3 
times) 
(3 sec) Spontaneous recall 
(2 sec) After: “one word 
was something to wear” 
After: “Was it X, X or X?” 
34 (3 sec) Spontaneous recall 
(2 sec) After: “one word was 
something to wear” 
After: “Was it X, X or X?” 
Short-term 
memory 
N/A N/A Second recall 
What three words did I ask 
you to remember earlier? (3 
times) 
(3 sec) Spontaneous recall 
(2 sec) After: “one word 
was something to wear” 
After: “Was it X, X or X?” 
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(Table C1 continued)     
Number CASI item CASI domain HSD (1983) MMSE (1975) 3MS (1987) 
35 (3 sec) Spontaneous recall 
(2 sec) After: “one word was 
something to wear” 
After: “Was it X, X or X?” 
Short-term 
memory 
N/A N/A Second recall 
What three words did I ask 
you to remember earlier? (3 
times) 
(3 sec) Spontaneous recall 
(2 sec) After: “one word 
was something to wear” 
After: “Was it X, X or X?” 
36 What do we call this part of 
the face/body? 
*Brow/forehead  
*Jaw/chin  
*Shoulder  
*Elbow  
*Wrist 
Language N/A N/A Naming 
What do we call this part of 
the face/body? 
- forehead 
-chin 
-shoulder 
-elbow 
-knuckle 
37 What is this? (show one at a 
time, any order ok) (show 
item: 2 sec for answer; if 
unable, place in hand: 4 sec 
for answer)  
*Spoon  
*Coin  
Language N/A N/A N/A 
38 What is this? (show one at a 
time, any order ok) (show 
item: 2 sec for answer; if 
unable, place in hand: 4 sec 
for answer)  
*Toothbrush  
*Key  
*Comb 
Language N/A N/A N/A 
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(Table C1 continued)     
Number CASI item CASI domain HSD (1983) MMSE (1975) 3MS (1987) 
39 Remember these 5 objects! 
(wait for 5 sec.; cover, then 
ask) 
-What 5 objects did I just 
show you?  
Spoon coin toothbrush key 
comb 
Short-term 
memory 
Recall the 5 
objects that 
were 
presented to 
you earlier 
N/A N/A 
                                                                                               Items not in CASI but were in respective scales 
   HSD (1983) MMSE (1975) 3MS (1987) 
   -What is your 
age? 
-How long 
have you been 
here? 
-When did 
WW2 end? 
-How many 
days are in a 
year? 
-Who is the 
prime 
minister? 
Language 
Name a pencil, and watch 
Mental reversal: count 
back from 5 to 1 OR spell 
‘world’ backward 
 
Note. The CASI was primarily developed using items from the HSD, MMSE, and 3MS. This table highlights how CASI items were 
identical to items from other scales (e.g., CASI item 32, 31), adapted and modified from one of the three measures (e.g., CASI item 
14, 28), or not a part of any of the three measures (e.g., CASI item 4, 26). Note that the MMSE and 3MS used terms to classify 
cognitive domains (e.g., language, mental reversal, registration)—these domains are bolded in this table. 
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APPENDIX D.    COGNITIVE ABILITIES SCREENING INSTRUMENT FACTOR 
ANALYSIS RESULTS ACROSS EXAMS 5-12 
 
 
Figure D1. Standardized confirmatory factor analysis model results for Exam 5 (N = 2,680). 
Crys = crystallized abilities. Fluid= fluid abilities.  
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Figure D2. Standardized confirmatory factor analysis model results for Exam 6 (N = 1,978). 
Crys = crystallized abilities. Fluid = fluid abilities.  
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Figure D3. Standardized confirmatory factor analysis model results for Exam 7 (N = 1,518). 
Crys = crystallized abilities. Fluid = fluid abilities.  
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Figure D4. Standardized confirmatory factor analysis model results for Exam 8 (N = 1,175). 
Crys = crystallized abilities. Fluid = fluid abilities.  
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Figure D5. Standardized confirmatory factor analysis model results for Exam 9 (N = 907). 
Crys = crystallized abilities. Fluid = fluid abilities.  
 
 
 
 
174 
 
 
Figure D6. Standardized confirmatory factor analysis model results for Exam 10 (N = 545). 
Crys = crystallized abilities. Fluid = fluid abilities.  
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Figure D7. Standardized confirmatory factor analysis model results for Exam 11 (N = 378). 
Crys = crystallized abilities. Fluid = fluid abilities.  
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Figure D8. Standardized confirmatory factor analysis model results for Exam 12 (N = 251). 
Crys = crystallized abilities. Fluid = fluid abilities.  
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APPENDIX E.    ASSOCIATION BETWEEN CASI ITEMS & DEMENTIA  
Thirty-nine logistic regression analyses was conducted to investigate how each of the CASI 
items (detailed in Table 6 of Chapter 4) at Exam 6 was linked to ADRD diagnosis (yes/no) 
across Exams 7-12 using the Aim 3 analytic sample. This test was conducted as a follow-up 
of Aim 3 because it is advantageous to use an exam proximal to ADRD Exams 7-12.  
 
Findings indicated that the following nine items were uniquely predictive of ADRD: items 3, 
4, 6, 16, 21, 24, 34, 35, and 39. Eight of these items had negative betas (i.e., higher scores on 
nine items was associated with reduced likelihood of ADRD development) and one item had 
a positive beta (i.e., higher scores on item 3 were associated with greater likelihood of ADRD 
development).  
 
Table E1. Association between Exam 6 CASI items and ADRD diagnosis across Exams 7-12, 
results from 39 logistic regressions (N =1,616) 
CASI item  Crystallized or Fluid b S.E. Odds ratio 95% CI p 
1 Crystallized 0.26 0.20 1.20 0.87 1.94 0.19 
2 Crystallized 0.83 0.44 2.31 0.96 5.52 0.06 
3 Crystallized 0.79 0.36 2.21 1.08 4.49 0.02 
4 Crystallized -0.30 0.14 0.74 0.55 0.98 0.03 
5 Crystallized 0.25 0.24 1.28 0.80 2.08 0.30 
6 Crystallized -0.17 0.08 0.84 0.71 0.99 0.04 
7 Fluid 0.05 0.08 1.05 0.90 1.23 0.46 
8 Fluid -0.06 0.33 0.93 0.48 1.81 0.85 
9 Fluid 0.00 0.06 1.00 0.88 1.13 0.98 
10 Fluid -0.04 0.05 0.95 0.85 1.07 0.45 
11 Fluid -0.07 0.05 0.92 0.84 1.02 0.14 
12 Fluid -0.01 0.05 0.98 0.89 1.09 0.78 
13 Fluid -0.07 0.05 0.92 0.83 1.02 0.13 
14 Fluid 0.18 0.25 1.19 0.71 2.01 0.49 
15 Fluid 0.01 0.14 1.01 0.76 1.34 0.92 
16 Fluid -0.11 0.05 0.88 0.79 0.99 0.03 
17 Crystallized -0.04 0.05 0.96 0.86 1.06 0.45 
18 Crystallized 0.04 0.13 1.04 0.79 1.36 0.74 
19 Crystallized -0.03 0.05 0.97 0.87 1.08 0.60 
20 Crystallized -0.10 0.20 0.89 0.60 1.33 0.59 
21 Crystallized -0.44 0.19 0.64 0.44 0.93 0.02 
22 Crystallized 0.10 0.09 1.10 0.91 1.33 0.29 
23 Crystallized -0.34 0.29 0.70 0.39 1.26 0.24 
24 Fluid -0.06 0.02 0.94 0.89 0.98 0.01 
25 Crystallized -0.01 0.02 0.98 0.92 1.03 0.51 
26 Crystallized 0.05 0.06 1.05 0.93 1.18 0.40 
27 Fluid -0.20 0.14 0.82 0.61 1.08 0.16 
28 Fluid 0.02 0.05 1.02 0.92 1.14 0.64 
29 Crystallized 0.08 0.14 1.08 0.82 1.43 0.56 
30 Crystallized -0.06 0.05 0.93 0.85 1.03 0.21 
31 Crystallized -0.00 0.03 0.99 0.92 1.07 0.96 
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(Table E1 continued)       
CASI item  Crystallized or Fluid B S.E. Odds ratio 95% CI p 
32 Crystallized 0.06 0.09 1.06 0.88 1.27 0.52 
33 Fluid -0.08 0.05 0.92 0.83 1.02 0.14 
34 Fluid -0.12 0.05 0.88 0.80 0.98 0.02 
35 Fluid -0.12 0.04 0.88 0.80 0.97 0.01 
36 Crystallized -0.10 0.07 0.89 0.77 1.03 0.13 
37 Crystallized 0.10 0.24 1.11 0.69 1.78 0.66 
38 Crystallized 0.27 0.25 1.32 0.80 2.17 0.27 
39 Fluid -0.11 0.05 0.89 0.80 0.99 0.03 
 
